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ABSTRACT 
 
 The mammalian central nervous system (CNS) has limited intrinsic repair mechanisms. 
Damage or trauma to the CNS causes a loss of cells, causing motor and cognitive impairments. 
Cell transplantation strategies have made great advances in the last few decades and have been 
essential in the field of regenerative medicine. Recently, biomaterials in conjunction with stem 
cells have been used to supplement therapeutic strategies. The objective of this project was 
using an interdisciplinary approach combining polymers, three-dimensional (3D) scaffolds and 
stem cells to provide a platform for enhancing cell proliferation and differentiation for future 
cell transplantation strategies.  
Poly (ε-caprolactone) (PCL) is a synthetic polymer that can be used to fabricate 
microfibers using a microfluidic technique. Adult rat hippocampal progenitor cells (AHPCs) 
were used to examine the ability of 3D microfibrous scaffolds to support the growth, 
proliferation and differentiation of cells in vitro. In contrast to conventional two-dimensional 
(2D) surfaces, our group revealed that PCL microfibers significantly increased proliferation 
and glial differentiation of AHPCs, demonstrating the importance of topographic cues on 
cellular behavior. Alternatively, we demonstrated the ability to encapsulate AHPCs within a 
hydrogel as opposed to seeding cells onto a polymer surface. Encapsulation and recovery of 
AHPCs from alginate hydrogels demonstrated an increase in proliferation and neuronal 
differentiation, suggesting that fibrous hydrogels may mimic the natural microenvironment 
present in vivo and modulate cell behavior.  
To implement cell-based biomaterial strategies, we chose zebrafish (Danio rerio) as 
our model because they are optically transparent as larvae, enabling transplantation studies to 
be followed in vivo. First, we developed an efficient method to dissociate neural tissue from 
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embryonic zebrafish brains in order to isolate neurons, with the ultimate goal of using these 
cells in conjunction with biomaterials to investigate novel therapeutic strategies. Second, we 
provide preliminary evidence on using zebrafish as a system to investigate biomaterial-based 
cell strategies. 
This work has provided evidence using a combinatorial approach of biomaterials and 
stem cells to promote cell proliferation and differentiation without the use of chemicals. 
Biomaterials provide a permissive environment leading to enhanced cell proliferation and 
differentiation, which may lead to the development of efficacious cell-based therapies.  
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CHAPTER 1.    GENERAL INTRODUCTION 
 
Introduction to the Dissertation 
Worldwide billions of people suffer from trauma or diseases affecting the central 
nervous system (CNS) which consists of the brain, spinal cord and retina. Severe damage to 
these areas leads to a loss of fundamental cells, particularly neurons and glial cells. 
Neurodegenerative diseases and traumatic brain injuries result from the loss of cells, causing 
cognitive and motor impairments. In comparison to amphibians, reptiles and fish, mammals 
have limited intrinsic repair abilities [1]. Currently, there is no treatment for CNS related 
diseases, however it is hypothesized that replacing damaged or lost cells may slow disease 
progression. These strategies are known as ‘cell transplantation therapies’ and have greatly 
advanced in the past few decades. Further, the discovery of stem cells has provided a promising 
approach to developing rational strategies to develop specific cell-based therapies for nervous 
system disorders.  
Experimental strategies using neural stem cells (NSCs) holds great promise for CNS 
rescue and repair due to their ability to self-renew and differentiate into neurons, astrocytes 
and oligodendrocytes, the three fundamental cells of the CNS [2, 3]. Previous studies have 
transplanted NSCs within a damaged nervous system [4-6] as a means to replace lost or 
damaged cells in vivo. Several questions arise for the use of NSCs in cell therapies including 
how to direct cell differentiation in vivo and what mechanism is responsible for enhancing 
functional recovery to the patient. Therefore, it is important to continue the extensive research 
in hopes of developing efficacious cell-based therapies for brain rescue and repair.  
After damage, the microenvironment is filled with inhibitory molecules and a glial scar 
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forms, making it a less permissive environment for repair [7, 8]. Thus, when cells are 
transplanted to such an environment, there is little chance of survival and integration into the 
host, leading to varying functional benefits for patients [9]. Within the local microenvironment, 
known as the ‘niche’, there are signals and cues that direct stem cell differentiation [10, 11].  
Studies have demonstrated the importance of the extracellular matrix on being one of the 
determinant factors guiding stem cell differentiation [12, 13], leading researchers to investigate 
techniques to mimic the natural microenvironment in vitro as a way to study these mechanisms 
in a controlled environment. 
Biomaterials and three-dimensional (3D) scaffolds offer a unique tool to study cell 
differentiation within a defined environment, thus mimicking a natural environment to better 
understand future in vivo outcomes. Natural and synthetic polymers can be biocompatible and 
biodegradable, leading investigators to utilize them in various forms. Neural tissue engineering 
is an emerging field within regenerative medicine that focuses on repairing the damaged 
nervous system using a combination of stem cells, biochemical factors and biomaterials 
(Figure 1). The overarching goal is to develop novel therapies that facilitate and promote cell 
transplantation strategies. This work attempts to better understand the influence 3D scaffolds 
have on stem cell proliferation and differentiation to determine their uses in biomaterial-based 
cell delivery methods. Specific aims for this research were as follows: 
1. Characterization of AHPCs seeded on PCL microfibrous scaffolds compared to 2D 
surfaces. 
2. Encapsulation, recovery and characterization of viable AHPCs from alginate 
hydrogels fabricated using a microfluidic technique. 
3. Dissociation of neural tissue from embryonic zebrafish brains to obtain a population 
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of neurons that could potentially be used to study biomaterial-based cell delivery 
systems. 
4. Provide preliminary evidence for using zebrafish as a model system to understand 
the potential for certain 3D scaffolds to serve as cell delivery systems. 
 
Figure 1: Overview of approaches combining stem cells, polymeric scaffolds, biomaterials, 
drug delivery systems, gene therapy and cellular engineering to develop experimental 
strategies for neural tissue engineering and repair. [14] 
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Dissertation Organization 
This dissertation is a collection of three manuscripts that are published or submitted to 
a peer-reviewed journal. Chapter 4 is a short research report in which preliminary, but novel, 
findings are described. These manuscripts are preceded by a general introduction and a 
comprehensive literature review. The dissertation concludes with a discussion and conclusions. 
Acknowledgments and references for each section are found at the end of their respective 
sections. 
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CHAPTER 2.    LITERATURE REVIEW 
 
Literature Review 
Parts of this literature review are adapted from the following book chapters:  
 
Sandquist, E. J., M. Uz, A. D. Sharma, B. B. Patel, S. K. Mallapragada and D. S. Sakaguchi 
(2016). Stem Cells, Bioengineering, and 3-D Scaffolds for Nervous System Repair and 
Regeneration. Neural Engineering: From Advanced Biomaterials to 3D Fabrication 
Techniques. L. G. Zhang and D. L. Kaplan. Cham, Springer International Publishing: 25-81. 
 
Patel, B. B., A. D. Sharma, N. Mammadova, E. J. Sandquist, M. Uz, S. K. Mallapragada and 
D. S. Sakaguchi (2019). Chapter 10 - Nanoengineered biomaterials for retinal repair. 
Nanoengineered Biomaterials for Regenerative Medicine. M. Mozafari, J. Rajadas and D. 
Kaplan, Elsevier: 215-264. 
 
The mammalian central nervous system 
 
The mammalian central nervous system (CNS) is a complex system consisting of the 
brain, retina and the spinal cord. It is responsible for integrating sensory information and 
coordinating movements via the peripheral nervous system (PNS). Two main classes of cells 
are present in the CNS: nerve cells and glial cells. Nerve cells, also known as neurons, are 
specialized cells responsible for transmitting information from the environment to other 
neurons. Neurons can be classified by shape as Ramón y Cajal first described [1]. Three groups 
of neurons exist: unipolar, bipolar and multipolar, characterized by the number of primary 
processes emanating from the cell body. Unipolar neurons have one branch that serves as the 
axon whereas a bipolar neuron has two processes: the axon that carries information to the CNS 
and the dendrite that conveys information from other neurons. Multipolar neurons are most 
dominant in the CNS and are characterized by a single axon and many dendrites. Further, there 
are three types of functional neurons: sensory, motor and interneurons. Sensory neurons carry 
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information from the body to the nervous system while motor neurons carry signals from the 
brain or spinal cord to the muscles. Interneurons can project signals over long distances 
(projection interneurons) or in close proximity (local interneurons) [2].  
Glial cells are support cells that surround the nerve cell bodies and axons. They have 
vital housekeeping roles such as removing debris after injury, contributing to repair processes, 
metabolic functions and guiding axonal growth during development [2]. In the mammalian 
CNS, there are two principal classes of glial cells: oligodendrocytes and astrocytes. 
Oligodendrocytes are responsible for producing myelin used to insulate nerve cell axons to 
conduct electrical signals. Astrocytes are the most abundant glial cell in the brain with a high 
density of potassium ion channels. Due to this, one of their fundamental roles is to maintain 
potassium ion concentrations in the extracellular space when neurons fire action potentials [3]. 
Other roles of astrocytes include regulating synaptic activities through the release of 
gliotransmitters and growth factors [4], influencing the formation of the blood-brain barrier [5] 
and promoting neurogenesis from adult neural stem cells in the brain [6].  
 
Neurogenesis  
 
In mammalians, the neuroectoderm of the neural plate gives rise to the neural tube. The 
brain, retina and spinal cord are derived from the neural tube, containing the neuroepithelial 
progenitor cells. While development continues, these cells proliferate and give rise to a 
population of neural stem cells (NSCs) pools. In later stages of development, NSCs undergo 
asymmetric division to give rise to specific progenitors such as glial progenitors. There are 
several regions of the CNS including the cortex, thalamus and spinal cord that contain 
populations of NSCs that give rise to neurons, a process known as neurogenesis. It was once 
established that neurogenesis does not continue after birth and no new cells are added into the 
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neuronal network. Additionally, NSCs are defined as cells that are able to proliferate and 
generate not only neurons, but astrocytes and oligodendrocytes too. It is important to note that 
a neural progenitor cell can differentiate into more than one cell type while a neural ‘precursor’ 
cell is referred to as a mixed population of cells, both with ‘stem’ and ‘progenitor’ properties. 
For many decades it was understood that neurogenesis does not occur after development and 
no new neurons are generated in adulthood. 
In 1983, Goldman and Nottebohm investigated what phenomenon contributes to the 
growing vocal control nucleus in adult female canaries. It was hypothesized that the likely 
factor could be due to neurogenesis. To test this, they injected thymidine-H3, a pyrimidine 
deoxynucleoside that incorporates into newly synthesized DNA, into brains. They found that 
neurons had incorporated the thymidine, indicating these were new neurons born after birth  
[7]. Later, the discovery of neurogenesis in adult mammalians gave hope that the brain has the 
capability to repair itself, but to an extent. One of the first studies investigating adult 
neurogenesis in rodents also used thymidine-H3 [8]. The brain has two regions in which 
dividing cells are found in vivo: the subventricular zone (SVZ) of the lateral ventricles and the 
subgranular zone (SGZ) part of the dentate gyrus of the hippocampus [9, 10]. In adults, the 
progenitor cells from the SVZ travel a long distance to the olfactory bulb via the rostral 
migratory stream and differentiate into neurons [11, 12]. Progenitors from the SGZ travel to 
the granule cell layer then differentiate into hippocampal granule cells [8, 13]. These 
progenitors are called neural stem cells (NSCs) which give rise to neurons and glia in 
embryonic, neonatal and adult stages in life.  
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Controversy regarding adult neurogenesis 
 
 Studies investigating neurogenesis have occurred in animals and very few have been 
completed in humans. Recent reports have investigated whether adult neurogenesis does occur 
in humans and whether animal models are relevant when studying human health. In 2018, two 
studies reignited the question on whether adult neurogenesis occurs in humans. Sorrells and 
colleagues demonstrated that the number of proliferating progenitors in the brain decreases 
rapidly after the first year and neurogenesis does not continue into adulthood [14]. On the other 
hand, a few weeks after that study was published, Boldrini and colleagues provided evidence 
that lifelong neurogenesis does occur in humans and pools of neural progenitors exist at various 
ages [15].  
 Both studies used similar methods to conduct experiments. Currently, the “gold 
standard” for studying adult neurogenesis in animals involves a birthdating method in which 
administration of bromodeoxyuridine (BrdU) (a thymidine analog) gets incorporated into the 
DNA of dividing cells, later detected using immunohistochemistry [16]. Several studies have 
demonstrated adult neurogenesis in the hippocampus does occur in humans [15, 17-19] along 
with nonhuman primates [20, 21]. However, earlier studies have also shown that the amount 
of adult neurogenesis is substantially decreased with age [22] and most recently, controversy 
arose when Sorrells et al. concluded the absence of neurogenesis in adults [14]. Using common 
markers such as doublecortin (DCX) and polysialylated-neural cell adhesion molecule (PSA-
NCAM) to label neurons, this study found that the number of proliferating neurons decreases 
rapidly after 13 years of age indicating the absence of adult neurogenesis [14]. However using 
similar methods, Boldrini and colleagues demonstrated that humans maintained similar levels 
of neurogenesis in adulthood [15]. Several technical differences may account for the opposing 
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results. Factors such as tissue collection, tissue preservation and fixation procedures may all 
lead to differences in staining, ultimately leading to differences in results. This is important 
when detecting neurons using the marker DCX because the longer the postmortem delay, the 
cell morphology changes thus hindering signals from immunohistochemistry. Sorrells and 
colleagues used brains with longer postmortem delays compared to Boldrini et al. which may 
have led to discrepancies in results. Overall, there is much controversy regarding adult 
neurogenesis in human brains and more research and techniques may help elucidate this topic.  
 
CNS regeneration 
 
Traumatic brain injuries and neurodegenerative diseases are the result of progressive 
degeneration of nerve cells causing sensory, motor and cognitive dysfunctions. The 
neuroregenerative capacity of the CNS varies across species such as fish and amphibia. Unlike 
the PNS, the mammalian CNS has a limited ability to regenerate after damage. One of the key 
differences between the mammalian PNS and CNS regenerative capacity is due to the glial 
cells (Schwann cells and oligodendrocytes, respectively) that produce the myelin sheath 
around axons that support them. The myelin sheath serves as an electrical insulator and 
promotes the propagation of an action potential. Studies have demonstrated that unlike the 
CNS, the PNS is a permissive environment allowing for regeneration of severed axons [23, 
24]. After a peripheral nerve injury (PNI), the nerve begins to degenerate and demyelinate 
causing loss of sensory and motor function. In the distal part of the nerve, Wallerian 
degeneration occurs while the proximal stump begins to grow and regenerate. Schwann cells, 
the glial cells of the PNS, begin to proliferate and remove myelin debris before macrophages 
join this process. These glial cells also secrete trophic factors such as nerve growth factor 
(NGF), brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic 
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factor (GDNF) in order to promote the survival of the injured neuron [25-28]. A cascade of 
signaling pathways ultimately leads to axonal regeneration and growth cone formation [29]. 
Additionally, Schwann cells upregulate adhesion molecules such as neural-cell adhesion 
molecule (NCAM) that are critical in supporting axonal regeneration [30].  
In contrast to the PNS, oligodendrocytes are the myelin-producing glial cells in the 
CNS. Oligodendrocytes extend processes that wrap around several neighboring axons. A 
population of adult oligodendrocyte progenitor cells (OPCs) (also known as nerve/glial antigen 
2 (NG2)-glia) are thought to have diverse roles such has influencing neuronal activity, synaptic 
growth and plasticity [31]. In demyelinating diseases, remyelination occurs rapidly and 
efficiently and could be attributed to either endogenous oligodendrocytes, progenitors 
differentiating into oligodendrocytes or other progenitor cells near the lesion site. During injury 
when myelin repair is needed, OPCs proliferate and differentiate into oligodendrocytes that are 
capable of remyelination [32, 33]. However, OPCs also produce chondroitin sulfate 
proteoglycans, known to have inhibitory effects on neuronal cells [34, 35]. In general, 
oligodendrocytes express multiple inhibitors of axon growth including myelin associated 
glycoprotein (MAG), oligodendrocyte myelin glycoprotein (OMgp) and Nogo-A that bind to 
receptor complexes on neurons activating Rho signaling pathways, ultimately leading to 
inhibition of axon outgrowth [36-38].  
When damage to the CNS occurs, it undergoes reactive gliosis (also called glial 
scarring) as a response mechanism. Neurons within the CNS lack intrinsic regenerative 
capabilities [39]. Glial cells, particularly astrocytes, become reactive, showing signs of 
hypertrophy in cellular processes and changes in function in order to help limit further tissue 
damage and restore homeostasis [40]. The upregulation of intermediate filament proteins, such 
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as glial fibrillary acidic protein (GFAP), vimentin and Nestin, are often diagnostic markers for 
CNS pathologies; GFAP in particular is a well-established marker for astrocytes [41]. A glial 
scar is formed and myelin-associated molecules within the site further inhibits axonal regrowth 
[42, 43]. However, a recent study demonstrated that astrocyte scars may be enabling 
spontaneous axon regrowth through the upregulation of certain chondroitin sulfate 
proteoglycans (CSPGs) that support axon regrowth [44]. Several other studies have 
demonstrated that the glial scar plays a role in reducing inflammation after stroke or spinal 
cord injuries (SCI) [45-47]. In an experimental model of Alzheimer’s disease, astrocytes have 
been shown to migrate and help degrade amyloid plaques [48]. Thus, although astrocytes may 
be inhibiting complete CNS regeneration, they are crucial cells within the CNS. 
 
Stem cells  
A stem cell is defined as a cell that is able to self-renew and differentiate from an 
immature cell to a post-mitotic mature cell. Second, stem cell division occurs asymmetrically, 
producing one identical daughter cell and one daughter progenitor cell that is more committed 
to a differentiative state. These two traits make stem cells an attractive and powerful option for 
developing therapeutic strategies. Stem cells can be transplanted as a way to alleviate 
symptoms associated with disease progression. Diseases such as Parkinson’s disease are 
characterized by the loss of dopaminergic neurons that cause motor and cognitive impairments 
[49]. To help replace dying cells, stem cells offer a unique approach to repopulate those lost 
cells with hopes of slowing disease progression. 
Stem cells can be derived from different tissues including brain, lung, kidney, bone 
marrow, adipose tissue, etc. and are characterized based upon their differentiation potential 
[50]. Totipotent stem cells are able to differentiate into all cells of an organism whereas 
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multipotent stem cells are more restricted in their differentiation capabilities. Multipotent stem 
cells were first identified in hematopoietic cells due to their ability to self-renew and 
differentiate into specific cell types [51, 52]. A stem cell’s fate is determined by its 
environment, also called its niche [53]. Stem cells have the capacity to secrete cytokines, 
chemokines, growth factors and extracellular matrix (ECM) molecules, all which provide 
neuroprotective benefits (reviewed in [54]).  In regard to seeking regenerative therapies, there 
is great potential for stem-cell based approaches to help replace cells that are lost to damage or 
disease. Not only do stem cells have the ability to differentiate into a variety of cell types, they 
also possess autocrine and paracrine capabilities making them a promising approach to 
therapies.  
 
Pluripotent stem cells 
Pluripotent stem cells have the ability to differentiate into cells from the three germ 
layers: endoderm, ectoderm and mesoderm. Two types of pluripotent stem cells exist: 
embryonic stem cells and induced pluripotent stem cells. Pluripotency can be confirmed by 
teratoma formation, a tumor with cells and tissue from all three germ layers and may consist 
of organs, teeth, muscle, cartilage and hair [55]. Chimera formation is another test of 
pluripotency in which embryonic stem cells can be injected into an embryo in order to evaluate 
their ability to form all three germ layers [56]. 
Pluripotent embryonic stem cells 
Mouse embryonic stem cells (ESCs) were first isolated from the inner cell mass of a 
blastocyst, which later gives rise to an embryo [57]. Transplantation of the mouse embryonic 
stem cells into the blastocyst proved pluripotency of the stem cells [56]. Later, non-human 
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primate ESCs were derived from rhesus monkeys [58] and marmosets [59]. Finally, in 1998, 
the first human embryonic stem cell lines were derived from donated embryos; once 
transplanted into mice, teratoma formation confirmed pluripotency of the human ESCs [60]. 
Embryonic stem cells can be induced towards a neuronal fate using retinoic acid (RA) 
[61, 62]. In culture, addition of basic fibroblast growth factor (bFGF) promotes ESCs to 
proliferate whereas removal of the factor promotes differentiation towards neuronal and glial 
fates [63]. In defined conditions, ESCs can be differentiated into glial precursors and 
differentiate into oligodendrocytes and astrocytes with great applications for studying myelin 
related diseases [64]. Embryonic stem cells have been differentiated into serotonergic neurons 
[65], GABAergic neurons [66], dopaminergic neurons [67], motor neurons [68] and cortical 
neurons [69]. Due to the pluripotent nature of the cells, ESCs can be also be differentiated into 
ocular lineages including retinal progenitors cells (RPCs) [70, 71], photoreceptor precursors 
[72, 73] and retinal pigment epithelial cells [74, 75]. Beyond differentiation into cells found 
within the CNS, ESCs have also been induced to differentiate into other cell types for various 
therapies. Cardiomyocytes have been generated using human ESCs with application for 
facilitating heart repair [76, 77]. Other cells include hepatocytes [78], insulin-secreting 
structures [79], endothelial cells [80], osteoblasts [81] and vascular progenitor cells [82].  
Embryonic stem cells have been proposed as therapeutic strategies for 
neurodegenerative released diseases. In rodent models of Parkinson’s disease, undifferentiated 
ESCs have been shown to differentiate into dopaminergic neurons and decreased motor 
impairments [67, 83-85]. Demyelination is a result of several neurodegenerative diseases, 
therefore making oligodendrocytes an ideal cell type to transplant. In culture, ESCs can be 
differentiated into oligodendrocytes and astrocytes precursors, and verified for their ability to 
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produce myelin in vivo. Once transplanted into a myelin deficient rat, the ES cell–derived glial 
precursors myelinated damaged axons in the brain and spinal cord, demonstrating them to be 
a valuable cell type for neural transplantation [86]. When ESCs are transplanted into rat spinal 
cords, Liu and colleagues demonstrated their ability to differentiate into myelin-producing 
cells to replace lost myelin within the CNS [87]. However, despite promising results in rodents, 
there are ethical and moral concerns associated with ESCs thus limiting their use in clinical 
therapies. 
Induced pluripotent stem cells  
Due to the ethical barriers associated with ESCs, research has been focused on using 
adult somatic cells and de-differentiating them back to a pluripotent state. These cells are 
known as induced pluripotent stem cells (iPSCS) and are patient-specific, thus reducing the 
risk of graft-host reactions. Four transcription factors have been shown to be sufficient to 
induce a pluripotent state from a somatic cell: Oct4, Sox2, Klf4 and cMyc, also known as the 
“Yamanaka factors” [88]. Dermal fibroblasts have been used to generate human iPSCs using 
the four defined transcription factors, with hopes of developing patient-specific therapies [89-
91]. Several studies have further differentiated iPSCs into neural precursors [92], 
oligodendrocyte precursors [93], dopaminergic neurons [84] and motor neurons [94]. Overall, 
the use of iPSCs has shown promise for developing cell-based therapies but may also be used 
for drug development and disease modeling studies in vitro.  
 
Multipotent stem cells 
Multipotent stem cells have the ability to self-renew and differentiate into specific 
lineages unlike pluripotent stem cells. Multipotent stem cells can be isolated from juvenile and 
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adult tissue including brain, spinal cord, retina, heart, liver, kidney, bone marrow, and more 
(Figure 1) [50]. In most cases, using adult stem cells for therapies is often seen as less 
controversial, but includes advantages like autologous transplantation which can help 
minimize the host immune reaction.  
 
Figure 1: Adult stem cells are naturally present throughout the body in various tissues and 
organs.  This figure illustrates the different tissue sources from which adult stem cells can be 
isolated [50]. 
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Adult neural stem cells and adult neural progenitors 
Neural stem cells (NSCs) are a multipotent cell population and are more restricted in 
potential in terms of differentiation [95-97]. They are a self-renewing population of cells that 
can differentiate into the fundamental cells of the CNS: neurons, astrocytes and 
oligodendrocytes [10, 98] and can be derived from ESCs and iPSCs under defined conditions 
[99-101]. Further, NSCs can be isolated from fetal or adult brain regions such as the SVZ and 
SGZ and grown in the presence of fibroblast growth factor-2 (FGF-2) [102] or epidermal 
growth factor (EGF) [103] to promote proliferation. To induce cell differentiation, the growth 
factor is usually withdrawn [9]. In vitro, cells are typically characterized by staining with 
antibodies against TuJ1 (class III beta-tubulin present in neurons), GFAP (glial fibrillary acidic 
protein present in astrocytes), and GalC (galactocerebroside present in oligodendrocytes) [9].  
 
Neural stem/progenitor cells aiding in CNS repair 
 
Neural stem/progenitor cells (NSPCs) have been proposed as a therapeutic strategy for 
CNS rescue and repair. It is important to note that studies transplanting ‘NSCs’ are often 
grafting a mixed population of cells, both “true” stem cells and more differentiated cells. 
Therefore, the term “neural progenitor cells” (NPCs) or “precursor cells is often used to define 
a mixed population of cells [104]. In general, NSPCs can be considered as an ideal cell type 
for brain rescue and repair due to certain characteristics. The ability to proliferate in vitro, 
survive transplantation into the nervous system, integrate with the host tissue and repopulate a 
damaged nervous system are all attractive characteristics for researchers developing cell-based 
therapies. Additionally, NSPCs can be genetically modified to release neurotrophic factors and 
neurotransmitters that facilitate regeneration and provide neuroprotection.  
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Neural stem/progenitor cells and neurotrophic factors 
Neural stem/progenitor cells have been studied extensively in vitro and in vivo. Once 
cells are characterized in vitro, studies have grafted stem cells back into the brain to further 
investigate the fate potential in vivo. The main objective for transplanting NSCs into a damaged 
environment is to stimulate the proliferation, survival, and migration of endogenous cells and 
replace the damaged or dead cells. Recent studies in the field have demonstrated recovery post 
transplantation is often mediated through neurotrophic systems. Neurotrophic factors are 
involved in diverse functions within the CNS including neural development, cell 
differentiation and proliferation, synaptic plasticity and synapse formation [105, 106]. Lu and 
colleagues demonstrated that NSCs constitutively secrete NGF, BDNF and GDNF in vitro and 
once transplanted, promote axonal regrowth in a rat spinal cord injury (SCI) model [107]. 
Additionally, NSCs have also been shown to express GDNF, along with BDNF and NGF, 
which has been postulated to support axonal regrowth in vivo [108]. Because neurotrophic 
factors are crucial in a variety of functions, NSCs have been transduced to secrete therapeutic 
levels of neurotrophic factors such as neurotrophin-3 (NT-3) [107, 109], NGF [110], BDNF 
[110, 111], and GDNF [112, 113] to promote better functional recovery in diseased animal 
models. Together, these studies demonstrate the potential of NSCs to be used for 
transplantation for CNS rescue and repair. 
 
Neural stem cell transplantation 
 
One of the hallmarks of a neuron is to transmit information through electrical signals 
using action potentials. Song and colleagues isolated NSCs from the adult hippocampus and 
demonstrated their capability to retain functional characteristics such as firing an action 
potential and forming functional synapses [114]. Gage and colleagues isolated NSCs from the 
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adult rat hippocampus that expressed neuronal and glial markers. After transplantation of these 
cells back into a rat hippocampus, they demonstrated the ability of the transplanted cells to 
migrate and integrate into the host tissue. The grafted cells were also able to differentiate into 
mature neurons [96]. Additionally, NSCs grafted into neurogenic regions differentiate into 
neurons however if transplanted into non-neurogenic regions this phenomenon is not seen 
[115]. Furthermore, exogenous transplanted NSCs are drawn to neurodegenerative 
environments and can rescue damaged neurons [116]. In rats with ischemic stroke, human 
NSCs transplanted intravenously resulted in improved sensorimotor deficits [117]. Cummings 
and colleagues cultured human NSCs as neurospheres and transplanted them into SCI mice to 
evaluate locomotor recovery [118]. This study demonstrated that if the transplanted cells were 
selectively ablated using diphtheria toxin, no functional recovery was seen suggesting that 
NSCs have therapeutic potential for aiding in CNS repair. Further, NSCs transplanted into 
retinas have migrated and integrated into hosts, and some even show grafted cells express 
mature neuronal markers [119-122] 
Building on rodent studies, research in primates further demonstrates that human NSPC 
derived neurospheres provide benefit and improve functional recovery in a SCI, while also 
differentiating into neuronal and glial lineages [123]. In studies conducted by Redmond and 
colleagues, human NSCs transplanted into the brains of Parkinsonian primates promoted 
endogenous tyrosine hydroxylase (TH) cells to survive [124] and later demonstrated that 
transplanted cells survived, migrated and even differentiated into TH positive cells [125, 126]. 
While stem cell-based therapies have proven to be useful, several studies have gained 
an understanding on how exogenous cells interact with the endogenous cells in a diseased 
environment. It has been shown that activity in the SVZ increases during injury indicating that 
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new neural cells are being born [127, 128]. During damage, endogenous NSCs can migrate 
from the site of birth to the injury site in order to replace specific cell types. Rats with cerebral 
ischemia were administered BrdU to label dividing cells and the phenotype of the proliferating 
cells was studied. In the injury model, the number of proliferating cells increased and expressed 
neuronal proteins such as NeuN and microtubule associated protein-2 (MAP2) [129]. Parent 
and colleagues investigated the effect of cerebral ischemia on neurogenesis within the SVZ 
and discovered that neurogenesis increases, leading to the production of new neurons [130]. 
After traumatic brain injury, expression of protein markers such as DCX and PSA-NCAM 
increased as well as the number of proliferating NSCs indicating increased neurogenesis [131]. 
Thus, promoting the endogenous stem cells to become activated may serve as a mechanism for 
neural repair. Gaining a more thorough understanding of adult neurogenesis can contribute 
greatly to our knowledge of neurodegenerative diseases and their treatments.  
 
Non-neural adult stem cells 
 
 Although the CNS is primarily an immunologically privileged site, it is still important 
to consider immune rejection of heterologous cell transplants. Using immunosuppressive drugs 
may also hinder the effectiveness of transplanted cells. Therefore, performing autologous cell 
transplantation is an attractive choice for cell-based therapies. There are various somatic stem 
cells that are commonly used for CNS rescue and repair: mesenchymal stem cells, adipose 
stem cells, umbilical cord blood cells and dental pulp stem cells. Although they are non-
neurogenic stem cells, they have shown remarkable abilities to induce neurogenesis and exert 
neuroprotection benefits in diseased models. 
 Mesenchymal stem cells (MSCs) were first recognized in bone marrow in which 
fibroblast colonies differentiated into osteoblasts, chondrocytes and adipocytes [132]. Sources 
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such as adipose tissue, placenta, umbilical cord blood and skin tissues have all been used to 
generate populations of MSCs. In addition, MSCs self-renew but also secrete pro-survival 
factors such as BDNF [133], vascular endothelial growth factor (VEGF) [134], insulin-like 
growth factor-2 (IGF-1) [135] and transforming growth factor-beta (TGFβ) [136]. Another 
advantage of MSCs is the expression of major histocompatibility complex (MHC) class I 
molecules [137]. Transplanted MSCs would be protected from being detected by natural killer 
cells, the major effector cells of the innate immune system [138] and thus be used in therapeutic 
strategies. 
There are several methods to induce MSCs into neural lineages such as the use of 
cytokines [139], soluble factors from neural cells [140], growth factors [141], or chemical 
induction via transdifferentiation [142, 143]. Transplantation of MSCs into rodent brains has 
shown that the exogenous cells can migrate and differentiate into astrocytes [144] and 
oligodendrocytes [145, 146]. Additionally in damaged retinas, bone marrow derived MSCs 
differentiated into retinal neural cells as detected by cell specific markers including calbindin, 
vimentin and rhodopsin [147]. Kicic and colleagues also demonstrated that transplanted MSCs 
to differentiate into photoreceptors [148]. 
Adipose-derived stem cells (ADSCs) are another alternate source of cells for neural 
repair strategies. In normal conditions, they can differentiate into adipocytes, osteoblasts, 
chondrocytes and muscle cells [149]. Similar to bone marrow derived MSCs, ADSCs are also 
easily obtained from adipose tissue which is readily available. Using specific methods, ADSCs 
can be induced towards neural lineages. Once differentiated into neural-like cells, these 
transdifferentiated cells express markers typical of neural lineages such as GFAP, Nestin and 
NeuN [150]. Another study demonstrated differentiation of ADSCs into neuron-like cells 
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expressing MAP2, neurofilament (NF) and neuron specific enolase (NSE) but also showed 
functional characteristics similar to neurons [151]. 
Transplantation of ADSCs have shown great results regarding nervous system repair 
and rescue. Human ADSCs have been induced into a neural lineage in vitro and subsequently 
transplanted into rats following middle cerebral artery occlusion, improving functional deficits 
[152]. Intravenous administration of human ADSCs in a rat traumatic brain injury model 
improved cognitive function and motor impairments [153]. In a mouse middle cerebral artery 
occlusion model, Zhou and colleagues demonstrated that the transplanted human ADSCs can 
transdifferentiate into neurons, thereby improving function and also protecting endogenous 
neurons in vivo [154]. Additionally, ADSCs treated with n-Butylidenephthalide, a compound 
with anti-inflammatory and neuroprotective effects, transplanted into a mouse model of 
Parkinson’s disease greatly improved motor function [155].  
Dental pulp stem cells (DPSCs) are self-renewing cells and were first isolated from 
third molar dental pulp [156] but can be derived from human exfoliated deciduous (SHED) 
teeth [157], supernumerary teeth [158], and natal teeth [159]. In certain conditions, these cells 
differentiate into adipocytes, chondrocytes and osteoblasts; however, several studies have 
induced DPSCs towards a neural lineage for nervous system repair. Using specific induction 
methods, DPSCs can be differentiated into neurons [160, 161] but more specifically 
dopaminergic neurons [162] and cholinergic neurons [163]. Transplantation of DPSCs have 
shown to exert neuroprotective benefits to endogenous cells in vivo, possibly through 
neurotrophic factor secretion [164-166]. Additionally, Song and colleagues sought to compare 
which cell type, DPSCs or bone marrow derived MSCs, would provide the most benefit in a 
rat stroke model. Rats were injected with these two different cell populations and although 
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both cell types improved functional recovery, DPSCs significantly reduced reactive gliosis 
thus indicating they may serve as a better cell type for treating stroke injuries [167].  
Human umbilical vein endothelial cells (HUVECs) can be harvested at birth from 
various parts of the umbilical cord including cord blood [168], Wharton’s jelly [169, 170] and 
cord vein endothelial lining [171]. Haile and colleagues investigated HUVECs as a possible 
cell type to generate neural cells. Using transcription factors necessary to induce a pluripotent 
state, they demonstrated that HUVECs can differentiate and generate neurons, astrocytes and 
oligodendrocytes [172]. As a therapeutic strategy for Parkinson’s disease, cord blood-derived 
stem cells treated with all-trans retinoic acid induced the expression of proteins Nurr1, Wnt1 
and En1, all found in dopaminergic neurons [173]. Lee and colleagues demonstrated that 
transplanted HUVECs provided neurovascular protection in a model for neonatal asphyxia 
[174, 175]. Stem cells derived from Wharton’s jelly have been used to generate dopaminergic 
neurons using a stepwise process in which factors including fibroblast growth factor-8 and 
sonic hedgehog were used. Immunolabeling revealed cells were positive for TH and also 
secreted dopamine in vitro indicating cells had differentiated. Additionally, once transplanted 
in a Parkinsonian rat, cells were viable after 4 months and rats showed improved motor 
function [176]. 
Olfactory ensheathing cells have been derived from the olfactory bulb of the forebrain 
and olfactory mucosa. These cells are unique because of their ability to secrete neurotrophic 
factors such as BDNF and NGF [177, 178] but also express cell surface molecules including 
N-CAM and laminin that support neurite growth [179]. Several studies utilize these 
characteristics and co-transplant OECs with another cell type. When transplanted with other 
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cells, including NSCs, OECs increase survival of transplanted cells and provide a functional 
benefit, further displaying a synergistic effect [180-182].  
Adult somatic stem cells are an important class of stem cells with great potential for 
neural repair but require further investigation prior to clinical studies. These cells have 
significant advantages including ease of isolation, fewer ethical concerns and lower risks of 
immunogenicity. Stem cells from pluripotent and multipotent sources offer a way to model 
disease biology and develop novel cell-transplantation based strategies. Stimulating 
endogenous neurogenesis along with cell transplantation may have great therapeutic potential 
for brain repair however challenges such as tissue/cell availability, cell survival, directing stem 
cell fate and appropriate host integration are concerns [183-185]. In a major effort to improve 
cell transplantation strategies, biomaterials have been proposed as to help advanced the field 
of regenerative medicine. Combining stem cell technology with bioengineering strategies 
provides a powerful and multifaceted tactic to develop novel experimental strategies useful for 
neural engineering.  
 
Biomaterials 
Biomaterials are substances that can interact with the biological system. In the past few 
decades, extensive studies using biomaterials have helped advance therapeutic strategies and 
make a noteworthy contribution in the field of neural tissue engineering. From providing 
structural support for transplanted cells to serving as novel delivery vehicles for therapeutic 
compounds, biomaterials have a wide array of uses in tissue engineering and regenerative 
medicine. Combining biomaterials with stem cell-based therapies can provide innovative ways 
to promote regeneration in the damaged brain. Additionally, the wide variety of extracellular 
matrix molecules, natural polymers and synthetic polymers used to construct scaffolds 
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introduces a large platform for aiding in CNS repair and rescue. Further, stem cell fate is 
determined by a variety of factors including the niche it is growing in. One of the forefront 
studies demonstrating this phenomenon was studying MSC differentiation on substrates with 
varying elasticities. Mesenchymal stem cells grown on soft substrates appeared neuronal-like 
compared to stiffer substrates that promoted cells towards osteogenic lineages [186]. Substrate 
modulus has also been shown to direct NSC differentiation, with softer and more elastic 
materials favoring neuronal differentiation and stiffer materials promoting glial differentiation 
[187, 188]. Stem-cell based therapies in combination with biomaterials can provide valuable 
insight to guide cell differentiation in vitro and in vivo.  
Synthetic and natural polymers 
In general, the engineered materials for neural repair should be biocompatible, 
biodegradable, and able to undergo further modulation in surface chemistry, degradation rates, 
and release mechanisms for drug/gene/cell delivery. Various natural and synthetic polymers 
have been used to fabricate scaffolds. Natural polymers are less cytotoxic and can be extracted 
from naturally occurring sources [189]. These include collagen, laminin, fibronectin, chitin, 
alginate, gelatin, etc. but face problems such as immunogenicity and are harder to manipulate 
compared to synthetic polymers [190]. Synthetic polymers for investigating neural repair 
include poly(glycolic acid) (PGA), poly(lactic acid) (PLA), poly(L-lactic acid) (PLLA) and 
poly(ɛ-caprolactone) (PCL) [50]. Disadvantages of synthetic polymers include lack of 
similarity to the ECM and the release of cytotoxic compounds following degradation. Scaffolds 
composed of synthetic or natural polymers are extensively studied for applications in tissue 
engineering, cell encapsulation methods, scaffolds for cell differentiation, gene delivery and 
drug delivery strategies [50, 191]. 
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Polymeric scaffolds 
A variety of scaffolding constructs can help increase the efficacy of cell-based 
strategies. From nano-scale to micro-scale scaffolds, studies have employed various techniques 
to fabricate scaffolds of different polymers. Additionally, a variety of stem cells have been 
studied in conjunction with scaffolds such as ESCs, iPSCs, MSCs, and NSCs for nervous 
system rescue and repair. In rat SCI models, PCL scaffolds seeded with Schwann cells and 
iPSC derived NSCs promoted tissue remodeling, thus improving motor function [192]. 
Polymeric scaffolds have also been used to increase the number of transplanted cells to a 
damaged retina. Lavik and colleagues seeded RPCs on polymeric scaffolds and transplanted 
them into a damaged rat eye. Results showed delivering RPCs via a scaffold directed cell 
differentiation towards photoreceptors as well as increased cell survival post-transplant [193]. 
Singh et al., developed a scaffold that mimics the ECM of a retina in order to promote 
differentiation of human ESCs into retinal cells. Once transplanted into mice, there was 
minimum immune response and several transplanted cells migrated to the inner retinal layers 
[194]. Several other studies have further demonstrated the use of cell-seeded polymeric 
scaffolds as potential cell delivery platforms to the brain [195-198] and retina [199-201]. 
Surface topography plays a fundamental role in determining cell fate due to changes in 
mechanical cues presented to cells such as tensile and elasticity. Scaffolds can serve as in vitro 
templates to direct stem cell differentiation. Adult hippocampal progenitor cells (AHPCs) 
grown on micropatterned polymers have demonstrated the importance of topography in 
promoting neuronal differentiation [202]. Micropatterned scaffolds have also been 
demonstrated to influence the alignment and elongation of transdifferentiated MSCs in vitro 
[203]. Silk fibronin films functionalized with integrin binding laminin peptide motifs increase 
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neuron specific markers MAP2, class III β-tubulin (TUBB3) and neurofilament light 
polypeptide (NEFL) from differentiated human MSCs [204]. Poly(ethylene glycol) diacrylate 
(PEGDA) scaffolds of varying moduli and seeded with RPCs demonstrated that cells grown 
on scaffolds have different adhesion properties as well as changes in expression of 
inflammation markers, suggesting the importance of scaffold design for future transplantation 
studies [205].  
 
Fibrous scaffolds 
Fibrous scaffolds provide more surface area allowing for increased cell adhesion, ideal 
for cell transplantation strategies. They may mimic the native microenvironment of the nervous 
system and serve as a platform for cell proliferation, adhesion, and differentiation. Scaffolds 
can be fabricated to mimic the natural ECM and aid in cell adhesion [206]. To fabricate 
microfibers within a micron range, a microfluidic spinning technique can be employed. 
Microfluidic fiber fabrication is a technique adaptable to a wide range of materials, cost-
effective (Sharifi, Kurteshi et al. 2016, Cheng, Jun et al. 2017) and is utilized in a range of 
applications such as biomedical and energy fields (reviewed in Webster, Greenman et al. 
2011). This method does not require high temperature, pressure, or voltage to fabricate fibers 
compared to an electrospinning method in which fibers are produced using a high voltage 
supply [207]. Both methods are commonly employed to fabricate nanofibers and microfibers 
from natural and synthetic polymers. 
Aligned fibers can offer directionality for neurite outgrowth in the presence of 
biochemical cues and without. Electrospun PCL nanofibrous mats have been modified with 
gelatin to enhance endothelial cell spreading and growth as detected by surface markers [208]. 
Collagen nanofibers increased synapse maturation for spinal cord derived NSCs by activating 
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the mitogen-activated protein kinase/extracellular signaling-regulated kinase 
(MAPK/ERK1/2) pathway [209]. Rat AHPCs seeded on PCL microfibers have shown to 
increase proliferation and glial differentiation in vitro compared to cells cultured on planar 
surfaces, suggesting that topography may play an important role in cell-fate determination 
[210, 211].  
The synergistic effect of combining GDNF with fibrous scaffolds improved recovery 
in rats following nerve gaps compared to non-modified fibers [212]. Poly (ε-caprolactone) 
nanofibrous scaffolds immobilized with BDNF, demonstrated enhanced NSC proliferation and 
promoted neuronal and oligodendrocyte differentiation [213].  A dual neurotrophic factor 
system can also be utilized to enhance nerve regeneration. Continual release of BDNF and 
ciliary neurotrophic factor (CNTF) from electrospun fibers promoted axonal growth from rat 
retinal ganglion cells, providing potential for the use of fibers to promote nerve growth in the 
CNS [214]. 
A common peptide used to promote cell proliferation, migration and survival is an 
arginine-glycine-aspartic acid (RGD) sequence [215]. Incorporation of RGD peptides within 
aligned nanofibers has demonstrated increased neuronal growth and axonal extension from 
human NSCs in vitro [216]. Studies have demonstrated the beneficial effects of multiple 
guidance cues to facilitate therapeutic strategies in vitro and in vivo.  
Hydrogels 
Scaffolds, such as natural and synthetic hydrogels, can serve as an artificial ECM that 
can be used to deliver cells. Commonly used hydrogels are fabricated from collagen, fibrin, 
alginate, polyacrylamide, polyethylene glycol, hyaluronic acid and polypeptides (reviewed in 
[217]. Hydrogels are cross-linked polymers that become hydrated in an aqueous environment. 
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They can provide a three-dimensional structure in which mechanical properties can be tailored 
in an effort to mimic the native tissue. Hydrogels have several attributes making them ideal 
scaffolds for transplantation. Porosity within hydrogels provides room for neurite outgrowth 
in vivo as demonstrated by several studies [218-220]. Hydrogels can retain cells within the 
injection site and provide protection to cells post-transplantation. Damaged environments are 
often hostile and impacts the exogenous cells from surviving, however hydrogels can provide 
a supporting environment and promote tissue repair.  
Mothe and colleagues injected NSPCs within a hydrogel, leading to improved cell 
survival as well as behavioral recovery after SCI [221]. Peptide-modified hydrogels have 
promoted survival and integration of human iPSC-derived OPCs in SCI rats [222]. Hyaluronic 
acid hydrogels encapsulated with iPSC-NPCs and transplanted into rat stroke brains promoted 
differentiation as assessed by the decreased expression of Sox2, a marker for progenitor cells 
[223, 224]. Human umbilical cord MSCs seeded within hydrogel scaffolds have repaired minor 
tissue damage in traumatic brain injury models [225]. Injectable and biodegradable scaffolds 
support and evenly distribute retinal stem/progenitor cells (RSPC) once transplanted into the 
sub-retinal space [226, 227]. In most recent studies, several types of hydrogels have further 
demonstrated promising results to aid in CNS repair [228-231], thus encouraging researchers 
to better understand hydrogel scaffolds in vitro and in vivo.  
Hydrogels can also be used to mimic native tissue present in vivo. Banerjee and 
colleagues demonstrated that the differentiation of NSCs encapsulated within alginate 
hydrogels differs depending on the modulus of the hydrogel. As the modulus of the hydrogel 
increases, proliferation of the NSCs decreases, whereas softer hydrogels enhanced expression 
of β-tubulin III, a marker for neurons [232]. One important consideration would be to evaluate 
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cells after encapsulation; to assess changes in proliferation and differentiation of cells it would 
be useful to recover cells from hydrogels. We suggest that encapsulating AHPCs may influence 
cell proliferation and differentiation in vitro, leading to a better understanding of how materials 
influence cell fate determination. Our goal was to recover encapsulated AHPCs from hydrogels 
in an effort to better understand the effects of a three-dimensional environment on stem cell 
proliferation and differentiation.  
Zebrafish as a model system 
For decades, small mammalian models including mice and rats have commonly been 
used as in vivo systems to evaluate human therapeutic strategies due to the close homology 
between the genomes [233]. However, these experiments are expensive and time consuming, 
prompting researchers to find alternatives. Zebrafish (Danio rerio) have been proposed as an 
in vivo model for several applications based upon anatomical and physiological similarities 
with humans and have been used to model human neurodegenerative diseases such as 
Alzheimer’s disease [234, 235]. Neurogenesis in zebrafish begins after gastrulation, with 
proliferation and differentiation of neural progenitor cells and formation of distinct brain and 
retina structures by 2 days post fertilization (dpf) [236, 237]. Zebrafish embryos are transparent 
throughout development and have high fecundity [238]. The cost and time of experiments is 
significantly decreased compared to other animal models, including rodents. Lastly, the ability 
to inject DNA or RNA constructs into a young embryo allow for genes to be easily visualized 
with fluorescent markers [239], offering a wide range of transgenic zebrafish. Thus, using 
zebrafish as a model system for various aspects of research has provided knowledgeable insight 
prior to conducting rodent studies. 
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Zebrafish cell culture systems  
Although zebrafish have great advantages as an in vivo system, only a handful of 
studies have investigated them in vitro. Cell culture technology offers insights into cell biology 
and can be utilized for biochemical and molecular assays but also used to better understand 
aspects of cell development in vitro. Zebrafish have the capacity to regenerate, making it 
important to understand what mechanisms cells use after injury for survival [240]. Cell culture 
provides a method to further explore cells including neurons, but in a controlled environment. 
Methods for isolating and dissociating zebrafish neural tissue have been previously described 
and are becoming more established.  
Primary and immortal cell lines have been established from adult and embryonic 
zebrafish. Embryonic zebrafish primary cells have been dissociated from neuronal and glial 
reporter lines [241], however offer little quantitative data on the population of cells present. 
Sakowski and colleagues adapted a protocol previously used to derive primary motor neurons 
from rats and applied it to zebrafish, successfully obtaining a population of motor neurons 
[242]. However, the study lacks quantitative data what percentage of cells isolated are 
identified as motor neurons versus other cells. Dissociated zebrafish embryos around 30 hours 
post fertilization (hpf) generated cultures of OPCs whereas embryos from 60 hpf generated 
more mature oligodendrocytes, offering two possible methods to better understand 
oligodendrocyte biology in zebrafish [243].  Adult zebrafish brains have also been used to 
generate primary cell lines [244] and neurospheres [245]. Despite successful isolation of 
zebrafish brain derived cells, protocols have not characterized populations of cells or 
investigated their dynamic behavior in vitro using time-lapse imaging. Further investigation is 
required to fully understand zebrafish cell physiology in vitro.  
 32 
 
 
Zebrafish as a model system for screening biomaterials 
To analyze how biomaterials can be used for medical applications in humans, it is 
important to conduct animal studies to better understand host responses to foreign materials. 
Recently, zebrafish have slowly advanced in the field of bioengineering and as a model to 
understand toxicity. Zebrafish hatching is an important event occurring at 3 dpf [246] that helps 
researchers understand the toxicity of certain nanoparticles. Titanium dioxide nanoparticles 
have been shown to cause premature hatching in zebrafish embryos, a biological response 
indicating toxicity to the animal [247].  Zhao and colleagues exposed zebrafish to nanoparticles 
composed of cadmium selenide or zinc and reported that hatching was inhibited, demonstrating 
that nanoparticles interacted with hatching enzymes in the zebrafish and became toxic to the 
animal [248].  
Zebrafish are an ideal model system to use for transplantation studies for variety of 
reasons. First, zebrafish can be treated with polythiourea (PTU), inhibiting melanogenesis 
[249]. Zebrafish would allow visualization of cell-seeded scaffolds without requiring sacrifice 
of the animal. This would allow the same zebrafish to be imaged for sequential days, allowing 
a better understanding of how the in vivo environment reacts to foreign materials within the 
nervous system. Second, they have a similar innate immune system compared to mammals 
[250]. Zebrafish have been commonly used as toxicity assays for drugs and materials including 
nanoparticles, carbon-based materials and polymers [251, 252]. Anticancer drugs loaded into 
oxidized graphene have been assessed in zebrafish embryos for 3 days and shown no 
detrimental effects in hatching, demonstrating potential for advancing graphene based 
biomedical applications [252]. Double-transgenic Tg(mpx:eGFP, mpeg1:mCherry larval and 
adult zebrafish, (neutrophils and macrophages labeled in green and red, respectively) were 
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used to implant monofilament polypropylene sutures with the intention of eliciting an immune 
response. This proof-of-concept study demonstrated the feasibility of using transgenic 
zebrafish to study live host responses from immune cells [253]. Poly (ε-caprolactone) 
microspheres implanted into zebrafish embryos triggered neutrophil and macrophage 
infiltration compared to polystyrene microspheres [254]. Additionally, Zhang and colleagues 
demonstrated that gelatin nanospheres loaded with vancomycin, an antibiotic, has improved 
therapeutic efficacy against infection in zebrafish larvae [255].  
Overall, previous studies have shown the potential usefulness of zebrafish embryos for 
in vivo evaluation of biomaterial-associated inflammatory responses. Further, high content 
screening systems are particularly useful for characterizing genetically engineered cells [256], 
drug metabolism [257], and conducting zebrafish toxicity assays [258]. However, there a major 
gap for using zebrafish as a model to study cell-based biomaterial strategies for the CNS 
(Figure 2). We proposed using transgenic zebrafish to test three-dimensional scaffolds as 
possible vehicles to deliver cells efficiently into the zebrafish. Our overall goal is to promote 
zebrafish as a high-throughput platform to study biomaterial-based therapeutic strategies for a 
variety of CNS diseases but also with applications for muscle degeneration and cardiac 
diseases.  
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Figure 2: Schematic illustration depicting workflow: the essence of high content image-based 
screening using zebrafish. (1) Combinatorial approach investigating biomaterials, drugs, 
and/or stem cell therapies in zebrafish. (2) In a 96 well plate, control and treated zebrafish can 
be immobilized in each well. (3) A high-content screening system is used for live, time-lapse 
imaging with fluorescence and light microscopy. (4,5,6) Data and analysis used to plan pre-
clinical trials in mammalian models with applications for human disease. 
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Abstract 
Biomaterials are essential for development of innovative biomedical and therapeutic 
applications. Biomaterials-based scaffolds can influence directed cell differentiation to 
improve cell-based strategies. Using a novel microfluidics approach, poly (ε-caprolactone) 
(PCL), is used to fabricate microfibers with varying diameters (3 µm-40 µm) and topographies 
(straight and wavy). Multipotent adult rat hippocampal stem/progenitor cells (AHPCs) are 
cultured on three-dimensional aligned PCL microfibrous scaffolds to investigate their ability 
to differentiate into neurons, astrocytes and oligodendrocytes. The results indicate that the PCL 
microfibers significantly enhance proliferation of the AHPCs compared to control, 2-D planar 
substrates. While the AHPCs maintained their multipotent differentiation capacity when 
cultured on the PCL scaffolds, there is a significant and dramatic increase in immunolabeling 
for astrocyte and oligodendrocyte differentiation when compared with growth on planar 
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surfaces. Our results show a 3.5-fold increase in proliferation and 23.4-fold increase in 
astrocyte differentiation for cells on microfibers. Transplantation of neural stem/progenitor 
cells within a PCL microfiber scaffold may provide important biological and topographic cues 
that facilitate the survival, selective differentiation, and integration of transplanted cells to 
improve therapeutic strategies. 
 
Keywords: Polycaprolactone; three-dimensional microfibrous scaffolds; biomaterials; neural 
stem cells; glial differentiation; regenerative medicine 
 
Introduction 
Severe brain injury as well as neurodegenerative conditions, often lead to life-long 
disability, reduced quality of life and heavy social as well as economic burdens. As such, 
considerable effort has been directed towards development of cell replacement strategies in 
animal models to investigate nervous system repair [1-4]. Further, genetically engineered cells 
can secrete neurotrophic factors thus providing a neuroprotective benefit to a site of injury [5-
8]. However, when cells are transplanted, the outcome often results in poor cell survival, poor 
host integration and little functional benefit due to the complexity of the central nervous system 
(CNS). Therefore, there is an urgent need to develop innovative techniques to increase 
efficiency for transplantation therapies.  
Biomaterials have emerged as an innovative and powerful adjunct in support of brain 
rescue and repair strategies. Studies have shown an improvement in cell engraftment using 
biomaterial supports, which resulted in increased cell survival [9, 10]. Various scaffolds can 
be placed into a site of injury in order to provide structural and architectural support to damaged 
brain tissue. Biomaterials, such as microfibers, can mimic the cellular microenvironment and 
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serve as a platform for cell adhesion, proliferation, and differentiation. Scaffolds incorporating 
extracellular matrix (ECM) molecules, natural polymers or synthetic polymers, can offer new 
ways to develop more effective transplantation therapies for the nervous system [11-13]. 
Recently, microfluidic platforms have shown promise to a wide range of applications 
from biomedical to energy areas [14-20]. Microfluidic fiber fabrication is versatile, 
straightforward, cost-effective, and biocompatible. Furthermore, this approach does not 
require high temperature, pressure, and voltage to fabricate fibers as is necessary for 
conventional methods [21-24]. Additionally, the microfluidic platform can be applied to create 
other bioactive materials, such as particles, liposomes, droplets, and vesicles [25, 26]. 
Using poly (ε-caprolactone) (PCL) fibrous scaffolds has two main advantages. PCL 
can be considered as a good candidate for long-term implantable devices due to its slow 
degradation rate compared to other synthetic polymers, like poly D, L-lactic-glycolic acid, 
making the microenvironment less acidic during the degradation process [27]. Additionally, 
PCL fibers can be fabricated without a cross-linking process. Therefore, the resulting fibers 
have high strain at break and are not likely to fragment easily during implantation.  
The discovery and characterization of adult neural stem/progenitor cells has been 
influential in understanding brain regenerative capabilities. Adult neural stem/progenitor cells 
(NPCs) are located in two main regions in the brain, the dentate gyrus of the hippocampus and 
the subventricular zone [28]. The ability of these cells to differentiate into neurons, astrocytes 
and oligodendrocytes, the principal neural cell types of the CNS, provides an advantage for 
studying directed cell differentiation [29]. Combined with biomaterials, scaffolds can also 
influence cell differentiation thus promoting stem cells into neural lineages for therapeutic 
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strategies for nervous system rescue and repair [30-35]. However, little is known about the 
extent to which PCL microfibers may impact cell proliferation and directed cell differentiation.  
Our group previously showed PCL microfibers can support adult hippocampal 
stem/progenitor cell (AHPC) proliferation and differentiation [16]. In the present study, we 
extend our previous observations and have conducted a systematic and quantitative 
characterization of the effect of microfluidic-spun PCL microfibers of varying sizes and 
topographies on AHPC proliferation and differentiation. In order to investigate these issues, 
we found the microfluidic approach provides excellent versatility for fabricating PCL fibers 
with a wide range of characteristics. We demonstrated that by changing the flow rate ratio 
between the core and sheath fluids, as well as PCL concentration (in the core fluid), we were 
able to achieve wavy and straight fibers with different sizes. These architectures have been 
fabricated using various techniques and in different size ranges however for our specific 
application of creating a 3-D microenvironment to enhance neural progenitor cell 
differentiation into glial cells, using fibers in similar size range of cells is preferred [36-38]. 
After culturing the AHPCs on the microfibrous scaffolds of various diameters and 
topographies, we found that the larger diameter microfibers appear to guide the differentiation 
to mature neurons, whereas all PCL microfibers promoted astrocyte differentiation. We 
demonstrated that PCL microfibers promote cell proliferation and influence differentiation to 
varying degrees. By investigating new platforms for cell transplantation, we are in a better 
position to understand how to improve the survival, differentiation and integration of 
transplanted cells for nervous system rescue and repair. 
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Materials and Methods 
Microfluidic Channel Fabrication 
The channel was created using a SU8 photoresist-patterned silicon wafer and soft 
lithography. In order to make the channel with its chevron grooves extending from the top and 
bottom of the channel, we used two silicon wafers. The height and width of the microchannel 
was 130 µm and 390 µm, respectively. The microchannel included four chevrons with 
dimensions of 130 µm × 100 µm (height × width), which were spaced 200 µm apart. The 
microchannel was made of Polydimethylsiloxane (PDMS; Dow Corning, Midland, MI), a 
biocompatible and transparent elastomer. To make the channel, Sylgard 184 elastomer base 
and cross-linker agents were mixed in a 10:1 ratio. After pouring the mixture on the molds, it 
was cured at 85 ºC for 25 minutes. Then, the PDMS layers were simply peeled off from the 
silicon wafer molds and bonded together via plasma treatment.   
 
Microfluidic Fiber Fabrication 
To fabricate microfibers we used two fluids, i.e. core and sheath fluids. The core fluid 
was prepared with two poly(ε-caprolactone) (Mn = 80,000) (PCL; Sigma-Aldrich, St. Louis, 
MO) concentrations of 2 and 5 wt% in 2,2,2-Trifluoroethanol (TFE; Oakwood Chemical, West 
Columbia, SC). For example, in order to make 5 wt% PCL, 2 g of PCL were dissolved in 40 
mL TFE at room temperature. The sheath fluid solution was made by using 5 wt% polyethylene 
glycol (Mn = 20,000) (PEG; Sigma-Aldrich) in the mixture of ethanol and deionized (DI) water 
with a volume ratio of 1:1. Both of the core and sheath fluids were introduced into the 3 inlet 
microchannel using a double syringe pump (ColeParmer, Veron Hills, IL) with different flow 
rates, and the PCL fiber was fabricated due to the phase inversion process. In this process, the 
molecules of the sheath and core fluids are replaced and because PCL is not soluble in the 
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sheath fluid, it precipitates in a form of microfibers (solvent extraction process). The position 
of the microchannel is vertical such that the outlet of the channel is in contact with a water 
bath. The production rate can vary based on the flow rates of the core and sheath fluids and the 
resulting fiber was collected around a frame in an aligned manner. 
 
Microfiber Substrate Preparation 
Microfiber substrate samples were prepared as previously described [16]. Briefly, each 
PCL fiber apparatus was composed of a 12 mm glass coverslip (Thermo Fisher Scientific, 
Waltham, MA), aligned PCL microfibers fixed at their ends to the coverslip via silicone 
medical adhesive, and small shards of fragmented coverslip to hold the ends of the microfibers 
in place in conjunction with the adhesive. 12 mm coverslips were cleaned with RBS 35 
detergent (1:50 in deionized water (DI) H2O; Thermo Fisher Scientific) and boiled for 15 
minutes followed by a rinse in DI water. Coverslips were air dried and sterilized under 
ultraviolet light. A small drop of silicone medical adhesive was applied to opposing ends of a 
sterile coverslip and then an array of horizontal and parallel PCL microfibers was placed onto 
the coverslip so that both ends lay in the adhesive. Fragments of coverslip were pressed onto 
the adhesive to securely bind the fibers to the coverslip. This leaves the ends of the microfiber 
array bound to the coverslip while the center of the array is loose from the coverslip in order 
to provide a 3-D cell culture condition on the fibrous scaffolds. After the adhesive dried, the 
samples were sterilized in 70% ethanol for 20 minutes and washed in Earle’s balanced salt 
solution (EBSS; Invitrogen, Carlsbad, CA). EBSS was then aspirated off and the samples were 
further sterilized in ultraviolet light for 10 minutes. Samples were incubated overnight at 4˚C 
with Entactin-Collagen IV-Laminin (ECL 10 µg/mL; Millipore, Burlington, MA) diluted in 
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Dulbecco’s modified Eagle’s medium/Ham’s F-12 (DMEM/F12, 1:1, Omega Scientific, 
Tarzana, CA). The next day samples were rinsed with EBSS and ready for cell plating. 
 
Cell Culture 
The adult rat hippocampal stem/progenitor cells (AHPCs) were a generous gift from 
F.H Gage (Salk Institute for Biological Sciences in La Jolla, CA). The AHPCs were isolated 
from Fischer 344 rats and were infected with a retrovirus to induce expression of green 
fluorescent protein (GFP) [39]. During the course of the experiments, it was evident that 
AHPCs were decreasing the expression of the GFP transgene, which may be attributed to cell 
differentiation. However, this did not affect the proliferation or survival of the cells.  
Cells were cultured in flasks coated with poly-L-ornithine (10 µg/mL; Sigma-Aldrich) 
and purified mouse laminin (5 µg/mL; R&D Systems, Minneapolis, MN) diluted in EBSS. 
Maintenance media (MM) was composed of DMEM/F12, 1:1 supplemented with 2.5 mM L-
alanyl-L-glutamine (GlutaMAX; Thermo Fisher Scientific), N2 supplement (Gibco BRL, 
Gaithersburg, MD), and 20 ng/mL basic fibroblast growth factor (human recombinant bFGF; 
Promega Corporation, Madison, WI). Cells were detached from the culture flask using 0.05% 
trypsin-EDTA (Gibco BRL), the cell suspension collected and centrifuged at 800 rpm for 5 
minutes. A hemocytometer and Trypan Blue were used to perform a viable count cells. AHPCs 
were plated at a density of 50,000 cells on each PCL-microfiber sample. Cells were maintained 
at 37 ˚C in 5% CO2/95% humidified air atmosphere. After one day in culture, differentiation 
was induced by growth factor withdrawal (differentiation medium, DM) and cells cultured for 
an additional six days. For feeding, half of the media was changed every other day.  
For control samples, 12 mm glass coverslips were coated with ECL (10 µg/mL) 
overnight at 4˚C. AHPCs were plated at a density of 10,000 cells on each control sample. After 
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one day in culture, differentiation was induced by growth factor withdrawal (differentiation 
medium, DM) and cells cultured for an additional six days. For feeding, half of the media was 
changed every other day.  
 
Immunocytochemistry 
Cultured cells were rinsed in 0.1 M phosphate buffer and fixed with 4% 
paraformaldehyde (PFA, Thermo Fisher Scientific) in 0.1 M phosphate buffer for 20 minutes 
at room temperature. The PFA was then aspirated off and cells were washed with phosphate 
buffered saline (PBS; Invitrogen). Next, cells were incubated for 1 hour at room temperature 
in a blocking solution composed of PBS supplemented with 2.5% normal goat serum and 2.5% 
normal donkey serum (Jackson ImmunoResearch, West Grove, PA), 0.4% bovine serum 
albumin (BSA; Sigma-Aldrich), and 0.2% Triton X-100 (Thermo Fisher Scientific). Cells were 
then incubated overnight at 4˚C in primary antibodies diluted in blocking solution (Table S1). 
The next day, cells were washed with PBS and followed by incubation at room temperature 
for 90 minutes in secondary antibodies (donkey anti-rabbit Cy3 or donkey anti-mouse Cy3 
(1:500; Jackson ImmunoResearch) and 4',6-diamidino-2-phenylindole (DAPI) nuclear stain 
(1:50; Invitrogen) all diluted in blocking solution). Samples were mounted on microscope 
slides with DAPI Fluoromount-G mounting media (Southern Biotech, Birmingham, AL) for 
imaging. 
 
Sample Preparation for SEM Imaging 
After 7 days in vitro (DIV), samples were fixed and rinsed in 0.1 M phosphate buffer. 
Samples were then placed in a solution of water and PBS at a ratio of 50:50 for 10 minutes and 
dehydrated in a graded ethanol series (increasing ethanol concentration by 10% increments). 
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Once samples were in 100% ethanol, samples were rinsed in a 3:1 solution of ethanol and 
hexamethyldisilazane (HMDS; Electron Microscopy Sciences, Hatfield, PA). The ratio of 
HMDS gradually increased from 25% to 100%. The ratio of ethanol:HMDS changed from 3:1 
to 1:1 and 1:3, each for ten minutes. The final step was to add 100% HMDS and allow the 
samples to air-dry overnight.  
 
Propidium Iodide Assay 
Propidium Iodide (PI, Thermo Fisher Scientific) staining was used to detect dead cells 
at 7 DIV. The stock solution of PI was diluted to 1.5 µM in AHPC culture medium. Culture 
medium from each sample was replaced with the PI solution and samples were incubated for 
20 minutes at 37˚C in 5% CO2/95% humidified air atmosphere. As a reagent control, several 
samples were incubated in 70% ethanol for 5 minutes to cause cell death prior to the addition 
of the PI solution. Following incubation, samples were rinsed with 0.1 M phosphate buffer and 
then fixed with 4% PFA in 0.1 M phosphate buffer for 30 minutes at room temperature. Next, 
samples were rinsed with PBS and incubated 30 minutes at room temperature with DAPI (1:50) 
diluted in blocking solution. Samples were then rinsed with PBS and mounted on microscope 
slides with DAPI Fluoromount-G mounting media for imaging. 
 
Imaging 
After immunocytochemistry samples were imaged using a Nikon Microphot FXA 
(Nikon Corp., Melville, NY, USA) microscope equipped with standard epifluorescence 
illumination and a Q imaging Retiga 2000R (Q Imaging, Burnaby, BC, Canada) digital camera. 
A 20x objective was used to obtain images for quantitative data analysis. For the analysis, 10 
microscopic fields were imaged per microfiber sample, each field representing 0.24 mm2. A 
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total of three independent culturing experiments were conducted, with a total of 15 images 
quantified per antibody, per microfiber sample. 
A Zeiss LSM700 Confocal microscope equipped with an AxioCam MRc5 was used to 
image samples for high-resolution images with 20x and 40x objectives. Stacks of various 
optical planes were taken for each microfiber type. Using ImageJ, z-stacks were rendered into 
maximum intensity projections to obtain a single image. In order to create movies using the z-
series of images, ImageJ was used to open the image sequence and save as an audio video 
interleave file. 
Scanning electron microscopy (SEM; JCM-6000 NeoScope Benchtop scanning 
electron microscope) was used to determine the size and surface properties of the PCL fibers 
as well as the distribution and position of the AHPCs on fibers. The substrates were iridium 
(Ir) coated (5 nm thickness) using a Q150T Turbo-Pumped Sputter Coater/Carbon Coater.  
 
Quantitative Data Analysis 
ImageJ software was used to analyze the images. From each replicate, 5 imaging fields 
were chosen per sample for each primary antibody. To calculate cell density, DAPI-stained 
nuclei were counted on microfibers. The length and diameter of the microfiber were measured 
in pixels with a ratio of 1.66 pixels to 1 µm. These values were then converted to the surface 
area of one half of a cylinder (imaged surface of the microfiber) using the equation surface 
area = π*(diameter in mm)*(length in mm)*0.5. The number of DAPI stained cells was divided 
by the microfiber surface area to determine cell density. 
After immunocytochemical experiments and imaging, quantitative analysis was 
conducted. 5 imaging fields were examined from microfiber samples and 5 imaging samples 
were examined for planar controls. The following counts were made in each field to determine 
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the percentage of immunolabeled cells for each respective antibody: total number of 
immunolabeled cells divided by the total number of cells (DAPI-stained nuclei) (see Table S1).  
 
Statistics 
GraphPad Prism v6 software (GraphPad Software, Inc., La Jolla, CA, USA) was used 
for statistical analysis. One-way ANOVA was used to compare the means across the various 
conditions for cell density, anti-nestin and Ki-67 antibodies. Two-way ANOVA was used to 
compare the means across the various conditions for anti-TuJ1, MAP2ab, GFAP and RIP 
antibodies.  A p-value of ≤ 0.05 was considered significant. Error bars represent the standard 
error of the mean. 
 
Results 
Microfiber fabrication and properties 
 
A schematic of our microfluidic fiber fabrication platform is illustrated in Figure 1. In 
this process, PCL solidification is due to the solvent extraction process. Following convergence 
of the sheath and core fluids in the channel, the molecules of the sheath fluid are exchanged 
with the molecules of the core fluid and PCL precipitates due to the insolubility of PCL in the 
sheath fluid. In this process, the sheath fluid plays a pivotal role in exerting lateral and vertical 
hydrodynamic focusing forces on the core fluid. The chevron region focuses the core fluid 
vertically. In this area, the hydrodynamic resistance in the perpendicular direction (to the flow) 
decreases and the sheath fluid fills the top and bottom of the microchannel, exerting vertical 
and lateral forces, to wrap around the core fluid, and focuses the core fluid at the center of the 
microchannel. The sheath fluid fills the chevron areas because the hydrodynamic resistance is 
inversely related to the flow rate and we used significantly higher flow rates for the sheath 
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fluid, blocking the core fluid from entering the chevron areas. This creates a shear force at the 
core fluid/sheath fluid interface due to the velocity and viscosity difference between the two 
fluids, which plays an important role to place the core fluid at the center of the channel, change 
the cross-section as well as the topographies of the resulting fiber, and align the polymer chain 
in the flow direction. In addition to the fiber fabrication process, Figure 1 schematically shows 
the impact of shear force at the fluid/fluid interface on the pattern of the PCL fibers.  
 Scanning electron micrographs illustrate the ability of the microfluidic approach to 
create fibers with different topographies such as straight (Figure 2 (A-C)) and wavy (Figure 
2 (D, E)) with different diameters. By changing the flow rate ratio (FRR) between the core and 
sheath fluids, as well as PCL concentration (in the core fluid), we were able to achieve 
architectures that have not been reported in other fiber fabrication studies including the 
microfluidic approach. Details about the PCL concentration and FRR used are provided in 
Table 1.  
The microfluidic fiber fabrication process is dependent on finding the range of flow 
rate ratios between the core and sheath fluids which allow for the continuous formation of 
fibers. For this study, different flow rates ratios (sheath flow rate: core flow rate) were tested 
in order to find the best flow rate range (50:10 – 200:2). If the flow rate ratio was lower than 5 
(50:10), the lateral focusing force from the sheath fluid was not enough to keep the core fluid 
at the center of the microchannel. Thus, the core fluid attached the walls of the microchannel 
and would quickly block it. Conversely, when higher flow rates were used, the phase inversion 
process was too rapid and resulted in sudden solidification of PCL when it was exposed to the 
sheath fluid in the microchannel and blockage occurred again. Additionally, if the FRR was 
higher than 100 (200:2), the back-flow effect was observed in the channel, as the lateral shear 
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force exerted from the sheath fluid to the core fluid was sufficient enough that the sheath fluid 
blocked the core fluid from entering the main part of the microchannel where the two fluids 
should meet. Instead, the sheath fluid would flow back to the core fluid channel, which caused 
early solidification of PCL and channel blockage.  
Although the FRR plays a significant role on the size, cross-sectional and lateral shapes 
(straight and wavy) of the fibers, this parameter has a limited effect on fiber shape and 
structure. This limitation prevented the fabrication of straight fibers in the size range of 20-30 
µm in this study. In fact, by decreasing the FRR to 5 (50:10), the size of the fiber increased to 
39 µm and the fiber shape changed from wavy to straight. In order to create straight fibers 
within the size range of 20-30 µm (Straight II), the PCL concentration, another important 
parameter, was reduced to 2% from 5% and the size of the resulting Straight II was found to 
decrease to 22.8 µm from 39 µm (Straight III). Decreasing the concentration of PCL reduces 
the mass solidification rate in the core fluid during the phase inversion process within the 
microchannel. 
This table shows that the Straight I microfibers can be created by using a high flow rate 
ratio (FRR) between the core and sheath fluids that results in high shear force at the interface. 
When the FRR decreases to the range of 18-30, the wavy shaped fibers were created and the 
diameter of the fibers increased. The decrease of the FRR to 50:10, gives Straight III PCL 
fibers with the diameter of 39.1 ± 1.8 µm.  
 
Cell adhesion on PCL microfibers 
 
To assess cellular adhesion, AHPCs were cultured on PCL microfibers precoated with 
an extracellular matrix substrate (Entactin-Collagen-Laminin IV (ECL)) for 7 days in vitro 
(DIV) in differentiation media (DM). Neural stem cells in vitro are cultured on an extracellular 
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matrix substrate such as laminin. Previous studies have shown that using an extracellular 
matrix substrate aids in cell adhesion, specifically on fiber matrices [32, 40, 41]. The details of 
our in vitro study are illustrated in Figure 1 (B-E). For comparison, cells were also grown on 
a planar surface of ECL-coated glass coverslips. The AHPCs were stained with DAPI, a 
nuclear stain, in order to perform cell counts and to assess differences of cell density on PCL 
microfibers versus planar controls. Our results show that PCL microfibers permit AHPC 
adhesion and Straight I microfibers had the highest cell density, with a mean of 10,325 cells 
per mm2 (Figure 3).   
Straight I microfibers bundled together, therefore increasing the surface area and 
allowing more cells to attach and cluster together (Figure 4 (A1-A3), Figure S3 (A1-A2)). 
Further, Straight II microfibers had more clusters of cells (Figure 4 (B1-B3)) compared to 
Straight III microfibers (Figure 4 (C1-C3)), which is likely due to the lower overall cell density 
on the Straight III microfibers. Interestingly, cells growing on Wavy I microfibers were evenly 
distributed and cell processes often followed the curvatures of the fibers (Figure 4 (D1-D3, E1-
E3)). These results indicate that not only do PCL microfibers support cell adhesion, but also 
fiber diameters influence cell density. 
 
Proliferation of AHPCs on microfiber substrates 
 
In order to determine if cell proliferation was impacted by the PCL microfibers we 
conducted Ki-67 immunolabeling.  The Ki-67 antigen is expressed in the cell nucleus during 
G1, S, G2 and M phases of the cell cycle. As illustrated in Figure 5, significantly greater 
percentages of AHPCs were Ki-67 immunolabeled on microfiber samples compared to the 
planar controls. Ki-67 immunolabeling was 2.7 to 3.5 fold greater on the microfibers compared 
to the planar controls (Figure 5 (A1-E1, F)). The percentage of Ki-67-immunolabeled AHPCs 
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on microfiber samples were found to be 10.8% ± 1.3, 10.5% ± 1, 9.5% ±1, 12.1% ± 1.4 and 
11.3% ± 1, (Straight I, Straight II, Straight II, Wavy I and Wavy II), respectively, compared to 
planar controls which only showed 3.5% ± 0.3 Ki-67 positive immunolabeled cells (Figure 5 
(A1-E1, F)). These results indicate that PCL microfibers provide structural support that helps 
promote cell proliferation.  
Propidium iodide (PI) staining was used to determine if there was any significant cell 
death of the AHPCs when growing on the PCL microfibers. Propidium iodide (PI) is a 
fluorescent nuclear and chromosome counterstain that is membrane impermeant and is 
commonly used to identify dead cells. In our study, we found few PI-positive cells on the 
microfibers (Figure S1). As a PI reagent positive control, AHPCs were incubated in 70% 
ethanol for 5 minutes, a condition effective at killing most of the cells. These results show that 
all microfiber substrates supported cell survival and caused negligible cell death.  
 
AHPCs maintain neural progenitor status on PCL microfibers 
 
AHPCs are neural stem cells, expressing a specific class of intermediate filament 
proteins. An antibody directed against nestin, a class of intermediate filament proteins found 
in NPCs, was used to identify the AHPCs. Previous studies have inferred that although neural 
precursors differentiate, they may still express markers indicative for precursor cells, such as 
nestin. Hence, we believe that although cells are differentiating, they maintain expression of 
nestin [39, 42]. Fluorescent images showed the majority of cells were immunopositive for 
nestin in the cell body and processes (Figure S2 (A1-E1)). No statistically significant 
differences were noted between microfiber samples and planar controls (Figure S2 (F)). These 
results indicate that growth of AHPCs on microfiber samples did not alter their progenitor 
status. Along with data previously shown, these results indicate that PCL microfibers provide 
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structural support that does not alter AHPC progenitor state but enhances cell proliferation, 
ideal for cell transplantation strategies. Adult hippocampal progenitor cells with processes 
oriented in the direction of the microfiber as well as the contour of the microfiber were 
commonly observed on different types of fibers as shown in Figure S3 (A1-E2). Figure S3 (F) 
shows the average (average ± standard error) of the neurite length corresponding to the AHPCs 
growing in one direction. Wavy fibers had longer neurite lengths than straight fibers, however 
no statistical difference was found.   
 
PCL microfibers support neuronal differentiation 
 
The AHPCs are multipotent and have the capacity to differentiate into neurons, 
astrocytes and oligodendrocytes [29]. Scaffolds can influence cell differentiation, which can 
be used to help promote targeted stem cell differentiation towards specific neural lineages as a 
therapeutic strategy for nervous system rescue and repair [11, 43]. Using 
immunocytochemistry, neuronal differentiation was characterized using neuron-specific 
antibody markers, TuJ1 (class III β-tubulin) and MAP2ab (microtubule associated protein 
2ab). AHPCs on microfibers and planar surfaces were immunopositive for TuJ1 but no 
significant differences were observed on any microfibers (p≤0.05), suggesting that although 
PCL microfibers may not increase neuronal differentiation, they support the ability of AHPCs 
to differentiate (Figure 6 (A1-E1, K)). Mature neurons can be identified using the anti-MAP2ab 
antibody, specific to microtubules within dendrites [44].The number of cells immunoreactive 
for MAP2ab on Straight III microfibers was significantly greater than planar controls, 14% ± 
1.8 vs. 6.3% ± 0.6, respectively (Figure 6 (F1-J1, K)) suggesting that specific topographies, 
surface and scaffold diameters, may help promote neuronal differentiation and maturation.  
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PCL microfibers enhance glial differentiation of AHPCs 
 
To determine if PCL microfibrous scaffolds stimulate glial differentiation, glial 
fibrillary acidic protein (GFAP) and receptor interacting protein (RIP) were used to 
characterize astrocytes and oligodendrocytes, respectively. Our results indicate a dramatic 
increase in the number of cells immunopositive for GFAP on all microfiber samples compared 
to the controls, ranging from a 16.7 to 23.4-fold increase. Fluorescent images show distinct 
immunolabeling in long processes and these cells appeared to have larger nuclei compared to 
cells that were negative for GFAP. On Straight I microfibers, distinct processes can be seen 
following the fiber length (Figure 7 (A1, F1)). When growing on Wavy I and II microfibers the 
glial processes often followed the contours of crests and troughs compared to those GFAP 
positive cells on Straight microfibers that appear to have linear processes. Quantitative analysis 
revealed the percentage of GFAP immunoreactivity of AHPCs on microfiber samples were 
17.9% ± 2.163, 18.2% ± 2, 15.9% ± 2.2, 17.4% ± 3.6, and 13.1% ± 2.5, respectively (Figure 
7 (A1-E1, K)). AHPCs differentiating on all PCL microfibers showed a remarkable increase in 
GFAP immunolabeling compared to the very low percentage (0.8%) on planar surfaces further 
indicating that PCL microfibers promote glial differentiation. Differentiation of AHPCs into 
oligodendrocytes was greater on the larger microfiber samples showing the highest RIP 
immunoreactivity of all PCL microfibers. RIP immunoreactivity was found in many short 
processes emanating from the cell bodies. Straight III and Wavy II, (Figure 7 (H1, J1)) showed 
significant differences in the number of RIP immunoreactive cells compared to planar controls, 
27% ± 3.6 and 21.7% ± 2.5 (Figure 7 (F1-J1, K)). Further, wavy II microfibers (larger diameter) 
are shown to have more RIP immunolabeled cells than Straight I microfibers (small diameter), 
suggesting that AHPCs can be biased toward oligodendrocyte differentiation on larger 
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microfibers with a wavy topography. Taken together, these results indicate that microfluidic 
spun PCL microfibers increase glial differentiation, favoring astrocytic differentiation of the 
AHPCs. 
  
AHPCs bridge across PCL microfibers 
 
The regenerative capacity of the CNS is limited, requiring sequential complex 
processes in which axons must make their way through a prohibitive glial scar and 
subsequently navigate to find their correct target region, or result in neuronal death [45]. An 
important step in the regenerative process involves the axons crossing the lesion site. 
Biomaterials can serve as bridges in which cells are able to migrate and extend processes, in 
hopes of reaching their target. Although AHPCs often formed mini-clusters reminiscent of 
neurospheres on Straight I microfibers (Figure S4 (A1-A2)), larger diameter microfibers 
displayed AHPCs bridging between fibers as illustrated in Figures S4 and S5. In many cases 
the microfibers were separated by more than 80 µms (Figure S4 (B1-E2)). These results were 
further validated in immunocytochemical experiments where cell bodies were often localized 
on one microfiber with its processes extending across and intricately wrapping around a nearby 
PCL microfiber (Figure S5 (A1-C1), Supplemental M1)). These results show that microfibers 
can support cells bridging between fibers, therefore forming an aligned scaffolding system 
useful for cell migration, alignment and structural organization during development and 
regeneration.   
 
Discussion 
We have successfully shown that biocompatible PCL microfibers support the adhesion 
and differentiation of AHPCs. Most importantly, the PCL microfibers promoted proliferation 
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of the AHPCs compared to a 2-D surface and have shown that PCL microfibers considerably 
enhance glial differentiation. An increased number of AHPCs were immunoreactive for GFAP, 
an astrocyte-specific class-III intermediate filament protein. Astrocytes are a major cell type 
in the mammalian nervous system. In addition to providing metabolic and nutritional support 
to their partner neurons, they also play important functions during development, including 
neuronal guidance, supporting proliferation and maintenance of neurons, stimulating 
neurogenesis, involvement in synaptogenesis and neurotrophic support due to their paracrine 
activities [46]. To our knowledge, for the first time, the 3-D microenvironment of PCL 
microfibers greatly enhanced neural progenitor cell differentiation into glial cells. 
 
Microfibrous scaffolds 
Microfibrous scaffolds have shown promise for serving as ideal drug carriers due to 
their high surface area to volume ratio and tunable morphologies [17]. We used both of the 
parameters involved in the microfluidic fiber fabrication, i.e PCL concentration and FRR, and 
were able to fabricate different types of fibers with a wide range of sizes. In the process of 
microfluidic fiber fabrication, core and sheath fluids were introduced into the microchannel, 
as described in the experimental section. Using the laminar flow regime, the diffusion occurred 
at the sheath/core fluids interface. In this paper, we showed that we could tune the shear force 
by changing the velocity and viscosity gradients at the interface, which resulted in different 
microfiber patterns: straight and wavy. These fiber topographies were expected since 
decreasing the shear force at the interface, resulted in fabrication of microfibers displaying a 
transition pattern between the straight and wavy microfibers. Depending on the flow rate ratio 
and the PCL concentration, chain shaped microfibers could also be fabricated. Additionally, 
because the flow rate ratio decreases, the hydrodynamic focusing force weakens and the core 
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fluid expands in the channel, which results in fabrication of fibers with larger diameters. To 
obtain straight PCL fibers with smaller diameters, it was necessary to adjust the flow rate ratio 
but also change the PCL concentration in the core fluid, another important parameter affecting 
the size of the PCL fibers. Therefore, we used a lower concentration of PCL in the core fluid, 
i.e. 2 wt%, which resulted in PCL fibers with smaller diameters after the phase inversion 
process and the exchange of molecules of the sheath fluid with the molecules of the core fluid 
in the microchannel. In this study, the diameter of the microfibers ranged from 3 µm to 40 µm, 
and we investigated the effect of fiber diameter as well as topography of the fibers on cellular 
behavior such as cell proliferation and neuronal/glial differentiation.  
AHPCs are capable of differentiating into neuronal and glial cells in vitro [39, 47]. In 
vivo the local microenvironment plays important roles in maintain the neural stem cell niche 
in order to regulate the their proliferation and differentiation [48-50]. Previously, our lab has 
shown that AHPCs on micropatterned polymer substrates favor neuronal differentiation 
compared to planar surfaces, even in the presence of soluble factors from astrocytes, indicating 
that surface topography played a fundamental role in neuronal differentiation [33, 51]. Our 
current study focused on further characterizing the AHPCs on PCL microfibers to better 
understand the differentiation and proliferation of the cells in an in vitro model. 
 
Scaffolds for cell differentiation 
Due to inefficiencies in cell transplantation alone, studies have begun to implement 
different biomaterials to support transplanted cells and to increase their survivability. Neural 
progenitor cell transplants have been used in various neurodegenerative disease models 
including Parkinson’s disease, spinal cord injury and Huntington’s disease. However, these 
cells have low integration efficiency into the brain circuitry, which may prevent long-term 
 80 
 
 
positive outcomes. In recent years, studies have started focusing on using scaffolds in order to 
direct cells towards specific lineages [52-54]. Additional studies have shown improvement of 
cell adhesion as well as differentiation of retinal progenitor cells seeded on polymeric scaffolds 
in a retinal degeneration model [54-56]. Taken together, studies have utilized biocompatible 
materials in order to investigate mechanisms to promote cellular proliferation and 
differentiation. 
One obstacle researchers face throughout in vitro studies is mimicking the native tissue 
present in the brain due to the lack of cell to extracellular matrix (ECM) interactions. However, 
biomaterials can serve as a way to mimic the ECM that is present in vivo. These PCL 
microfibers promoted the differentiation of the AHPCs towards glial lineages  (GFAP – 
astrocytes and RIP – oligodendrocytes). In addition to their crucial roles in regulating neuronal 
function, astrocytes also respond to CNS injury [57]. Astrocytes become activated during 
injury and form a glial scar to provide protection but can also increase inflammation in some 
neurological diseases, including Alzheimer’s [58, 59]. 
PCL microfibers may provide topographic and guidance cues, which promote cell 
proliferation and glial differentiation. Along with biochemical signals, cells also regulate their 
behavior using mechanical stimuli from their local microenvironment [60, 61]. Mechanical 
properties of the ECM are of growing interest because in vivo, cells are within a 3-D matrix of 
varying properties such as stiffness and geometry, both of which can be manipulated using 
biomaterials. In this way, biomaterials provide an experimental model in vitro to study cell 
directionality, migration and motility. 
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Conclusions 
A microfluidic platform was used to fabricate PCL fibrous scaffold with a wide range 
of size and patterns in order to study their effects on cellular behavior. Our results have shown 
promise in being able to promote cell proliferation and glial cell differentiation. Combining 
cellular therapeutic strategies with biomaterials can provide a necessary and more conducive 
environment with structural support for cells to survive, proliferate and differentiate into 
specific cell lineages that can be used for CNS rescue and repair. 
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Figures and figure legends 
 
Figure 1. (A) Schematic of microfluidic fiber fabrication process and the effect of shear force, 
at the sheath/core fluids at the fluid/fluid interface, on the topography of the resulting fibers. 
(B) Microfibers placed in a 35 mm petri dish. (C) Sterilized using 70% ethanol. (D) ECL 
diluted in DMEM/F-12 at a concentration of 10 µg/mL. (E) AHPCs cultured in T-75 flask until 
80% confluent, (F) Cells collected using trypsin, and (G) cultured on ECL-coated microfiber 
and control samples for 7 DIV in differentiation media.  
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Figure 2. Scanning electron microscope images of the microfluidic-spun PCL fibers fabricated 
with different patterns of (A) Straight I. (B) Straight II. (C) Straight III. (D) Wavy I. (E) Wavy 
II. Scale bar = 20 µm.  
 
 
 
 
 
 
Table 1. Details of the PCL concentration and flow rate ratio (FRR) used to fabricate PCL 
microfibers with different patterns and diameters. Abbreviation: SEM, standard error the mean. 
N=3 independent experiments for a total of 90 imaging fields analyzed.  
 
PCL 
Concentration 
(w%) 
Sheath:Core 
flow rate 
ratio (FRR) 
Pattern 
Diameter 
(µm) 
(± SEM) 
Median 
(µm) 
Minimum 
(µm) 
Maximum 
(µm) 
5 200:2 Straight I 3 ± 0.11 2.8 1.2 6.8 
2 150:10 Straight II 22.8 ± 0.84 23.5 8.5 42.1 
5 50:10 Straight III 39.1 ± 0.60 39 25.3  
58.4 
 
5 150:5 Wavy I 26.5 ± 0.49 26 16.9 39.9 
5 90:5 Wavy II 29.3 ± 0.76 27.5 16 49 
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Figure 3. The cell density of AHPCs growing on PCL microfibers. Straight I microfiber 
samples had a higher cell density versus all other microfiber types including the planar control 
samples. (A1-E1) AHPCs stained with DAPI on various PCL microfiber diameters. (A2-E2) 
DAPI merged with DIC. Scale bar = 40 µm. Abbreviations: DAPI, 4',6-diamidino-2-
phenylindole; DIC, differential interference contrast. (F) Quantitative analysis of cell density 
on various microfiber samples. Error bars represent standard error of the mean. N = 18 indepe-
ndent experiments for a total of 90 imaging fields. *Significantly different at p ≤0.05. 
***Significantly different at p ≤0.01. ****Significantly different at p ≤0.0001. 
 91 
 
 
 
Figure 4. SEM images of the AHPCs aligned on the surface of different diameters and shapes 
of the microfluidic-spun PCL fibers after 7 days in vitro. (A1-A3) Straight I: 5% PCL and FRR: 
200:2. (B1-B3) Straight II: 2% PCL and FRR: 150:10. (C1-C3) Straight III: 5% PCL and FRR: 
50:10. (D1-D3) Wavy I: 5% PCL and FRR: 150:5. (E1-E3) Wavy II: 5% PCL and FRR: 90:5. 
(A1-E1) scale bar = 20 µm. (A2-E2) scale bar = 10 µm. (A3-E3) scale bar = 5 µm. 
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Figure 5:  Proliferation of AHPCs on PCL microfibers. (A1-E1) Fluorescent images of AHPCs 
illustrating immunoreactivity for Ki-67 on various PCL microfiber diameters: Ki-67-Cy3 (red) 
with DAPI staining (blue). (A2-E2) Ki-67-Cy3 and DAPI merged with DIC. Scale bar = 20 µm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; DIC, differential interference contrast. 
(F) Quantitative analysis of proliferation of AHPCs immunoreactive for Ki-67 antibody. Error 
bars represent standard error of the mean. N = 3 experiments, 5 imaging fields per experiment.  
**Significantly different at p≤0.001. ****Significantly different at p≤0.0001. 
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Figure 6: Neuronal differentiation on PCL microfibers. (A1-E1) Fluorescent images of AHPCs 
immunolabeled for TuJ1 on various PCL microfiber samples: TuJ1-Cy3 (red) with DAPI 
staining (blue). (A2-E2) TuJ1-Cy3 and DAPI merged with DIC. (F1-J1) Fluorescent images of 
AHPCs immunolabeled for MAP2ab on various PCL microfiber samples: MAP2ab-Cy3 (red) 
with DAPI staining (blue). (F2-J2) MAP2ab-Cy3 and DAPI merged with DIC. Scale bar =  20 
µm. Abbreviations: TuJ1, βIII-tubulin; MAP2ab, microtubule associated protein 2ab; DAPI, 
4',6-diamidino-2-phenylindole; DIC, differential interference contrast. (K) Quantitative 
analysis of neuronal differentiation of AHPCs immunoreactive for TuJ1 or MAP2ab 
antibodies. Error bars represent standard error of the mean. N = 3 independent experiments, 5 
imaging fields quantified per experiment.  *Significantly different at p≤0.01. **Significantly 
different at p≤0.002. ****Significantly different at p≤0.0001 
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Figure 7: Glial differentiation on PCL microfibers. (A1-E1) Fluorescent images of AHPCs 
illustrating immunoreactivity for GFAP on various PCL microfiber samples: GFAP-Cy3 (red) 
with DAPI staining (blue). (A2-E2) GFAP-Cy3 and DAPI merged with DIC. (F1-J1) 
Fluorescent images of AHPCs illustrating immunoreactivity for RIP on various PCL 
microfiber samples: RIP-Cy3 (red) with DAPI staining (blue). (F2-J2) RIP-Cy3 and DAPI 
merged with DIC. Scale bar = 20 µm. Abbreviations: GFAP, glial fibrillary acidic protein; 
RIP, receptor interacting protein; DAPI, 4',6-diamidino-2-phenylindole; DIC, differential 
interference contrast. (K) Quantitative analysis of glial differentiation of AHPCs 
immunoreactive for GFAP or RIP antibodies. Error bars represent standard error of the mean. 
N = 3 independent experiments, 5 imaging fields per experiment.  *Significantly different at 
p≤0.05. **Significantly different at p≤0.0058. ***Significantly different at p≤0.0002. 
****Significantly different at p≤0.0001. 
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Table S1: List of primary antibodies 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antibody Specificity Source Vendor Dilution 
Ki-67 (16667) Proliferating cells Rabbit polyclonal Abcam 1:200 
Nestin  (Rat401) Neural Progenitors Mouse monoclonal DSHB 1:200 
TuJ1 (βIII-
tubulin) 
(MAB1195) 
Immature neurons Mouse monoclonal 
R&D 
Systems 1:200 
MAP2ab 
(M1406) Mature neurons 
Mouse 
monoclonal Sigma 1:250 
GFAP (glial 
fibrillary acidic 
protein) 
(MAB360) 
Astrocytes Mouse monoclonal Millipore 1:500 
RIP (receptor 
interacting 
protein) 
Oligodendrocytes Mouse monoclonal DSHB 1:300 
 96 
 
 
 
Figure S1: AHPCs live/dead cell assay using propidium iodide. (A1-3)) As a control for the PI 
reagent, microfiber samples were subjected to ethanol, in order to cause cell death. Dead cells 
will be stained with PI and fluoresce red under a fluorescent microscope. All cell nuclei stained 
with DAPI (blue). (B1-3) Straight I microfiber. (C1-3) Straight II microfiber sample. (E1-3) Wavy 
I microfiber sample. (F1-3) Wavy II microfiber sample. Scale bar = 50 µm.  
 97 
 
 
 
Figure S2: Neural progenitors on PCL microfibers. (A1-E1) Fluorescent images of AHPCs 
illustrating cells immunoreactivity for nestin on various PCL microfiber diameters: nestin-Cy3 
(red) with DAPI staining (blue). (A2-E2) nestin-Cy3 and DAPI merged with DIC. 
Abbreviations: nestin, intermediate filament protein; DAPI, 4',6-diamidino-2-phenylindole; 
DIC, differential interference contrast. (F) Quantitative analysis of AHPCs immunoreactive 
for nestin antibody. Error bars represent standard error of the mean. N = 3 independent 
experiments, 5 imaging fields per experiment.  **Significantly different at p≤0.001. 
****Significantly different at p≤0.0001. 
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Figure S3. AHPCs directionally grown on PCL fibers of different sizes and shapes. (A1-A2) 
Straight I: 5% PCL and FRR: 200:2. (B1-B2) Straight II: 2% PCL and FRR: 150:10. (C1-C2) 
Straight III: 5% PCL and FRR: 50:10. (D1-D2) Wavy I: 5% PCL and FRR: 150:5. (E1-E2) 
Wavy II: 5% PCL and FRR: 90:5. (F) Average neurite length for AHPCs growing on different 
types of fibers. (A1-E1) Scale bars = 20 µm. (A2-E2) Scale bars = 10 µm.  
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Figure S4. SEM images of the AHPCs bridging from one fiber to another fiber. (A1-A2) 
Straight I: 5% PCL and FRR: 200:2. (B1-B2) 2% PCL and FRR: 150:10. (C1-C2) 5% PCL and 
FRR: 50:10. (D1-D2) 5% PCL and FRR: 150:5. (E1-E2) 5% PCL and FRR: 90:5. (A1-E1) scale 
bar = 10 µm. (A2-E2) scale bar = 5 µm. 
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Figure S5: AHPCs bridging between PCL microfibers of varying distances. (A1) Fluorescent 
image of AHPCs immunolabeled for nestin on PCL microfiber samples: Nestin-Cy3 (red) with 
DAPI staining (blue). (A2) Nestin-Cy3 and DAPI merged with DIC. (B1) Fluorescent image of 
AHPCs immunolabeled for GFAP on PCL microfiber samples: GFAP-Cy3 (red) with DAPI 
staining (blue). (B2) GFAP-Cy3 and DAPI merged with DIC. Maximum z-projection of GFAP 
immunolabeling of AHPCs on microfiber (Supplemental M1). (C1) Fluorescent image of 
AHPCs immunolabeled for RIP on PCL microfiber samples: RIP-Cy3 (red) with DAPI 
staining (blue). (C2) RIP-Cy3 and DAPI merged with DIC. Scale bar = 40 µm. Abbreviations: 
nestin, intermediate filament protein; GFAP, glial fibrillary acidic protein; RIP, receptor 
interacting protein; DAPI, 4',6-diamidino-2-phenylindole; DIC, differential interference 
contrast. 
 
Supplemental Movie 1: AHPCs with processes wrapped around Straight III PCL microfiber. 
GFAP-Cy3 (red) with DAPI staining (blue). Maximum intensity projection created from 39 
µm z-stack with 1 µm slices. Scale bar = 50 µm. Abbreviations: GFAP, glial fibrillary acidic 
protein; DAPI, 4',6-diamidino-2-phenylindole.  
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Abstract 
Due to the limitations imposed by traditional two-dimensional (2D) cultures, biomaterials have 
become a major focus in neural and tissue engineering to study cell behavior in vitro. 2D 
systems  fail to account for interactions between cells and the surrounding environment; these 
cell-matrix interactions are important to guide cell differentiation and influence cell behavior 
such as adhesion and migration. Biomaterials provide a unique approach to help mimic the 
native microenvironment in vivo. In this study, a novel microfluidic technique is used to 
encapsulate adult rat hippocampal stem/progenitor cells (AHPCs) within alginate-based 
fibrous hydrogels. To our knowledge, this is the first study to encapsulate AHPCs within a 
fibrous hydrogel. Alginate-based hydrogels were cultured for 4 days in vitro and recovered to 
investigate the effects of a 3D environment on stem cell fate. Post recovery, cells were cultured 
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for an additional 24 or 72 hours in vitro before fixing cells to determine if proliferation and 
neuronal differentiation were impacted after encapsulation. The results indicate that the 3D 
environment created within a hydrogel promotes AHPC proliferation and neuronal 
differentiation, however this effect is acute. By 72 hours post recovery, cells had comparable 
levels of proliferation and neuronal differentiation compared to control conditions. Fibrous 
hydrogels may better mimic the natural microenvironment present in vivo and be used to 
encapsulate AHPCs, enhancing cell proliferation and selective differentiation. Understanding 
cell behavior within 3D scaffolds may lead to the development of directed therapies for central 
nervous system repair and rescue. 
 
Keywords: Three-dimensional scaffolds; hydrogels; fibrous scaffolds; neural stem cells; 
proliferation; neuronal differentiation; tissue engineering; transplantation. 
 
Introduction 
Neurodegenerative diseases and injury can lead to severe deficits in sensory, motor and 
cognitive function, prompting researchers to investigate and develop novel therapeutic 
strategies targeting these conditions. Cellular therapies, including stem and progenitor cell 
transplants, may be used as a means for aiding regeneration by 1) directing those cells to 
differentiate into specific neurons or glial cells for cell replacement or 2) to serve as a source 
of neurotrophic/growth factors to enhance neuroprotection and repair. Multipotent adult neural 
stem/progenitor cells (NSCs) are an appealing source of cells to study and use in 
transplantation due to their ability to differentiate into neurons, astrocytes and 
oligodendrocytes [1]. Further, it is important to study these cells in a more native environment, 
rather than in a two-dimensional (2D) system. Traditional 2D cultures fail to reliably mimic 
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the natural microenvironment present within tissues [2]. Therefore, recent advances in tissue 
engineering have largely focused on using biomaterials in combination with cells as a means 
to better understand their three-dimensional (3D) microenvironment present in vivo.  
Encapsulating cells during scaffold formation provides structural support similar to that 
of the tissue microenvironment [3]. Scaffolds such as hydrogels are ideal for cell encapsulation 
because they provide a 3D framework in which the mechanical properties can be tailored to 
specific tissue constructs. Hydrogels are cross-linked networks of polymers that swell when 
hydrated providing an environment that mimics more native tissue structure ideal for cell 
growth [4].  Polymerization processes employing natural and synthetic hydrogels have been 
used to encapsulate cells [5]. One such natural polymer is alginate, a Food and Drug 
Administration (FDA)-approved and biocompatible polymer that is found in brown algae and 
some bacteria [6, 7]. Alginate can be polymerized by chemical cross-linking, allowing for more 
controllable and tunable mechanical and degradation properties [8]. Further, it has been used 
in multiple areas of regenerative medicine including cartilage and bone repair making it a 
versatile polymer for investigating tissue engineering [9, 10].  
To facilitate cell survival, cell encapsulation methods must be biocompatible and 
minimize the use of harsh conditions for polymerization. One approach is using a microfluidic 
platform in which polymerization can occur via cross-linking of a core and sheath fluid [11-
15]. Previous studies have used microfluidics to encapsulate cells within microparticles, 
microspheres, and microgels [16-19]. In addition to these applications, the microfluidic 
technique is capable of forming continuous fibers. Fibers are ideal for aiding in cell alignment 
and elongation during regeneration. Further, the ability to adjust parameters such as 
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concentrations of sheath and core fluids as well as flow-rates, provides more flexibility during 
the fabrication [20] and encapsulation process.  
The present study consists of two major goals: The first aim is to utilize a microfluidic 
technique to encapsulate adult hippocampal progenitor cells (AHPCs) within alginate 
hydrogels. Although NSCs have been encapsulated within alginate hydrogels [21], using 
fibrous hydrogels has, to our knowledge, not been reported. Fibrous scaffolds are an area of 
interest in tissue engineering and regenerative medicine because they can mimic the native 
extracellular matrix (ECM), an important regulator of cell migration, cell fate determination 
and dynamic behavior such as adhesion and proliferation [22, 23].  Secondly, to better 
understand the effects of the 3D environment created by the hydrogels, cells were recovered 
after encapsulation using a phosphate buffered saline to investigate changes in proliferation 
and differentiation of the AHPCs. 
Here, we report the ability to encapsulate AHPCs within microfluidic-spun fibrous 
scaffolds. Importantly, the encapsulation procedures had no deleterious effects on cell viability 
though positively impacted proliferation and neuronal differentiation of cells. Specifically, our 
results demonstrate recovered AHPCs had increased proliferation and neuronal differentiation 
after 24 hours of recovery, however, by 72 hours post recovery, there was no significant 
difference in cell proliferation or neuronal differentiation compared with control cells. 
Encapsulation of AHPCs within microfluidic-spun hydrogels can be used to direct cell 
differentiation and improve upon current transplantation strategies for nervous system rescue 
and repair.  
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Materials and Methods 
Preparation of Microfluidic Device and Channels 
The microfluidic mold used for this study was created on a silicon wafer using soft 
photolithography as previously described [24, 25]. Briefly, to create the microfluidic device, 
polydimethylsiloxane (PDMS, Dow Corning Corporation, Midland, MI) was mixed in a 1:10 
ratio of elastomer curing agent to elastomer base and was poured onto the molds. After 
allowing time for degassing, the two halves were hardened at 80°C for 25 minutes. Layers 
were added via plasma cleaning on medium strength for 20 seconds for added thickness. The 
two halves were prepared using the same plasma cleaning process, and then were aligned 
visually using a dissecting microscope. Microfluidic channels were generated using PDMS, 
IDEX Health and Science Polymer Tubing (1/16x0.04x5ft), and Devcon Home 1:1 Epoxy. 
Devices were sterilized via autoclaving.  
 
Preparation of Solutions 
The pre-gel solution was made by dissolving 6% alginate (Alfa Aesar, Haverhill, MA) 
in Corning Cellgro Sterile WFI-Quality water at room temperature overnight. Before use, pre-
gel solutions were filtered using syringe filters under pressure in the following sequence: 3 µm 
pore size, 0.45 µm pore size, and sterile 0.22 µm pore size. Half of the prepared solution was 
stored at room temperature, while the other half was placed in the freezer for storage and later 
use. For the sheath fluid, 0.5% CaCl2 5% poly(ethylene glycol) (PEG) solutions were created 
with deionized water and sterile filtered with a 0.22 µm pore size syringe filter. 
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Cell Culture 
 
Adult hippocampal progenitor cells (AHPCs) were generously gifted by Dr. F. Gage 
(Salk Institute for Biological Sciences, La Jolla, CA). The AHPCs were isolated from Fischer 
344 rats and were infected with a retrovirus to induce expression of green fluorescent protein 
(GFP) [26]. The AHPCs were cultured in poly-L-ornithine (POL; 10 µg/mL; Sigma-Aldrich, 
St. Louis, MO) and laminin (10 µg/mL; R&D Systems, Minneapolis, MN) coated T-75 tissue 
culture flasks in maintenance media (MM) composed of Dulbecco’s modified Eagle’s 
medium/Ham’s F-12 (DMEM/F-12, 1:1; Omega Scientific, Tarzana, CA) supplemented with 
2.5 mM L-glutamine (GlutaMAX; Thermo Fisher Scientific, Waltham, MA), N2 supplement 
(Gibco BRL, Gaithersburg, MD), and 20 ng/mL basic fibroblast growth factor (bFGF; 
Promega Corporation, Madison, WI). Cells were maintained at 37°C in 5% CO2/95% 
humidified air atmosphere. Half of the volume of cultured media was replaced with fresh MM 
every two days. To collect cells for encapsulation, they were detached using 0.05% trypsin-
EDTA (Gibco BRL). Cell suspensions were collected and centrifuged at 800 rpm for 5 minutes 
then resuspended in fresh MM. 
 
Cell Encapsulation 
 
The 6% alginate solutions were mixed in a 1:3 ratio with cell suspension (average of 
7,500 cells/µL) and media, respectively. The resulting mixture was placed into a 1 mL BD 
syringe and introduced with a constant flow into the core channel of the microfluidic device. 
Similarly, the sheath solution was pumped into the two side channels to help guide and solidify 
the core solution. A flow rate ratio of 250:10 (µL/min: µL/min) sheath:core rate was used to 
fabricate all fibers, which were introduced into a 5% calcium chloride dihydrate (CaCl2; Fisher 
Scientific, Hampton, NH) and Poly(ethylene Glycol) (PEG; Sigma-Aldrich) to adjust 
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viscosity. Hydrogels were collected into 24 well plates and cultured for 4 days in MM at 37°C 
in 5% CO2/95% humidified air atmosphere. To compare cells growing within hydrogels, two 
control conditions were also established in parallel: 1) cells were collected prior to addition of 
alginate solution and 2) cells were subjected to the same alginate solution used to fabricate all 
fibers, but without the polymerization step. Cells from these controls were collected and 
cultured on glass coverslips coated with poly-L-ornithine (10 µg/mL) and purified mouse 
laminin (5 µg/mL) (POL) diluted in Earle’s Balanced Salt Solution ((EBSS) Gibco BRL). Cells 
grown in hydrogels and control conditions were cultured for 4 days in vitro (DIV).  
 
Cell Recovery 
 
 After 4 DIV, fibers were collected from wells using a P-1000 micropipette and 
centrifuged at 800 rpm for 5 minutes. The supernatant was discarded and the pellet resuspended 
with 5 mL of sterile filtered 0.1 M PO4 buffer for 20 minutes to depolymerize the alginate 
hydrogels. After 20 minutes, the solution was centrifuged at 800 rpm for 5 minutes. The 
supernatant was discarded and the pellet was re-suspended with fresh MM. The cells cultured 
under the control conditions were collected from the POL coverslips using 0.05% trypsin-
EDTA. The cells were centrifuged at 800 rpm for 5 minutes and the pellet resuspending in 
fresh MM. A Trypan blue (Gibco BRL) viable cell count was performed on the cell samples 
collected from the hydrogels and the two control conditions and cells were seeded onto POL 
glass coated coverslips (12,000 cells/coverslip) from each condition. Cells were cultured at 
37°C in 5% CO2/95% humidified air atmosphere for either 24 or 72 hours after recovery. 
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Immunocytochemistry 
 
After 24 or 72 hours after recovery, the cultured cells were rinsed twice with 0.1 M 
PO4 buffer, fixed with 4% paraformaldehyde (PFA; Fisher Scientific) in 0.1 M PO4 buffer for 
20 minutes then rinsed with phosphate buffered saline (PBS; Invitrogen, Carlsbad, CA) 3 
times for 7 minutes each. Samples were incubated in blocking solution composed of 0.2% 
Triton X-100 (Thermo Fisher Scientific), 2.5% normal donkey serum (NDS; Jackson 
ImmunoResearch), 2.5% normal goat serum (NGS; Jackson ImmunoResearch), and 0.4% 
bovine serum albumin (BSA; Sigma-Aldrich) in PBS at room temperature for 1 hour. 
Primary antibodies rabbit a Ki-67 (16667, Abcam), mouse a TuJ1 (MAB1195, R&D 
Systems), or mouse a GFAP (MAB360, Millipore) were diluted in blocking solution and 
samples were incubated overnight at 4°C. The next day, samples were rinsed 4 times for 8 
minutes each with PBS and secondary antibodies (donkey anti-rabbit Cy3 or donkey anti-
mouse Cy3 (1:500; Jackson ImmunoResearch) and 4',6-diamidino-2-phenylindole (DAPI) 
nuclear stain (1:50; Invitrogen) were diluted in blocking solution and incubated at room 
temperature for 90 minutes. After incubation, samples were rinsed 4 times for 8 minutes each 
in PBS. Samples were mounted onto glass slides using Vectashield with DAPI (Vector 
Laboratories; Burlingame, CA). Samples were stored at 4°C in the dark until imaging. 
 
Imaging 
 
After immunocytochemistry samples were imaged using a Nikon Microphot FXA 
(Nikon Corp., Melville, NY, USA) microscope equipped with standard epifluorescence 
illumination and a Q imaging Retiga 2000R (Q Imaging, Burnaby, BC, Canada) digital camera. 
A 20x objective was used to obtain images for quantitative data analysis. For the analysis, 5 
microscopic fields were imaged per condition per sample, each field representing 0.24 mm2. 
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A total of six independent experiments were conducted, with a total of 30 images quantified 
per antibody, per condition. A Zeiss LSM700 Confocal (Oberkochen, Germany) microscope 
equipped with an AxioCam MRc5 was used to image samples for high-resolution images with 
a 20x objective.  
 
Quantitative Data Analysis 
 
After immunocytochemical experiments and imaging, quantitative analysis was 
conducted using the Fiji software [27]. From each replicate, 5 imaging fields were chosen per 
sample for each primary antibody for a total of 30 imaging fields quantified. The following 
counts were made in each field to determine the percentage of immunolabeled cells for each 
respective antibody: total number of immunolabeled cells divided by the total number of cells 
(DAPI-stained nuclei). GraphPad Prism v6 software (GraphPad Software, Inc., La Jolla, CA, 
USA) was used for statistical analysis. ANOVA was used to compare the means across the 
conditions per antibody. A p-value of ≤ 0.05 was considered significant. Error bars represent 
the standard error of the mean. 
 
Results 
Increase in proliferation after recovery from hydrogels  
 
AHPCs were successfully encapsulated into fibrous hydrogels using a microfluidic 
platform. Figure 1 (A1,B1) shows phase contrast images at low and high magnifications of 
AHPCs encapsulated within alginate hydrogels at 4 DIV. To assess changes in proliferation 
and differentiation, AHPCs were recovered from hydrogels using phosphate buffered saline 
which depolymerizes the hydrogel. Cells were collected and plated on POL coated glass 
coverslips and cultured for an additional 24 or 72 hours. After recovery, cells were monitored 
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for normal growth in vitro and it was evident that the cells continued to proliferate post 
recovery from 24 to 72 hours and have short processes characteristic of the AHPCs in vitro 
(Figure 1 (A2-A4, B2-B4). These results demonstrate successful recovery of viable cells after 
encapsulation within alginate hydrogels.  
To determine if encapsulation within alginate fibers affects AHPC proliferation, 
immunocytochemistry experiments were conducted after recovery to detect the Ki-67 antigen, 
a nuclear protein present during G1, S, G2, and M phases of the cell cycle [28]. Our results 
demonstrate that 24 hours after cell recovery, significantly more AHPCs were proliferating 
compared to control conditions (Figure 2).  Further, when comparing the two control 
conditions, there were no significant differences demonstrating that the increase in 
proliferation of the recovered AHPCs can be attributed to the 3D environment provided by the 
hydrogels and not due to the alginate solution (Figure 2 (A1-A2, B1-B2, C1-C2)). The 
percentage of Ki-67 immunolabeled AHPCs was 6.1% ± 1.3, 11.9% ± 3.7, and 19.1% ± 4.5 
(control cells in MM, alginate solution control and recovered AHPCs), respectively (Figure 2 
(D1-D2)). When assessing proliferation after 72 hours post recovery, no significant differences 
were found between all conditions. Taken together, these results may indicate that the increase 
in the number of AHPCs proliferating following recovery from the hydrogels is likely due to 
the 3D fibrous environment of the hydrogel, not the alginate solution itself, and the alginate 
hydrogels provide cues promoting cell proliferation.  
 
Recovered AHPCs have increased neuronal differentiation 
  
A number of studies have demonstrated that 3D scaffolds can be used to influence and 
direct cell differentiation without chemical inducers [21, 29-31].  The multipotent AHPCs have 
the ability to differentiate into neurons, astrocytes and oligodendrocytes in vitro [32]. Neuronal 
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differentiation of the AHPCs was characterized using the TuJ1 (class III β-tubulin) antibody, 
a marker for developing neurons [33, 34]. Though some AHPCs in all conditions were 
immunopositive for TuJ1, there was an increase in TuJ1 immunoreactivity for cells after 24 
hours post recovery from the hydrogels (Figure 3 (A1-C1)). The percentage of TuJ1-
immunolabeled AHPCs 24 hours post recovery was 5.9% ± 1.7, 5.9% ± 0.6, and 13.5% ± 2.2 
compared to 6.3% ± 1, 7.3% ± 1.2, and 8.3% ± 1.9 following 72 hours post recovery (control 
cells in MM, alginate control and recovered AHPCs, respectively (Figure 3 (D1-D2)). No 
significant differences were found after 72 hours post recovery (Figure 3 (A2-C2)). Overall, 
alginate-based fibrous hydrogels have the ability to direct encapsulated AHPCs to differentiate 
into neurons. Further, results suggest the 3D environment is providing unique cues for cells to 
differentiate and this response is acute rather than long-term.  
Lastly, to determine if alginate hydrogels affect glial differentiation of AHPCs, glial 
fibrillary acidic protein (GFAP) was used to determine if astrocytes were present after recovery 
(Figure 4 (A-C)). While a small percentage of cells from all conditions (control cells in MM, 
alginate control and recovered AHPCs) were positive for GFAP immunolabeling, no 
significant differences between conditions were detected ((p≤0.05) (Figure 4 (D1-D2)). These 
results support previous studies in which AHPCs in MM have less than 2% of cells 
differentiating into GFAP immunopositive cells, even after 6 DIV [35]. 
Together, these results demonstrate that encapsulation of AHPCs within fibrous 
hydrogels influences proliferation and differentiation. The changes in mechanical and physical 
properties of the scaffold due to microfluidic spinning of alginate may have contributed to the 
increase in proliferation and neuronal differentiation of the recovered AHPCs. Recovered cells 
had increased proliferation and neuronal differentiation compared to control conditions at 24 
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hours after recovery. Interestingly, 72 hours after recovery, AHPCs in all conditions displayed 
similar levels of proliferation and neuronal differentiation. Thus, the 3D environment created 
by the hydrogel influenced cell proliferation and differentiation in vitro. Hydrogels may be 
used as scaffolds to investigate novel methods to influence cell proliferation and direct stem 
cell fate. 
 
Discussion 
Using the microfluidic technique, we have successfully encapsulated AHPCs within 
alginate-based fibrous hydrogels and cultured them for 4 DIV. Viable cells were recovered and 
immunostained after 24 or 72 hours to assess changes in proliferation and differentiation of 
cells. Our results demonstrate recovered AHPCs had an increase percentage of proliferating 
cells as well as immature neurons compared to cells cultured in control conditions. 
Interestingly, this effect was short-term and only seen at 24 hours; by 72 hours, the percentage 
of cells positive for Ki-67 or TuJ1 were comparable to control conditions. Overall, our results 
demonstrate that the 3D environment enhanced AHPC proliferation and neuronal 
differentiation after encapsulation within hydrogels. 
To encapsulate AHPCs within alginate-based fibrous hydrogels, a microfluidic 
platform was used because this technique is biocompatible compared to other techniques such 
as electrospinning, which requires high voltages and harsh methods to achieve polymerization 
[36]. Bacterial cells, growth factors and drugs have been encapsulated using the 
electrospinning technique [37-39]. To the best of our knowledge, there has been no report of 
successful encapsulation of AHPCs using the electrospinning method. Therefore, a 
microfluidic approach is ideal for cell encapsulation, which can lead to development of 
biomaterial-based therapeutic strategies.  
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Neural stem cells have previously been encapsulated within alginate-based hydrogels 
in order to study cell behavior in vitro and in vivo [40, 41]. Banerjee and colleagues found that 
hydrogel modulus influences stem cell differentiation; particularly hydrogels with elastic 
moduli similar to brain tissue promoted encapsulated cells towards a neuronal lineage. 
However, this study only examined NSCs once encapsulated but not after recovery from the 
hydrogels [21]. Another study recovered viable NSCs that were encapsulated in calcium 
alginate beads, however no changes in proliferation or differentiation were assessed [42]. Our 
results provide a quantitative analysis of recovered AHPCs from alginate hydrogels in order to 
better understand how the 3D environment influenced cell proliferation and differentiation in 
vitro.  
In addition to previous literature, our interest focused on fabricating fibrous scaffolds 
for cell encapsulation using a microfluidic technique. Few studies have investigated cell 
encapsulation within alginate-based fibrous hydrogels fabricated using a microfluidic 
approach [43, 44]. However, there has been no report of encapsulation and recovery of AHPCs 
from alginate fibrous hydrogels. The microfluidic platform can be versatile when fabricating 
fibers, which can be used to better mimic the microenvironment of native tissue. Fibers can be 
clinically relevant for guiding axon regrowth and guidance for spinal cord and peripheral nerve 
injuries [45] as well as scaffolds to guide cell differentiation [30]. 
One of the key influencers of cell migration and cell fate determination is the 
microenvironment created by the ECM [46, 47]. The ECM is a complex network of fibrous 
proteins (such as fibronectin, laminin and collagen) and carbohydrates that is crucial for 
providing mechanical cues that aid in cell adhesion and signaling in vivo, making it difficult to 
mimic in vitro [2]. Traditional 2D models face challenges in mimicking the native tissue 
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present in the brain due to the lack of complex cell to ECM interactions. However, 
biomaterials, such as hydrogels, can serve as a platform to mimic the ECM present in vivo. 
Integrins on the cells’ surface sense the mechanical properties within the ECM [48] and are 
important in cell adhesion and differentiation of NSCs. Notch1 and integrin receptors are 
highly expressed in mammalian NSCs and involved in adhesion along with cell fate 
determination [49]. Integrins expressed in AHPCs play a crucial role in the morphological 
differentiation [50].  Our results demonstrate that encapsulated and recovered AHPCs had 
increased proliferation and neuronal differentiation, indicating there may be a connection to 
signaling pathways utilizing integrin-mediated focal adhesions in this study.  
Taken together, multiple studies have utilized materials, topographies and mechanical 
properties to investigate ways to control cell proliferation and differentiation as well as gain a 
better understanding of how cells rely on the microenvironment for fate determination [51-53]. 
Moreover, the ability to control stem cell proliferation and differentiation without chemical 
inducers is clinically relevant in neural tissue engineering.  
 
Conclusion 
A microfluidic platform was used to encapsulate AHPCs within an alginate-based 
hydrogel fibers. Our results show that fibrous hydrogels promote cell proliferation in vitro and 
support neuronal and glial differentiation. Hydrogels can be used to develop rationale strategies 
for cell transplantation due to their ability to mimic the native microenvironment and direct 
cell differentiation. Hydrogels in combination with cell encapsulation and transplantation 
approaches can be used for multiple biomedical engineering applications including cellular 
therapies, drug and gene delivery strategies. 
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Figures and figure legends 
 
Figure 1: AHPCs encapsulated within fibrous hydrogels and recovered after 4 DIV. 
Proliferation of AHPCs post cell recovery in vitro indicate that cells survive following 
encapsulation within alginate hydrogels. (A1,B1) AHPCs encapsulated within alginate 
hydrogels. (A2-A4) AHPCs recovered from hydrogels at 24, 48 and 72 hours post recovery. 
(B2-B4) AHPCs recovered from hydrogels at 24, 48 and 72 hours post recovery at higher 
magnification. Top row images taken with a 10x objective. Bottom row images taken with a 
20x objective. Scale bar = 50 µm. 
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Figure 2: Proliferation of AHPCs following recovery after 4 days of encapsulation. 
Fluorescence images of AHPCs illustrating immunoreactivity for Ki-67 24 hours after 
recovery (A1-C1) and 72 hours after recovery (A2-C2): Ki-67-Cy3 (red) with DAPI staining 
(blue). AHPCs cultured in maintenance media (A1-A2), alginate control (B1-B2), and recovered 
from hydrogels (C1-C2). Asterisks indicate the location of the higher magnification inset 
images. Higher magnification images are of the Ki-67-Cy3 channel only. Scale bar = 50 μm 
(20 μm for insets). Abbreviations: DAPI, 4',6-diamidino-2-phenylindole. (D1 and D2), 
Quantitative analysis of AHPCs immunoreactive for Ki-67 antibody. Error bars represent 
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standard error of the mean. N = 6 independent experiments, 5 imaging fields per experiment.  
*Significantly different at p≤0.05.  
 
Figure 3: Neuronal differentiation of recovered AHPCs after 4 days of encapsulation. 
Fluorescence images of AHPCs illustrating immunoreactivity for TuJ1 24 hours after recovery 
(A1-C1) and 72 hours after recovery (A2-C2): TuJ1-Cy3 (red) with DAPI staining (blue). 
AHPCs cultured in maintenance media (A1-A2), alginate control (B1-B2), and recovered from 
hydrogels (C1-C2). Asterisks indicate the location of the higher magnification inset images. 
Higher magnification images are of the TuJ1-Cy3 channel only. Scale bar = 50 μm (20 μm for 
insets). Abbreviations: DAPI, 4',6-diamidino-2-phenylindole. (D1 and D2), Quantitative 
analysis of AHPCs immunoreactive for TuJ1 antibody. Error bars represent standard error of 
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the mean. N = 6 independent experiments, 5 imaging fields per experiment.  *Significantly 
different at p≤0.05.   
 
Figure 4: Glial differentiation of recovered AHPCs after 4 days of encapsulation. 
Fluorescence images of AHPCs illustrating immunoreactivity for GFAP 24 hours 
after recovery (A1-C1) and 72 hours after recovery (A2-C2): GFAP-Cy3 (red) with 
DAPI staining (blue). AHPCs cultured in maintenance media (A1-A2), alginate 
control (B1-B2), and recovered from hydrogels (C1-C2). Asterisks indicate the location 
of the higher magnification inset images. Higher magnification images are of the 
GFAP-Cy3 channel only. Scale bar = 50 μm (20 μm for insets). Abbreviations: DAPI, 
4',6-diamidino-2-phenylindole. (D1 and D2), Quantitative analysis of AHPCs 
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immunoreactive for GFAP antibody. Error bars represent standard error of the mean. 
N = 6 independent experiments, 5 imaging fields per experiment.
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Abstract 
Background 
Primary cell culture is a valuable tool to utilize in parallel with in vivo studies in order to 
maximize our understanding of the mechanisms surrounding neurogenesis and central nervous 
system (CNS) regeneration and plasticity.  The zebrafish is an important model for biomedical 
research and primary neural cells are readily obtainable from their embryonic stages via tissue 
dissociation.  Further, transgenic reporter lines with cell type-specific expression allows for 
observation of distinct cell populations within the dissociated tissue. 
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New Method 
Here, we define an efficient method for ex vivo characterization and quantification of neural 
tissue dissociated from embryonic zebrafish. 
Results 
Zebrafish brain dissociated cells survived in culture for up to 9 days in vitro (div).  Anti-Elavl 
and anti-Acetylated Tubulin antibodies were used to identify neurons in culture; at 3 div 
approximately 48% of cells were Elavl positive and 85% expressed serotonin, suggesting our 
protocol can efficiently isolate neurons from whole embryonic zebrafish brains. Live time-
lapse imaging was also carried out to analyze cell migration in vitro.  
Comparison with Existing Methods 
Primary cultures of zebrafish neural cells typically have low rates of survivability in vitro.  We 
have developed a new culture system that improves long term cell viability, enabling direct 
analysis of cell-cell and cell-extracellular matrix interactions.   
Conclusions 
These results demonstrate a practical method for isolating, dissociating and culturing of 
embryonic zebrafish neural tissue. This approach could further be utilized to better understand 
zebrafish regeneration in vitro 
Introduction 
The use of zebrafish, Danio rerio, has emerged as a powerful tool in several aspects of 
developmental biology and biomedical research, frequently utilized as an in vivo model for 
several etiologies due to their optical clarity and external embryonic development [1]. The 
zebrafish boasts a fully sequenced genome, which makes it favorable to use for gene editing 
technologies such as TALEN or CRIPSR/Cas9 [2].  Likewise, the availability of cell and tissue 
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specific fluorescent reporter lines allows for direct observations in the developing organism 
[3]. 
During embryonic development, neurogenesis begins in the zebrafish soon after 
gastrulation, defined by rapid proliferation and differentiation of neural progenitor cells, 
driving the formation of distinct brain and retinal structures as early as 2 days post fertilization 
(dpf) [4, 5]. Complementary to the dynamic shaping of the early nervous system, regeneration 
of mature neural tissue has been observed in the adult zebrafish.  Functional and anatomical 
recovery of the CNS after brain or spinal cord injury occurs after initiation of axon regeneration 
and neurogenesis from putative stem cells [6], existing mature neurons [7], and radial glial 
cells [8].  These investigations have been crucial to our understanding of the cellular and 
molecular processes of neurogenesis and may potentially lead to the application of these 
findings in treating CNS disease or injury.   
In addition to in vivo models, in vitro models have also been productive in gaining 
insights on the mechanisms of neuron specification and the active analysis of neural migration, 
though these studies have been primarily conducted in cells isolated from mammalian models 
[9-11]. In vitro methods utilizing neural tissue from both larval and adult zebrafish have been 
previously described and are becoming more prevalent, though methods commonly result in a 
heterogeneous population of cells isolated from whole zebrafish embryos [12-24]. The benefit 
of a primary culture system is that it allows direct observation of cell-type specific processes, 
which can easily be subject to molecular manipulation, chemical toxicity screening, and/or live 
imaging.  Additionally, zebrafish brain-derived cells can provide insight into mechanisms 
specific to lower vertebrates and help us understand regeneration and plasticity that may be 
applicable to human medicine. 
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Here, we report a novel and efficient method to isolate and dissociate zebrafish neural 
tissue adapted from a previous method of neural progenitor isolation from fetal mouse intestine 
[25]. Current protocols have demonstrated little quantitative assessment of zebrafish neural 
tissue derived cells. We sought to characterize the various cell types in culture using 
immunocytochemistry experiments. Zebrafish brain-derived cells were cultured for up to 9 
days in vitro (div) with characterization of cells at 3 and 6 div.  Our results produced a clean 
and efficient method for utilizing zebrafish as a source for primary neural culture.  Further, we 
performed time-lapse imaging to better understand the dynamic nature of the dissociated cells 
and analyzed migration rates for different cell morphologies.  
 
Methods 
Fish Stocks and Husbandry 
 
Embryos were obtained from the wild-type zebrafish line NHGRI (Zebrafish 
International Resource Center - ZIRC) and from zebrafish lines Tg(elavl3:GFP) [26] (provided 
by Dr. Robert Cornell, University of Iowa) and Tg(gfap:GFP)mi2001 [27]. Adult fish used for 
the generation of embryos were raised at 28.5°C in a light/dark cycle according to standard 
zebrafish husbandry protocols [28].  All experiments were performed within U.S. laws, 
guidelines, and policies for laboratory animals and were approved by the Institutional Animal 
Care and Use Committee (IACUC) and Institutional Biosafety Committee at Iowa State 
University. 
 
Embryo Collection and Gnotobiotic Techniques  
  
Fertilized embryos were collected after natural spawning.  At 24 hours post fertilization 
(hpf), developing embryos were incubated in 100 units/mL penicillin, 100 µg/mL 
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streptomycin, and 0.25 µg/mL Amphotericin B Anti-biotic/Anti-mycotic solution (Sigma 
Aldrich, St. Louis, MO) in sterile embryo media (0.63g marine salt/liter) for 2-6 hours at 
29.6°C.  Embryos were rinsed in fresh sterile embryo media, washed in 0.005% sodium 
hypochlorite for 2 minutes, a subsequent rinse of sterile embryo media, then washed in 0.01% 
polyvinylpyrrolidone-iodine for 2 minutes.  After disinfection, the embryos were rinsed two 
times in sterile embryo media and raised in an incubator at 29.6°C until 48-hpf (modified from 
[29] At 48-hpf, surviving embryos were selected, rinsed in 0.005% sodium hypochlorite and 
placed in fresh sterile embryo media before being processed for cell culture. 
 
Dissection and Dissociation  
 
Embryos were staged to long pec stage (48-hpf) and where required, selected for GFP 
expression [28].  Embryos still in the chorion at the time of processing were manually removed 
from the chorions using fine forceps.  For dissection, embryos were anesthetized in 0.01% 
MS222 (tricaine methanesulfonate, Sigma Aldrich) in Hank’s Balanced Salt Solution (HBSS; 
Sigma Aldrich).  Removal of the whole brain was done by first separating the head from the 
remaining embryo at the anterior portion of the spinal cord and then applying gentle pressure 
immediately anterior of the optic tectum. The whole brain was released from the cut posterior 
portion of the head.  Tissue was collected in HBSS on ice with a maximum of 20 brains per 
tube, then spun down at 1500 rpm for 5 minutes at 4°C and remaining HBSS removed.  For 
dissociation, Accumax™ (Innovative Cell Technologies, Inc, San Diego, CA) was added at a 
volume of 200 µL, followed by a 7-minute incubation in a 37°C water bath.  To stop the 
dissociation reaction, 700 µL of zebrafish culture media (see below) was added to the tube and 
mixed by gentle pipetting.  The sample was then spun again at 1500 rpm for 5 minutes at 4°C 
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and the cell-free supernatant discarded.  The remaining pellet was resuspended in 100 µL of 
fresh culture media and placed on ice until plating.   
 
Substrate Preparation and Cell Culture 
 
Entactin-Collagen IV-Laminin (ECL; Millipore, Burlington, MA) was diluted in L-15 
basal media to a final concentration of 10 µg/mL and vortexed. Using a 12-channel 
micropipette, 100 µL of ECL solution was added into each well of a 96-well plate (Greiner 
Bio-One, Kremsmünster, Austria). The plate was sealed using Parafilm and stored overnight 
at 4°C.  
For propidium iodide experiments, 12 mm glass coverslips were cleaned with RBS-35 
detergent (1:50 in deionized (DI) water; Thermo Fisher Scientific, Waltham, MA) and boiled 
for 15 minutes. Coverslips were rinsed in DI water and sterilized under ultraviolet light for 1 
hour. Coverslips were coated with ECL diluted in L-15 basal media (10 µg/mL) overnight at 
4°C. 
After dissociation, a Trypan blue (Sigma Aldrich) viable cell count was performed 
using a hemocytometer. The zebrafish brain-derived neural cells were plated at 6,000 cells/well 
in 96 well plates. Zebrafish complete media was composed of L-15 (Sigma Aldrich), 
supplemented with 2.5 mM L-alanyl-L-glutamine (GlutaMAX; Thermo Fisher Scientific), 15 
ng/mL epidermal growth factor (human recombinant EGF; Thermo Fisher Scientific), 10% 
fetal bovine serum (FBS; Atlanta Biologicals, Flowery Branch, GA) and 5% zebrafish embryo 
extract. Embryo extract was prepared as detailed in Kinikoglu et al., 2013.  Briefly, 200 3-dpf 
embryos were rinsed with 0.5% sodium hypochlorite in sterile embryo medium followed by 
three subsequent washes in calcium-magnesium-free PBS. Embryos were transferred to a 1.5 
mL microcentrifuge tube and excess PBS was removed, leaving only enough PBS to cover the 
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embryos in the tube. Embryos were then homogenized on ice using a pestle, followed by 
addition of L-15 basal media, and centrifugation at 900 rpm at 4°C for 6 minutes. The 
supernatant was removed and filtered through a 0.22 µm sterile filter and stored at -20°C.  
Cells were maintained in ambient temperature in a sterile environment. For time-lapse 
studies, media from wells was removed, the wells rinsed with sterile HBSS and fresh media 
was added prior to placing the 96 well plate into the ImageXpress Micro XLS. For 
immunocytochemistry experiments to characterize cells, media was changed every other day 
and cells were cultured for 3, 6 or 9 div.  
 
Immunocytochemistry  
 
After 3 or 6 days, the cells were rinsed twice with 0.1 M phosphate buffer followed by 
fixation with 4% paraformaldehyde (PFA; Thermo Fisher Scientific) in 0.1 M phosphate buffer 
for 20 minutes.  After fixation, samples were rinsed (3 x 5 minutes) using phosphate buffered 
saline (PBS) and incubated for 90 minutes in a blocking buffer: 0.2% Tween20, 2.5% normal 
donkey serum (NDS; Jackson ImmunoResearch, West Grove, PA), 2.5% normal goat serum 
(NGS; Jackson ImmunoResearch), and 0.4% bovine serum albumin (BSA; Sigma-Aldrich) in 
PBS.  Primary antibodies (Supplemental Table 1) were diluted in blocking buffer and 
incubated overnight at 4°C.  Samples were rinsed (4 x 8 minutes) in PBS, followed by 
incubation in secondary antibody (Table 1) and 4',6-diamidino-2-phenylindole (1:50, DAPI; 
Invitrogen, Carlsbad, CA) nuclear stain diluted in blocking buffer and incubated for 90 minutes 
at room temperature.  After secondary antibody incubation, wells were rinsed with PBS (4 x 8 
minutes). Plates were sealed with Parafilm and stored at 4°C until ready for imaging. 
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Immunohistochemistry 
 
 Zebrafish larvae (2, 5, or 8-dpf) were anesthetized in 0.01% MS222 and fixed in 4% 
PFA in 0.1 M phosphate buffer for 4-6 hours at 4°C, then subsequently washed in PBS.  For 
cryoprotection, fixed larvae were incubated in 5% sucrose/PBS solution for 1-3 hours at room 
temperature followed by 30% sucrose/PBS solution at 4°C overnight.  Tissue was then placed 
in OCT (Fisher Healthcare, Houston, Texas) at room temperature before being flash frozen 
using dry ice.  Sections were cut at 10 μm on a cryostat (Leica CM1850, Wetzlar, Germany), 
left to dry overnight on a slide warmer at 37°C, and processed directly.  For antibody staining, 
tissue was rehydrated and permeabilized for 15 minutes in PBS with 0.1% Tween 20 (PBSTw) 
and blocked as described above.  Sections were encircled with a histology pap pen to maintain 
antibody concentration over tissue.  Primary antibodies (Table 1) were added in fresh blocking 
buffer and incubated in a humidified box at 4°C overnight.  Slides were washed (3 x 10 
minutes) in PBSTw, incubated in secondary antibody (Table 1) for 60 minutes at room 
temperature, followed by washes (4 x 10 minutes) in PBSTw.  Slides were allowed to air dry, 
mounted using Vectashield Antifade Mounting Medium with DAPI (Vector Labs, Burlingame, 
CA), and left to cure overnight at 4°C.  Images were taken on a LSM700 (Zeiss, Oberkochen, 
Germany) confocal microscope equipped with an AxioCam MRc5 using a 20x objective.  For 
quantification of Elavl (n = 8), 5-HT (n = 8), TH (n = 8), ChAT (n = 8), and GFAP (n = 8) 
immunoreactivity, the percentage of the total image area threshold (transverse section of the 
forebrain or midbrain) was analyzed using ImageJ [30].  
 
Propidium Iodide Staining 
 
Propidium Iodide (PI; Thermo Fisher Scientific) staining was used to detect dead cells 
at 3, 6 and 9 div. For these experiments, cells were cultured on ECL coated 12 mm glass 
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coverslips. The stock solution of PI was diluted to 1.5 µM in zebrafish culture medium. For PI 
staining at each time-point, culture media was replaced with the PI solution and incubated for 
20 minutes at room temperature. As a reagent control, one sample per time-point was incubated 
in 70% ethanol for 8 minutes to cause cell death before adding PI solution. After incubation, 
samples were rinsed with 0.1 M phosphate buffer, fixed with 4% PFA in 0.1 M phosphate 
buffer for 20 minutes at room temperature and rinsed with PBS. To stain cell nuclei, samples 
were incubated with DAPI (1:50) diluted in blocking solution for 30 minutes at room 
temperature. Samples were rinsed with PBS and mounted on microscope slides with DAPI 
Fluoromount-G mounting media for imaging. 
 
Cell Quantification and Imaging 
 
After immunocytochemistry, cells were imaged on the ImageXpress Micro high 
content screening system (HCS; Molecular Devices, San Jose, CA). Each 96-well plate was 
loaded into the ImageXpress Micro and allowed to equilibrate for 45 min at 25°C. Imaging 
was performed using a 20x objective. From one well, 49 microscopic fields were imaged. For 
imaging, four wavelengths were selected: Cy3 for primary antibodies (550 nm), GFP for 
endogenous transgene expression (395 nm), DAPI for nuclei (358 nm) and phase contract. For 
quantification, all sites were analyzed quickly and without bias using a multiwavelength cell 
scoring module in the MetaXpress 4.0 software (Molecular Devices). The percentage of 
positively stained cells was calculated by dividing the number of cells immunoreactive for 
each antibody by the total number of DAPI-stained nuclei per image. After, the average 
percentage of Cy3 expression was calculated and averaged across replicates. 
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 Time-Lapse Imaging 
 
For time-lapse imaging, Tg(elavl3:GFP) and Tg(gfap:GFP)mi2001 transgenic fish lines 
were dissociated and plated into an ECL coated 96-well plate as described above. After 24 
hours in vitro, media from all wells was removed using a multi-channel pipette and rinsed with 
sterile HBSS. Fresh media was added to all wells and the plate was placed into the 
environmental chamber of the HCS system set to 25°C and the plate allowed to equilibrate for 
1 hour prior to imaging. For time-lapse imaging, the 20x objective was used. Four wells per 
zebrafish line (Tg(elavl3:GFP) and Tg(gfap:GFP)mi2001) were selected for imaging and four 
sites from each well were imaged. A total of 16 sites were imaged from each zebrafish line. 
Two wavelengths (phase contrast and GFP fluorescence) were selected for time-lapse imaging. 
Once the focus was established, images were captured every 5 minutes for 24 hours from all 
sites. Time-lapse imaging analysis for cell migration/cell tracking is described below. 
 
Cell Migration 
 
Cells from each zebrafish transgenic line (Tg(elavl3:GFP) and Tg(gfap:GFP)mi2001) 
were selected for analysis. Cells were tracked using MetaXpress software using the “Track 
objects” feature. For each cell tracked, the distance traveled, and the migration rate were 
collected. Cells tracked were single cells that remained within the imaging field for 24 hours. 
The selected cells’ movements were tracked on a frame by frame basis using the cell tracker 
tool in the MetaXpress software. The output raw data was logged into a Microsoft Excel file. 
To better understand how migration may be different among cells, tracked cells were further 
classified based on cell morphology: spindle, flat or round). The data for average velocity of 
migration and total migration distance were compared between different cell morphologies 
using a one-way ANOVA or an ordinary t-test.  
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Results 
Culture of zebrafish-brain derived cells 
   
Zebrafish offer several advantages compared to mammals to study development. The 
zebrafish embryo is transparent and develops ex vivo, allowing for in vivo imaging and 
monitoring of neurodevelopment. Although in vivo approaches to study development have 
been well documented, little research has been directed to developing in vitro systems using 
zebrafish. Current protocols to dissociate cells from neural tissue have shown variable cell 
viability and quantitative analyses of cells [12, 14, 15, 21]. In an attempt to utilize current 
protocols, we made efforts to adapt those protocols with different variations, but had little 
success (Supplemental Table 2). Therefore, the purpose of this study was to develop a new 
method to isolate and dissociate zebrafish neural tissue for primary culture that can be cultured 
for a longer period of time than current protocols.  As a result of our experiments, we identified 
AccumaxTM as the best enzymatic component for dissociation that also yielded the highest cell 
survival and viability.   
To generate primary neural tissue, whole brains from embryonic Tg(elavl3:GFP), 
which expresses GFP in neurons and can be easily identified in culture, and wild-type zebrafish 
were isolated and dissociated using the protocol described above (summarized in Figure 1). 
The cells were cultured as a monolayer on ECL-coated 96 well plates. As shown in Figure 1, 
the cells displayed a variety of morphologies such as  round with short and long processes, 
spindle-shaped and flat fibroblast-like. Cell morphology changed over time.  Initially, cells 
were spread out and grow as a monolayer and later coalesced and/or divided, often forming 
sphere-like structures. Zebrafish brain-derived cultures were viable for up to 9 div.  
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Cell viability 
 
Propidium iodide (PI) staining was used to evaluate cell survival from the dissociated 
zebrafish neural tissue at 3, 6 and 9 div (Figure 2). This assay uses a red-fluorescent nuclear 
and chromosome counterstain that is only permeable to dead cells. The dissociated neural cells 
were seeded onto ECL coated glass coverslips. As a positive reagent control, 2 coverslips at 
each time-point were exposed to 70% ethanol to intentionally kill cells. At 3 div, approximately 
27% PI-labeled cells were detected following the ethanol incubation as illustrated in Figure 2 
(A1-A3). The percentage of PI-labeled dead cells at 3 div (3.1%) was negligible with only a 
few cells labeled with PI compared to ethanol treated cells (Figure 2 (B1-B3, C1-C3)). For cells 
treated with ethanol at 9 div, 62% were stained with PI but only 28.2% of cultured cells were 
PI stained indicating there was no substantial cell death occurring. (Figure 2 (D1-D3)). These 
results indicate that our culture conditions provide high survivability of dissociated zebrafish 
brains for up to 9 div.  
 
Characterization of dissociated neural tissue 
 
Embryonic wild-type and Tg(elavl3:GFP) zebrafish brains were isolated and 
dissociated in order to obtain a primary culture of neuronal cells. A total of 40 brains were 
dissected and dissociated for each replicate. An image-based high content screening (HCS) 
system using MetaXpress software coupled with immunocytochemistry using a panel of cell 
type specific antibodies was used to characterize the differentiation of the dissociated neural 
tissue. This technology enables screening a panel of cell-specific antibodies at multiple time-
points. Compared to conventional imaging methods, using a HCS system is rapid and allows 
for non-bias characterization.  For this study, adult fish from 5 different tanks represented 5 
experimental replicates. From each replicate, 40 brains were dissociated and plated into 32 
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wells of a 96 well plate. Three replicates were plated in a single 96 well plate while the 
remaining 2 replicates were plated in a second plate. In each well, 49 microscopic imaging 
fields were taken using three fluorescent filter sets: Cy3, GFP and DAPI and transmitted light 
for a total of 196 images per well. For characterization, four wells were used per cell-specific 
antibody, leading to 784 imaging fields analyzed per replicate, for a total of 3,920 sites 
analyzed between all 5 replicates per antibody. 
 Cells were plated into an ECL coated 96 well-plate and characterized using 
immunostaining for various neuronal and glial cell specific antibody markers. First to detect 
neurons in culture, two pan-neuronal antibodies were used: Elavl, an early marker for neurons 
[31] and Acetylated Tubulin, an axonal marker which demarcates axonal tracts in the zebrafish 
brain [32]. These two neuronal antibodies were used together to label the nucleus and processes 
of the neuron (referred to as Elavl-Acetylated Tubulin in this study). At 3 div, approximately 
47% of cells were immunopositive for Elavl-Acetylated Tubulin. Several cells had long axons 
labeled with Acetylated Tubulin at 3 div (Figure 3 (A1)) and at 6 div (Figure 3 (B1)). 
Quantification revealed there was no significant difference for Elavl-Acetylated Tubulin 
expression between 3 and 6 div cultures (47.6% ± 8.8 and 27.3% ± 4.3, respectively). Although 
there is a slight decrease in the number of cells labeled with Elavl-Acetylated Tubulin at 6 div, 
this protocol allowed for longer zebrafish neuron survival in vitro over previous protocols.  
To detect serotonergic neurons within cultures, we found 85% expressed 5‐
hydroxytryptamine (5‐HT) (Figure 4), a neurotransmitter important in development and 
neurogenesis in zebrafish [33] as well as mammals [34] however this was significantly 
decreased by 6 div (48% ± 5).  No detectable immunolabeling was found for tyrosine 
hydroxylase (TH) and choline acetyltransferase (ChAT) (data not shown).   
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To determine if this dissociation and culturing protocol promoted the survival of other 
neural tissue cell types, we investigated the presence of glial cells, which are abundant in the 
CNS of zebrafish. Glial fibrillary acidic protein (Gfap) identifies glial cells within the zebrafish 
brain including radial glia and astrocytes [35]. The percentage of cells immunostained with 
Gfap at 3 div (26% ± 1.8) were comparable to those at 6 div (30.1% ± 2.2) indicating no loss 
of Gfap immunopositive cells in our cultures (Figure 5 (A1 and B1)). These results indicate 
our method of dissociating embryonic zebrafish neural tissue is efficient in maintaining a 
viable population of glial cells. Frozen-sectioned zebrafish brain tissue at comparable time-
points were immunolabeled as positive controls for the antibodies (Supplemental Figure 1(A).  
The neuronal subtypes 5-HT, ChAT, and TH, as well as pan-neuronal marker Elavl and the 
glia marker Gfap were detected in our sections, though ChAT and TH positive cells were 
substantially lower than Elavl, 5-HT, and Gfap, similar to the results from the neural tissue 
culture (Supplemental Figure 1(B).   
Thus far, using our method to dissociate zebrafish neural tissue we have created a 
primary culture containing neurons and glial cells. Unlike previous studies, our cultures 
survive up to 9 div as detected with the propidium iodide assay. In our cultures, approximately 
85% of cells express 5-HT at 3 div, indicating the presence of neurons in culture.  Further, 
compared to previous studies, neurons in our culture are present for up to 6 div as detected by 
Elavl-Acetylated tubulin immunostaining. 
 
Migration of cells in vitro 
 
To investigate the behavior of neuronal and glial cells in vitro, embryonic brain tissue 
from two transgenic zebrafish lines (Tg(elavl3:GFP) marking the neuronal populations and 
Tg(gfap:GFP)mi2001 marking the glia populations were dissociated using the protocol described 
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above. The behaviors of the dissociated cells were monitored using time-lapse digital 
microscopy with transmitted and fluorescence illumination of the HCS system. Multiple sites 
were time-lapsed imaged and used to calculate the distance travelled for Tg(elavl3:GFP) 
(Supplemental video 1) and Tg(gfap:GFP)mi2001  (Supplemental video 2) cell types as well as 
their migration rates.  
The average velocity of cell migration and total distance travelled by cells was obtained 
using MetaXpress software for both cell types. First, cells were classified based on morphology 
(flat, spindle or round). Distance travelled and migration rates were calculated for cells 
dissociated from Tg(elavl3:GFP) or Tg(gfap:GFP)mi2001 zebrafish larval brains. From cells 
dissociated from Tg(elavl3:GFP) neural tissue, the GFP expressing round cells (17.5 ± 1.18 
µm/h) and GFP-expressing spindle shaped cells (12.04 ± 1.07 µm/h) had higher migration rates 
compared to flat cells (6.65 ± 0.67 µm/h) (Figure 6A). Additionally, the average total 
migration of round cells (279.28 ± 22.72 µm) during the 24 hour imaging period was higher 
than flat cells (117.91 ± 11.47 µm) (Figure 6B). These results are captured in supplementary 
video 1 as round cells migrate long distances towards other cells, rather than being isolated. 
Further, round cells are migrating towards flatter cells and often change behavior; once adhered 
to flatter cells, the round cells do not migrate as fast and the distance travelled is lower. 
Interestingly, cell behavior was distinct among different morphologies which may be 
associated to neuronal subtypes present in culture.  
From cells dissociated using Tg(gfap:GFP)mi2001 neural tissue, we observed both GFP-
expressing round and spindle shaped cells but no flat cells in culture.  GFP-expressing round 
and spindle shaped cells migrated similar distances (336.4 ± 77.87 µm and 328.3 ± 52.89 µm, 
respectively) and with similar average migration rates (13.78 ± 3.17 µm/h and 13.45 ± 2.15 
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µm/h, respectively) over a period of 24 hours. Overall, GFP positive Gfap cells, regardless of 
cell morphology, migrated relatively larger distances (331.8 ± 43.39 µm) compared to GFP 
positive Elavl3 cells (114.2 ± 41.07 µm), demonstrating that overall, glial cells travelled longer 
distances than neurons in vitro.  
 
Discussion 
Primary cell culture is used as a tool to understand cell biology under defined 
conditions as an alternate to in vivo systems. However, zebrafish primary cultures receive little 
attention due to the fact that zebrafish serve as a great in vivo system to study genetics, 
development, regeneration and more. Unlike in vivo systems, in vitro systems offer several 
advantages, such as studying cell behavior in controlled environments and provide a better 
understanding of cellular mechanisms and interactions.  Zebrafish primary culture can be used 
to investigate developmental and regenerative processes by studying cell-cell and cell-
extracellular matrix interactions, as well as for drug screening and toxicity bioassays. 
Currently, several protocols exist to isolate neural cells from larval and adult zebrafish tissue, 
though they do not look at survival past 7 days in culture and most cells in culture died after 3 
div [12-14, 16, 20, 21, 23, 24]. However these protocols have not described conditions that 
permit survival of cells long-term and lack quantitative analysis of the dissociated cells. The 
current study examines a new method for isolation and dissociation of embryonic zebrafish 
brains with quantitative characterization of the primary culture and cultures that survive for up 
to 9 div. Immunohistochemistry conducted alongside immunocytochemistry experiments 
validate that our antibodies are properly immunostaining neuronal subtypes including ChAT 
and TH although they were not present in vitro.  
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Our protocol resulted in successful dissociation and culture of embryonic zebrafish 
neural tissue for up to 9 days in vitro.  For optimal growth conditions, epidermal growth factor 
(EGF) was necessary to promote survival of cells. Initial experiments did not include EGF and 
cells were not viable for longer than 3 div with very small processes. Although the process of 
enzymatic dissociation may affect the growth of neurons previously developed in the brain, 
the addition of EGF promoted cell growth and survival in vitro for up to 9 div.  The inclusion 
of zebrafish embryo extract also promoted viability and growth in the culture; when omitted 
from culture we observed slower growth and less cell attachment.  Furthermore, incubation 
times of Accumax™ were optimized to achieve adequate cell dissociation with extensive cell 
survival. We found that incubating cells for longer than 7 minutes resulting in considerably 
less cell attachment and survival after 1 div and incubation times less than 7 minutes resulting 
in substantially large clusters of undissociated tissue.  The amount of dissected tissue per tube 
was also a factor in cell viability. The cells with decreased surface area at the bottom or center 
of the collection tube experienced a hypoxic-like effect, ultimately effecting the likelihood of 
cell survival after plating.  Overall cell viability and attachment probability could be estimated 
after plating by observing cells under phase contrast. Round, phase bright cells had higher 
attachment probably compared to darker cells along with debris in wells, which may indicate 
dead cells. 
Embryonic zebrafish brain cultures contain neuronal and glial cells, with a majority of 
neurons co-expressing pan-neuronal marker Elavl and serotonin (5-HT), indicating a 
serotonergic phenotype.  The 5-HT neurotransmitter has various roles in the CNS, stemming 
from the raphe nuclei and contributing to the proliferation, migration, differentiation of 
neuroblasts, synapse formation, and regulating neurite outgrowth [36-40]. Around 85% of cells 
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in our culture system were 5-HT positive at 3 div, coinciding with a timeline of rapid 5-HT 
innervation  observed in the larval zebrafish at 5-dpf [41] (brain tissue from 2 dpf + 3 div would 
be equivalent to 5-dpf) . Interestingly, this decreases after 6 div to 48%, exhibiting a possible 
decrease in this developmental time point as observed in vivo [41].  Surprisingly, 
immunoreactivity was not detected when using antibodies directed against other neuronal 
subtypes ChAT and TH, though the subtypes were observed in whole tissue sections. This 
could be as a result of the dissociation process, which could alter the endogenous signaling in 
dissociated tissue.  Additionally, at the initial dissociation timepoint of ~48 hpf, secondary 
neurogenesis has commenced in the embryonic zebrafish brain [27].  From this timepoint on, 
the distribution of proliferative cells, newly determined neurons, and advanced post-mitotic 
neurons is dynamic, with tighter spatio-temporal restriction on the distinct populations as the 
brain develops [42].  The substantial differences in immunoreactivity we observed in our 
culture and our tissue sections of the neuronal subtypes versus the predominate labeling of 
serotonergic cells is possibly a result of the progressive rates of maturation in our culture post-
dissociation.  We also observed Gfap-positive cells in 25% of cells after 3 div, with a slight 
increase to around 30% of cells after 6 div.  In the developing brain, Gfap positive radial glia 
have been shown to be progenitors for astrocytes and neurons in mammals suggesting that 
radial glia were present in culture [43].   
Cell culture systems allow researchers to study cell behavior in a controlled 
environment. Using our protocol, cells were successfully dissociated from zebrafish neural 
tissue and used for time-lapse microscopy. Round shaped cells had a strong tendency to adhere 
to flatter cells, which may be indicative of radial glial cells in culture.  In the CNS, radial glial 
cells support neuronal migration during development and guide axons to their correct targets 
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[44, 45]. These results support our analysis of cell migration because Gfap-positive cells 
migrated longer distances than Elavl3-positive neurons. Time-lapse microscopy can be used 
to monitor cell division, apoptosis as well as be used to study cell-cell interactions. Therefore, 
our protocol is sufficient in producing a clean and viable culture that can be used for real time 
imaging experiments. 
Overall, our method for dissociation of embryonic zebrafish brains is efficient to 
generate a heterogenous primary culture of neurons and glia.  It requires basic microdissection 
skills, standard lab equipment, and minimal reagents.  Further, our study examined the 
population in detail by conducting immunocytochemistry for neuronal subtypes as well as glial 
cells.  Our culture method could be used to compliment studies using fluorescence-activated 
cell sorting (FACS) or magnetic-activated cell sorting (MACS) for more targeted cell type 
observations.  Whether paired with in vivo models or utilized exclusively, zebrafish in vitro 
methods can provide further insight into the molecular mechanisms between cell-cell 
interactions and in a variety of applications including developmental biology and regeneration.   
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Figures and figure legends 
 
Figure 1. Primary neural cell culture from embryonic zebrafish.  (A) Schematic illustration 
depicting (1) Embryos collection and disinfection, (2) dissection of neural tissue from 48-hpf 
staged embryos, (3) enzymatic dissociation at 37ºC for 7 minutes using AccumaxTM, (4) cell 
resuspension in complete media (5) and plating cells in 96 well plates maintained at ambient 
temperatures.  Following culture period, (6) plates were used for high content imaging. Cells 
were (7a) time-lapsed for 24 hours or (7b) characterized using immunocytochemistry, (8) 
followed by data analysis performed using the MetaXpress software. (B) Phase contrast images 
of zebrafish-brain derived cells at initial isolation (1 div) through 9 div. At 1 div, small clusters 
of cells along with cells with short and long processes, spindle-shape and large flatter cells are 
seen. In later days, a greater proportion of cells displayed a flattened morphology and cells 
clustered together to form sphere-like structures. Scale bar = 50 μm.  
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Figure 2. Propidium iodide cell viability assay at 3, 6 and 9 div of dissociated zebrafish 
neural tissue. (A1-A3) As a control for the PI reagent, samples were subjected to 70% ethanol 
incubation (10 minutes) to intentionally cause cell death. Dead cells were stained with PI (red) 
and all cell nuclei stained with DAPI (blue). (B1-B3) 3 div cells, (C1-C3) 6 div cells, and (D1-
D3) 9 div cells. Scale bar = 50 μm. (E) Quantitative analysis for number of dead cells at various 
time-points. Error bar represent standard error of the mean. n= 3 independent experiments, 5 
imaging fields per replicate. Abbreviations: DAPI, 4′,6‐diamidino‐2‐phenylindole; PI; 
propidium iodide. *Significantly different at p≤0.05. 
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Figure 3. Dissociated zebrafish neural tissue immunolabeled with neuronal markers anti-
Elavl-Acetylated Tubulin at 3 and 6 div. Fluorescence images of zebrafish brain-derived 
cells illustrating immunoreactivity for Elavl-Acetylated Tubulin at 3 div (A1-A3) and 6 div (B1-
B3): Elavl-Acetylated Tubulin:FITC (green) (to identify neuronal nuclei and processes, 
respectively) with DAPI staining (blue). Asterisks indicate the location of the higher 
magnification inset images. Higher magnification images are of the Serotonin-Cy3 channel 
only. Scale bar = 50 μm (25 μm for insets). Abbreviations: DAPI, 4',6-diamidino-2-
phenylindole. (C): Quantitative analysis of zebrafish brain-derived cells immunoreactive for 
Elavl-Acetylated Tubulin. Error bars represent standard error of the mean. n = 5 independent 
experiments, 196 imaging fields per experiment.  No significant differences found between 3 
div and 6 div cultures.  
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Figure 4. Co-labeling with neuronal markers, anti-5-HT, anti-Elavl and anti-Acetylated 
Tubulin antibodies at 3 and 6 div of dissociated zebrafish neural tissue. Fluorescence 
images of zebrafish brain-derived cells illustrating immunoreactivity for 5-HT and Elavl-
Acetylated Tubulin at 3 div (A1-A3) and 6 div (B1-B3): 5-HT:Cy3 (red) and Elavl-Acetylated 
Tubulin:FITC (green) with DAPI staining (blue). Scale bar = 50 μm. Abbreviations: DAPI, 
4',6-diamidino-2-phenylindole. (C): Quantitative analysis of zebrafish brain-derived cells 
immunoreactive for 5-HT at 3 div and 6 div. Error bars represent standard error of the mean. 
n = 5 independent experiments, 49 imaging fields per experiment. *Significantly different at 
p≤0.05. 
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Figure 5. Co-labeling with an anti-Gfap antibody to identify glial cells and anti-Elavl and 
anti-Acetylated Tubulin antibodies to identify neurons at 3 and 6 div of dissociated 
zebrafish neural tissue. Fluorescence images of zebrafish brain-derived cells illustrating 
immunoreactivity for Gfap and Elavl-Acetylated Tubulin at 3 div (A1-A3) and 6 div (B1-B3): 
Gfap:Cy3 (red) and Elavl-Acetylated Tubulin:FITC (green) with DAPI staining (blue). Scale 
bar = 50 μm. Abbreviations: DAPI, 4',6-diamidino-2-phenylindole. (C): Quantitative analysis 
of zebrafish brain-derived cells immunoreactive for Gfap at 3 div and 6 div. Error bars 
represent standard error of the mean. *Significantly different at p≤0.05. 
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Figure 6: Zebrafish dissociated neural cells tracked with image acquisition and analysis 
software. (A) Average distance travelled and (B) average migration rates (expressed as µm/hr) 
for GFP positive Tg(elavl3:GFP) dissociated cells based on morphology.  (C) Average 
distance travelled and (D) average migration rates for GFP positive Tg(gfap:GFP)mi2001 
dissociated cells based on morphology. Each bar represents the average of 7-9 imaged cells 
from 2 time-lapse videos over 24 hours. Error bars represent standard error of the mean. 
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Supplemental Table 1: Primary and Secondary Antibodies Used 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary Antibody Host  Dilution  Supplier  Code 
Elavl Mouse 1:250 Thermo Fisher  A21271 
Acetylated Tubulin Mouse 1:500 Sigma Aldrich T6793 
Gfap Rabbit 1:250 Sigma Aldrich SAB270247
5 
Serotonin (5-HT) Rabbit 1:100  Sigma Aldrich S5545 
Tyrosine Hydroxylase Rabbit 1:100 Chemicon AB152 
ChAT Rabbit 1:100 Sigma Aldrich AB1582 
Secondary Antibody Host  Dilution  Supplier  Code 
Mouse IgG 488 Goat  1:500 Thermo Fisher A11029 
Mouse IgG 568 Goat 1:500 Thermo Fisher A11004 
Rabbit IgG 568 Goat  1:500 Thermo Fisher A11011 
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Supplemental Table 2: Enzymatic trials determining the effectiveness of specific enzymes 
to dissociate neural tissue from embryonic zebrafish for neuronal cultures.  Temperature, 
volume, and incubation times varied between experiments and affected the overall cell survival 
and attachment rates, with AccumaxTM  demonstrating the optimum outcome.   
 
 
 
 
 
 
 
 
 
Enzyme Digestion 
Time 
Temperature 
(Celsius) 
Results 
Trypsin 
0.025%/Ringers  
10, 15, 20, 
25, 30 
minutes 
  
24° No survival/attachment at 24 hours 
in vitro 
Trypsin 
0.05%/Ringers  
10, 15, 20, 
25, 30 
minutes 
  
24° No survival/attachment at 24 hours 
in vitro 
Trypsin 
0.05%/Dissociation 
Medium  
(Chen et. al, 2013) 
10, 15, 20, 
25, 30 
minutes 
  
24° No survival/attachment at 24 hours 
in vitro 
 
Trypsin0.05%/Custom 
commercial brand 
solution (Anderson et. 
al, 2001) 
 
10, 15, 20, 
25, 30 
minutes  
 
24° 
 
No survival/attachment at 24 hours 
in vitro 
 
Pancreatin 
 
3, 10 minutes 
 
24° 
 
No survival/attachment at 24 hours 
in vitro  
Papain 15, 30 
minutes 
37° No survival/attachment at 24 hours 
in vitro  
AccumaxTM 5, 7, 10 
minutes 
37° Survival and attachment up to 9 DIV 
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Supplemental Figure 1.  Positive control for immunofluorescence staining.  (A) Primary 
antibodies directed against Elavl, 5-HT, ChAT, TH, and Gfap were used to determine 
localization in the larval zebrafish brain at 2 dpf, 5 dpf, and 8 dpf, respective to the time points 
studied in vitro.  (B) Quantification of total area immunofluorescence for respective antibody.  
One-way ANOVA comparing the mean of each column with Elavl; p≤0.05.  
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Supplemental Video 1: Time-lapse microscopy of cells dissociated from neural tissue 
dissected from Tg(elavl3:GFP) zebrafish. Images were captured every 5 minutes over 18 
hours. GFP-expressing cells indicate neurons. Videos were used to analyzed cell migration and 
cell velocity using MetaXpress software. Scale bar = 50 µm. 
 
Supplemental Video 2: Time-lapse microscopy of cells dissociated from neural tissue 
dissected from Tg(gfap:GFP)mi2001 zebrafish. GFP-expressing cells indicate glial cells. Images 
were captured every 5 minutes over 18 hours. Videos were used to analyzed cell migration and 
cell velocity using MetaXpress software. Scale bar = 50 µm. 
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Abstract 
Nearly 1 billion people worldwide suffer from central nervous system (CNS) diseases and 
disorders. Trauma to the CNS leads to a loss of neurons and glial cells in the brain, causing 
motor and cognitive impairments. It is thought that replenishing damaged or lost cells could 
slow disease progression and facilitate recovery. Cell-based therapies have shown promise in 
experimental animal models and human clinical trials. Researchers have focused efforts on 
rodent mammalian models to investigate therapies that could have potential for treating human 
diseases. A major limitation of cell transplantation strategies is the inability of cells to survive 
in damaged environments, leading to little recovery. Biomaterials are biocompatible and 
biodegradable that play a crucial role in regenerative medicine as they aid in cell survival and 
differentiation. Poly(ɛ-caprolactone) (PCL) microfibrous scaffolds or cell-seeded gelatin 
scaffolds were implanted into larval 5 days post fertilization (dpf) Tg(gfap:GFP mi2001 larval 
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Danio rerio (commonly known as zebrafish) brains. Zebrafish are an excellent model system 
due to their transparency and quick development, allowing for visualization of the transplanted 
cells and biomaterials throughout development without requiring sacrifice. Gelatin scaffolds 
were seeded with glial cells isolated from the Xenopus retinal neuroepithelium and labeled in 
vitro with CellTracker CM-DiI, a red fluorescent dye. Zebrafish with implants containing 
visible DiI-labeled cells survived up to 5 days post-transplant. Sectioned tissue revealed the 
scaffold within neural tissue and an enhanced glial response, a phenomenon also seen in 
rodents. Zebrafish are a more cost-effective animal model and thus should be considered for 
pre-clinical in vivo studies. Here, we show preliminary evidence that zebrafish could serve as 
a model to screen biomaterial-based therapeutic strategies using two types of three-
dimensional (3D) scaffolds. 
 
Keywords: Zebrafish, biomaterial, poly(ɛ-caprolactone) (PCL) microfibrous scaffolds, gelatin 
scaffolds, three-dimensional scaffolds 
 
Introduction 
Developing effective cell transplantation strategies is crucial in regenerative medicine 
due to the number of diseases and trauma affecting the central nervous system (CNS). Damage 
to the brain leads to loss of neurons and glial cells, causing motor and cognitive impairments. 
The mammalian CNS has little regenerative capabilities and endogenous neurogenesis is not 
sufficient to overcome injury [1, 2]. Studies have demonstrated that replenishing injured or lost 
cells could help slow disease progression and facilitate recovery [3-5]. Although advances have 
been made in the field of cell transplantation strategies, challenges such as donor tissue 
availability, low survival of transplanted cells and limited integration into host tissue [6, 7] 
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have guided researchers to investigate alternative ways to increase the efficacy of such 
therapies.  
Biomaterials have gained interest in the field of regenerative medicine due to features 
like biodegradability and biocompatibility of polymers and their ability to mimic the 
extracellular matrix (ECM) of the surrounding tissue, giving cells an environment most similar 
to the one in which they naturally grow [8-10]. Studies have demonstrated how polymeric 
scaffolds can enhance growth and survival of cells in vitro [11-13] and in vivo [8, 14-16], thus 
making them a novel approach for regenerative medicine therapies. Providing support to 
grafted cells can guide restructuring of the damaged surrounding tissue and increase cell 
survivability in vivo [8]. Further, endogenous repair mechanisms increase after cell 
transplantation strategies, providing insight into how exogenous cells influence endogenous 
cell survival [17-19]. Therefore, it is important to facilitate transplanted cell survival due to the 
increasing evidence that such therapies may accelerate CNS rescue and repair. 
Various biocompatible and biodegradable polymers are studied as potential delivery 
vehicles for cell transplantation experiments. Animal testing is a mid-point between in vitro 
and clinical trials, thus making it an important step to better translate laboratory findings to an 
in vivo model. Currently, rodents serve as one of the most common experimental models due 
to their similarities with human anatomy and development [20, 21]. However, zebrafish are 
emerging as important tools in biomedical research and neuroscience [22, 23]. The zebrafish 
genome has been fully sequenced [24], their rapid development makes studies less time-
consuming [25] and the availability of transgenic lines available surpasses that of rodents [26]. 
Also, the innate immune system of a zebrafish closely resembles that of mammals, making 
them a popular choice for pharmacogenetics and neuropharmacology [27]. Zebrafish are 
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commonly used in toxicity assays for validating drug concentrations and nanoparticle 
formulations [28]. Nanoparticles have been used in the field of nanomedicine, a field which 
focuses efforts on developing therapies using nanoscale materials to prevent or treat diseases 
[29]. The blood-brain barrier is responsible for regulating small molecules and many drugs are 
not able to cross the barrier [30]. As such, nanoparticles loaded with drugs can be manipulated 
in a way that promotes crossing of the blood-brain barrier. Surface chemistry and nanoparticle 
size influence the ability of the nanoparticle to cross the barrier [31]. Zebrafish have been used 
to understand the inflammatory response of gold [32], silver [33] copper [34] and 
nanoparticles, providing researchers with evidence on the toxicity of such nanoparticles in an 
in vivo model. Recently, zebrafish have been used to assess toxicity beyond nanoparticles and 
have used scaffolds such as hydrogels [35] and microparticles [36], to further understand the 
immune response associated with such scaffolds as they are commonly employed for 
regenerative medicine strategies.  
We describe the use of a synthetic scaffold composed of poly (ε-caprolactone) (PCL) 
fabricated into microfibers of 7 µm using a microfluidic technique [37]. It is biocompatible 
and Food and Drug Administration (FDA) approved for use in the human body [38, 39]. As 
such, it is commonly used for a variety of biomedical applications and is also biodegradable, 
ideal to serve as a cell transplant scaffold as it would slowly degrade over time [40, 41]. Lastly, 
PCL has been shown to support neural stem cell adhesion, proliferation and differentiation in 
vitro [11, 42], making it an ideal candidate for cell delivery. A second polymer, gelatin, was 
used to fabricate three-dimensional (3D) scaffolds that could be utilized to seed cells for 
transplantation studies. Gelatin is a natural protein derived from the hydrolysis of collagen and 
it is hydrated in an aqueous environment [43]. Previously, these gelatin scaffolds have 
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promoted transdifferentiated mesenchymal stem cells (MSCs) to secrete neurotrophic factors, 
thus providing a favorable environment for cell growth in vitro [44]. We sought to utilize these 
scaffolds as a method to deliver cells to the CNS.  
For our experiments using cell-seeded gelatin scaffolds, exogenous cells were labeled 
with a red fluorescent dye in vitro. Xenopus laevis retinal neuroepithelial cells (XR1 cells) are 
a population of self-renewing glial cells [45]. These cells can be isolated from the 
neuroepithelium of the amphibian retina and grown at room temperature, making them an ideal 
cell line to use in combination with zebrafish, as their optimal growth temperature is more 
similar to the host’s body temperature than mammalian cell lines would be. In this preliminary 
study, we investigated the potential use of PCL microfibers and cell-seeded gelatin scaffold 
implants in an in vivo model. We propose the use of zebrafish as a novel model system for 
screening biomaterial implants prior to rodent studies. Zebrafish have high fecundity and are 
transparent for the first few days post-fertilization and can remain transparent even longer if 
genetically modified or treated with chemicals such as polythiourea (PTU) [46]. This allows 
for live screening and imaging of cell-seeded scaffolds, without sacrificing the animal. They 
are also relatively inexpensive to care for and produce and, since zebrafish are commonly used 
for genetic studies, there are a number of transgenic fish lines to be used advantageously. The 
zebrafish, a teleost, has a remarkable capacity for CNS regeneration [47]. Therefore, we are 
also able to observe general regenerative abilities of zebrafish as we utilize them for 
biomaterial-based cell delivery systems in order to optimize transplantation methods for larger 
animal models.  
The overall goal of these preliminary experiments was to evaluate the use of zebrafish 
as a model to better understand the use of various biomaterials in the CNS. These results can 
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be used to quickly understand the effects of biomaterials before proceeding to a larger animal 
model, such as rodents. Our proof of concept study has provided implications for furthering 
the use of zebrafish as an animal model in biomedical engineering. 
 
Materials and Methods 
Zebrafish Husbandry  
Embryos were obtained from the transgenic zebrafish lines Tg(gfap:GFP)mi2001 [48] 
and wild-type zebrafish line NHGRI (Zebrafish International Resource Center - ZIRC). 
Tg(gfap:GFP)mi2001 express green fluorescent protein (GFP) in glial cells throughout the 
nervous system. Adult fish used for the generation of embryos were raised at 28.5°C in a 
light/dark cycle according to standard zebrafish husbandry protocols [25].  All experiments 
were performed within U.S. laws, guidelines, and policies for laboratory animals and by 
approval of the Institutional Animal Care and Use Committee (IACUC) and Institutional 
Biosafety Committee at Iowa State University. Embryos were sorted for GFP expression after 
24 hours post fertilization (hpf). At five days post-fertilization (dpf), zebrafish were used for 
experimental studies with PCL microfibers or cell-seeded gelatin scaffolds.  
Animals were reared and euthanized in accordance with protocol # 8-17-8587-I 
approved by the Iowa State University IACUC. All protocols were in compliance with the 
American Veterinary Medical Association and the National Institutes of Health guidelines for 
the humane use of laboratory animals in research. 
 
Fabrication of Gelatin Scaffolds 
Type B gelatin from bovine skin (Sigma Aldrich, St. Louis, MO) was used to fabricate 
scaffolds composed of 5% (w/v) gelatin dissolved in deionized water at 55°C using an 
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electrospinning technique (previously described in [49]. Briefly, the gelatin solution was 
injected into a syringe and kept at -20°C for phase separation for 5 hours and incubated in cold 
ethanol (-18°C) overnight. Following the incubation, the scaffold was immersed in nonsolvent, 
1, 4- dioxane for 2 days and freeze-dried for 3 days. For culturing, scaffolds were sterilized 
rinsed in 70% ethanol three times for 10 minutes each followed by ultra-violet radiation 
overnight before seeding cells. 
 
Poly (ε-caprolactone) Microfiber Fabrication  
Details for the fabrication of the microfibers can be found in Sharifi et al [42]. In brief, 
a microfluidic device, made of three channels that merge into one, was halfway submerged in 
sterile culture grade water. The two outer channels contained the sheath fluid and the middle 
channel contained the core fluid. After the fluids entered the individual channels, the sheath 
fluid focused the core fluid laterally, shaping it into a thin strip. Samples obtained were 7 µm 
in diameter and cut to 0.5 mm in length using a scalpel for implant studies. 
 
Retinotectal Labeling 
To label retinotectal projections within zebrafish after implants, NHGRI  wild-type 
zebrafish embryos were implanted with a PCL microfiber and fixed using 4% 
paraformaldehyde (Sigma-Aldrich) in 0.1 M phosphate buffer. After fixation, one fish with a 
PCL microfiber located within neural tissue was mounted in 1% agarose (Thermo Fisher 
Scientific, Waltham, MA). The agar was cut away to expose the eye and the lens was lifted to 
inject the CellTrackerTM CM-DiI (ThermoFisher Scientific, Hampton, NH). A small drop of 
agar was put over the top of the eye and the mount was kept in phosphate buffered saline (PBS; 
Gibco BRL, Gaithersburg, MD) for 2 days prior to imaging. 
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XR1 Cell Culture 
Xenopus laevis cells were previously isolated from stage 24 to 26 embryos 
neuroepithelium (XR1) [45]. Cells were cultured in L15 basal media (Sigma Aldrich) 
supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Atlanta, GA), 1% 2.5 
mM L-alanyl-L-glutamine (GlutaMAX; Thermo Fisher Scientific), 0.5% 
penicillin/streptomycin (ThermoFisher Scientific), 1% Fungizone (Amphotericin B, Gibco 
BRL, Gaithersburg, MD) and 15 ng/mL epidermal growth factor (human recombinant EGF, 
Thermo Fisher Scientific), until cells became 70% confluent. Fresh culture media was added 
regularly and cells were cultured at room temperature. When confluent, cells were detached 
from flasks using 0.05% Trypsin-EDTA (Invitrogen, Carlsbad, CA).  
 
Labeling XR1 Cell in vitro 
One day prior to seeding XR1 cells into scaffolds, cells were labeled with 
CellTrackerTM CM-DiI (DiI; Thermo Fisher Scientific), a red fluorescent dye. To label cells in 
flasks, XR1 media was removed and cells were rinsed with Hank’s Balanced Salt Solution 
(HBSS; Sigma Aldrich) once to remove any excess culture media. Next, CM-DiI was diluted 
in HBSS to a concentration of 1 µg/mL and added to flasks for 20 minutes, agitating and 
rotating the flask 90° every 5 minutes. After incubation, the DiI solution was removed, cells 
were rinsed with HBSS two times, and fresh culture media was added. Cells were kept in the 
dark to avoid quenching fluorescence.  
 
 Seeding Cells into Gelatin Scaffolds for Implantation 
DiI-labeled cells were collected using 0.05% Trypsin-EDTA and centrifuged at 1000 
rpm for 8 minutes, then resuspended with fresh media. Cell counts were performed using a cell 
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hemocytometer and Trypan Blue dye (Sigma Aldrich). Cells were seeded into scaffolds at a 
density of 200,000 cells per sample and cultured at room temperature for five days in 
maintenance media. Cell-seeded scaffolds were fed every 2 days. After 5 days, scaffolds were 
placed in HBSS to prepare for implants.  
 
XR1-Seeded Gelatin Scaffold Implantation 
Five dpf Tg(gfap:GFP)mi2001  [48] fish were anesthetized using 200 mg/L MS222 
(tricaine methanesulfonate, Sigma Aldrich) and immobilized in a droplet of 1% low-melting 
agarose. A small piece of gelatin scaffold seeded with DiI-labelled cells was implanted into 
the right side of the brain using fine forceps. Fish were imaged every 24 hours starting 1-day 
post-implantation using a Zeiss LSM700 Confocal microscope equipped with an AxioCam 
MRc5 (Oberkochen, Germany). 
 
Immunohistochemistry 
Tg(gfap:GFP)mi2001 zebrafish larvae at 5 dpf were anesthetized in 200 mg/L MS222 
and fixed in 4% PFA in 0.1 M PO4 buffer for 4-6 hours at 4°C, then subsequently washed in 
PBS. Fixed larvae were subjected to a 1-3 hour incubation in 5% sucrose/PBS solution at room 
temperature followed by 30% sucrose/PBS solution at 4°C overnight.  Whole zebrafish were 
embedded in OCT at room temperature and frozen using dry ice. Coronal sections were cut at 
10 μm on a cryostat (ThermoFisher Scientific, Microm HM550), left to dry for 48 hours on a 
slide warmer at 37°C, and stored in a -20°C freezer until use for immunohistochemistry. Before 
proceeding with immunohistochemistry, slides were screened for any red fluorescence, an 
indication of DiI labeled cells. These slides did not undergo immunohistochemistry. Slides 
were thawed for 10 minutes, rehydrated with PBS for 15 minutes, and washed once more with 
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PBS for 10 minutes. DAPI (4',6-diamidino-2-phenylindole) (2 µg/mL, Invitrogen, Carlsbad, 
CA) diluted 1:50 in PBS was applied for 10 minutes. Samples were washed twice more with 
PBS for 10 minutes each. Slides were mounted with coverslips using Vectashield and stored 
at 4°C until imaging. 
Slides containing brain tissue of fish implanted with gelatin scaffolds not displaying 
DiI labeling were thawed for 10 minutes, then rehydrated and permeabilized with PBS-
Tween20 (0.1%) for 15 minutes. Sections were encircled with a histology pap pen in order to 
maintain antibody concentration over time. Blocking solution included 5% normal blocking 
serum (NDS, Jackson ImmunoResearch, West Grove, PA; NGS, Jackson ImmunoResearch) 
1% bovine serum albumin (BSA; Sigma Aldrich), and 1% dimethyl sulfoxide (DMSO, Sigma 
Aldrich) in PBS. Samples were incubated with blocking solution for 1 hour at room 
temperature to prevent nonspecific binding of antibodies. Primary antibodies were incubated 
in a humidified box for 48 hours at 4°C (listed in Table 1 below). Mo α Acetylated Tubulin 
labels alpha-tubulin, present on the axons of mature neurons. 
After the primary antibodies were incubated overnight, slides were washed 6 times, for 
5 minutes each with PBS. Appropriate secondary antibodies were diluted in blocking solution 
and applied for 80 minutes at room temperature. Secondary antibody donkey anti-mouse Cy3 
(1:500, Jackson ImmunoResearch, West Grove, PA) diluted in blocking solution was applied 
to samples immunolabeled with Mo α Acetylated Tubulin. Next, slides were rinsed 4 times, 
for 5 minutes each with PBS. DAPI was diluted in blocking solution at 1:50 and was applied 
for 10 minutes. Slides were then washed 2 times, for 5 minutes each with PBS. Finally, slides 
were mounted with coverslips using Vectashield Antifade Mounting Medium with DAPI 
(Vector Labs) and stored at 4°C until imaging. 
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DAPI Labeling for XR1 Cells Within Gelatin Scaffolds 
Growth medium was gently aspirated from scaffolds, and samples were washed with 
PBS twice. Samples were fixed in 4% PFA in 0.1 M phosphate buffer for 20 minutes. The 
fixative was removed, and samples were rinsed with PBS 2 times for 7 minutes each. DAPI 
was diluted in PBS and applied for 10 minutes at room temperature. Coverslips were mounted 
on microscope slides using Vectashield and stored at 4°C until imaging. 
 
Imaging 
A Zeiss LSM700 Confocal microscope equipped with an AxioCam MRc5 was used to 
image all samples for high-resolution images with 20x and 40x objectives. Stacks of various 
optical planes were taken for each diameter type. Photoshop CC was used to merge images 
and make figure plates.  
 
Results 
Zebrafish survival and behavior after PCL microfiber implants 
Zebrafish were implanted with PCL microfibers into the telencephalon and assessed 
for survival, visibility of microfiber and behavior. In order to implant PCL microfibers into 
brains, 5 dpf Tg(gfap:GFP)mi2001 were anesthetized and immobilized within agarose. Using 
fine needles, a small opening was created to push the microfiber into the CNS. Fish survived 
up to 3 days post implantation (dpi) before fixation and cryosectioning. An example of a fish 
implanted with a PCL microfiber is shown in Figure 1. Compared to a control fish with no 
implant (Figure 1 (A1-A4)), cross-sections of a fish with an implanted microfiber revealed its 
location in the ventricle with disorganization in the brain (Figure 1 (B1-B4)). Higher 
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magnification images demonstrate the PCL microfiber with some overlap of GFAP processes 
along with DAPI nuclei surrounding the microfiber (Figure 1 (C1-C4, D1-D4)).  
Retinotectal labeling with DiI tract tracer was performed to assess development of 
retinotectal tract in the presence of a microfiber. DiI was placed on the retina of a larval NHGRI 
zebrafish with a microfiber implant slightly ventral to the right lobe of the optic tectum (Figure 
2). The DiI staining was characteristic of normal development in a 7 dpf zebrafish, which may 
indicate that retinal ganglion cells of the right eye innervate the optic tectum properly despite 
the presence of a microfiber. 
 
Labeling XR1 cells in vitro and seeding into gelatin scaffolds 
 
Based upon our preliminary results using PCL microfibers as a method to deliver cells 
to the CNS, we found it was difficult for cells to remain adhered during transplantation 
procedures. Often times, forceps used to transfer fibers to the brain would disrupt cells on the 
surface of the microfiber, leading to loss of cells. Therefore, we hoped to use a 3D scaffold in 
which cells can be seeded within an environment that protects them during implant studies. 
Gelatin scaffolds were fabricated using an electrospinning technique as described above. For 
our study, mammalian cells were not an ideal option due to the differences in growing 
temperatures. Therefore, we proposed to use a lower vertebrate glial cell line as a cell type to 
study cell-based biomaterial strategies in zebrafish. In order to visualize cells post-
transplantation, cells were stained with a fluorescent dye, CM-DiI, and seeded onto gelatin 
scaffolds (Figure 3). The distribution of DAPI-stained nuclei is consistent across the surface 
of the gelatin scaffolds, however the presence of DiI labeling is not, for unknown reasons. This 
observation is one reason as to why not all the implanted fish have visible DiI labeled cells 
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within the scaffolds. Cutting scaffolds prior to implantation led to some small implanted 
fragments with little to no DiI labeled cells.  
 
Implantation of gelatin scaffolds  
 
Zebrafish with gelatin implants were able to survive up to 5 dpi, with gelatin implants 
visible in the brains 1 dpi. Figure 4 illustrates 6 dpf fish at 1 day post implantation (dpi) with 
gelatin scaffold (shown in white box). Zebrafish were swimming and had strong heartbeats at 
1 dpi, indicating no detrimental effects on overall fish health within the first 24 hours. In order 
to better understand the effect gelatin scaffolds had on the architecture of the brain, zebrafish 
were anesthetized and fixed using 4% PFA in 0.1 M phosphate buffer. After cryosectioning, 
tissue was immunostained with Acetylated Tubulin, a marker for mature axons. In some cases, 
no scaffold was present in sectioned tissue (Figure 5). Transgenic Tg(gfap:GFP)mi2001 express 
GFP in glial cells, which are known to react to trauma within the CNS [50]. Figure 5 (A1 -A4) 
are coronal sections of a zebrafish without an implant. Neuronal and glial architecture were 
found to be intact with no damage, and minimal GFAP fluorescence. However, implanted 
zebrafish have noticeably increased GFAP expression within the disrupted ventricle (Figure 5 
(B1 -B4)). It is evident that in the case of the gelatin scaffold within the CNS, there is a 
noticeable increase in GFAP expression, particularly around the ventricles. Although there was 
trauma, the zebrafish continued to survive, indicating that the scaffold elicited a glial response, 
however it was not detrimental to the overall zebrafish health.  
 
Implantation of XR1 seeded gelatin scaffolds  
 
In order to understand how cells could be transplanted within a 3D scaffold to a 
zebrafish CNS, XR1 glial cells were dyed in vitro then seeded onto gelatin scaffolds. 
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Compared to mammalian cells, XR1 cells are grown at room temperature that is closer to the 
optimal temperature of a zebrafish. A small hole was created in the most posterior part of the 
brain and angled towards the optic tectum. One particular fish survived for 5 days post implant 
with visible DiI labeling in the diencephalon and mesencephalon regions of its brain (Figure 
6). GFAP expression in the brains of zebrafish appears to greatly increase at 1 dpi, however 
decreasing gradually a few days post-transplantation.  
Gelatin scaffolds were visible in multiple sequential sections of the zebrafish brain. 
Figure 7 demonstrates this in parallel to control fish sections. It is clearly demonstrated that 
implanted fish have an increased glial response to the gelatin scaffolds in comparison with 
control fish. The gelatin scaffold seems to be within the metencephalon (composed of the 
cerebellum and pons) and the hindbrain, indicating successful implantation into neural tissue. 
Overall, our results can be used as a stepping ground to further utilize zebrafish as a model to 
better understand glial mechanisms involved with biomaterial-based cell delivery strategies. 
Quantitative analysis is needed to further validate these qualitative results, however this proof-
of-concept study validates the use and ease of using zebrafish as a model system for studying 
biomaterial-based cell transplantation strategies.   
 
Discussion and Conclusions 
These preliminary studies were conducted to investigate the survival and glial response 
of larval zebrafish implanted with PCL microfibers or cell-seeded gelatin scaffolds. We 
demonstrate for the first time the use of zebrafish in conjunction with delivering cell-seeded 
3D scaffolds to the CNS. These preliminary results suggest that the implant was not 
significantly affecting normal zebrafish activity, thus PCL and gelatin are suitable candidates 
for transplantation. Additionally, zebrafish is an excellent model for screening biomaterials 
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implants for cell-based therapies in vivo due to the similarities with mammalian innate immune 
system. In the future, we hope to implant neural stem cell (NSC)-seeded PCL microfibers into 
the zebrafish CNS and assess cell survival, migration and differentiation to correlate our in 
vitro studies. 
The number of zebrafish in our sample size for PCL microfibers and gelatin scaffolds 
varies due to a number of reasons. The primary reason is the implantation may have caused 
extensive damage during the procedure and the scaffolds would not stay implanted in the tissue 
of the animal. Sharp probes were used to manipulate the fiber that could easily injure the 
animal. Second, scaffold size may influence the regeneration of the fish; if the scaffold was 
large, the chances of the zebrafish surviving the implant greatly decreased. Manipulation of 
micron-range scaffolds is difficult and thus needs to be improved for future studies. Third, the 
behavioral deficits were found mainly in zebrafish with large implants and extensive damage 
led to hematoma formation and death. Since implantation requires puncture of the brain, which 
controls behavior, this outcome was not surprising. Regeneration in the zebrafish CNS is 
remarkably robust, so extending the length of time post implantation may show complete 
regeneration along with correction of impaired behavior. However, some zebrafish also 
displayed proper development and regeneration in response to the implant, as seen by the 
decrease of GFAP expression as the days post implant increase. Finally, the optic tectum was 
properly innervated by the retinal ganglion cells in the presence of a microfiber implant, as 
indicated by DiI retinotectal labeling results, suggesting that the zebrafish was still capable of 
processing visual information and had continued to develop the nervous system normally 
despite the microfiber manipulation. However, more studies conducting this experiment are 
necessary to validate our initial findings. 
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The purpose of this study was to investigate the ability of gelatin to serve as a 
biocompatible scaffold for XR1 cell transplantation. We assessed the ability of this material to 
deliver cells to the brains of zebrafish, as well as the glial response of the zebrafish brain to 
these implants. Other studies have previously shown the ability of gelatin to be compatible 
with various cells, including cardiac progenitor cells [51, 52], mesenchymal stem cells [44, 53, 
54], and even human retinal pigment epithelial cells [55]. Additionally, they can be used to 
guide the differentiation of cells, including that of mesenchymal stem cells into motor neuron-
like cells [56]. In our studies, we determined that XR1 cells can be successfully grown on 
gelatin scaffolds and that they were able to survive on these scaffolds through the process of 
implantation. 
Due to the low immunogenicity of gelatin as a scaffolding biomaterial, transplants are 
able to be performed with minimal immune damage to the surrounding tissue [57].  
Endogenous GFAP expression increases greatly at 1 dpi, with levels decreasing gradually in 
the days following. However, increased expression of GFAP by astrocytes is known to occur 
following neurotrauma [58], so this observation is not unexpected. Because this GFAP 
expression decreases back to near-basal levels by five days post-implantation, we can infer that 
the gelatin scaffolds are not particularly detrimental. 
In other studies, transplantation of neural stem cells using gelatin scaffolds into a 
transected rat spinal cord has shown to offer some functional benefit to the host, promote 
differentiation and increase axon outgrowth of the transplanted cells and promote hindlimb 
movement and recovery [59]. Similarly, transplantation of a gelatin-based sponge seeded with 
bone marrow-derived mesenchymal stem cells into intervertebral lumbar discs helped repair 
defects in the annulus fibrosus [60]. 
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In future experiments, we aim to increase the number of cells seeded into these gelatin 
scaffolds in order to more effectively deliver cells to the brains of zebrafish. Additionally, we 
plan to analyze the ability of these cells to integrate and/or proliferate once transplanted. 
Finally, we hope to perform cell transplantations using cells derived from the brains of 
zebrafish. Ideally, this would allow for better cell survival and integration, as the transplanted 
cells would not  be foreign to the innate immune system.  Overall, we believe we provide 
preliminary evidence for using zebrafish as an important tool when investigating biomaterial-
based cell delivery systems, as it is cost-effective and quicker compared to rodents. 
 
Acknowledgements 
This work was partially supported by the Stem Cell Research Fund, the Department of 
Genetics, Development and Cell Biology, the Iowa State University College of Liberal Arts 
and Sciences Dean’s High Impact Award for Undergraduate Research. 
 
References 
1. Jessberger, S., Neural repair in the adult brain. F1000Research, 2016. 5: p. F1000 
Faculty Rev-169. 
2. Sun, D., The potential of endogenous neurogenesis for brain repair and regeneration 
following traumatic brain injury. Neural regeneration research, 2014. 9(7): p. 688-
692. 
3. Jeong, S.-W., et al., Human Neural Stem Cell Transplantation Promotes Functional 
Recovery in Rats With Experimental Intracerebral Hemorrhage. Stroke, 2003. 34(9): 
p. 2258-2263. 
4. Kelly, S., et al., Transplanted human fetal neural stem cells survive, migrate, and 
differentiate in ischemic rat cerebral cortex. Proceedings of the National Academy of 
Sciences of the United States of America, 2004. 101(32): p. 11839. 
 175 
 
 
5. Pluchino, S., et al., Injection of adult neurospheres induces recovery in a chronic 
model of multiple sclerosis. Nature, 2003. 422: p. 688. 
6. Brundin, P., et al., Improving the survival of grafted dopaminergic neurons: a review 
over current approaches. Cell Transplant, 2000. 9(2): p. 179-95. 
7. Castilho, R.F., O. Hansson, and P. Brundin, Improving the survival of grafted 
embryonic dopamine neurons in rodent models of Parkinson's disease. Prog Brain 
Res, 2000. 127: p. 203-31. 
8. Park, K.I., Y.D. Teng, and E.Y. Snyder, The injured brain interacts reciprocally with 
neural stem cells supported by scaffolds to reconstitute lost tissue. Nature 
Biotechnology, 2002. 20: p. 1111. 
9. Schmidt, C.E. and J.B. Leach, Neural Tissue Engineering: Strategies for Repair and 
Regeneration. Annual Review of Biomedical Engineering, 2003. 5(1): p. 293-347. 
10. Khademhosseini, A. and R. Langer, A decade of progress in tissue engineering. 
Nature Protocols, 2016. 11: p. 1775. 
11. Patel, B.B., et al., 3D Microfibrous Scaffolds Selectively Promotes Proliferation and 
Glial Differentiation of Adult Neural Stem Cells: A Platform to Tune Cellular 
Behavior in Neural Tissue Engineering. Macromolecular Bioscience, 2019. 19(2): p. 
1800236. 
12. Horne, M.K., et al., Three-Dimensional Nanofibrous Scaffolds Incorporating 
Immobilized BDNF Promote Proliferation and Differentiation of Cortical Neural 
Stem Cells. Stem Cells and Development, 2009. 19(6): p. 843-852. 
13. Singh, D., et al., A biodegradable scaffold enhances differentiation of embryonic stem 
cells into a thick sheet of retinal cells. Biomaterials, 2018. 154: p. 158-168. 
14. Führmann, T., et al., Injectable hydrogel promotes early survival of induced 
pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma 
formation in a spinal cord injury model. Biomaterials, 2016. 83: p. 23-36. 
15. Lavik, E.B., et al., Fabrication of degradable polymer scaffolds to direct the 
integration and differentiation of retinal progenitors. Biomaterials, 2005. 26(16): p. 
3187-3196. 
 176 
 
 
16. Tate, C.C., et al., Laminin and fibronectin scaffolds enhance neural stem cell 
transplantation into the injured brain. Journal of Tissue Engineering and 
Regenerative Medicine, 2009. 3(3): p. 208-217. 
17. Tfilin, M., et al., Mesenchymal stem cells increase hippocampal neurogenesis and 
counteract depressive-like behavior. Mol Psychiatry, 2010. 15(12): p. 1164-75. 
18. Ben-Shaanan, T.L., T. Ben-Hur, and J. Yanai, Transplantation of neural progenitors 
enhances production of endogenous cells in the impaired brain. Mol Psychiatry, 
2008. 13(2): p. 222-31. 
19. Munoz, J.R., et al., Human stem/progenitor cells from bone marrow promote 
neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl 
Acad Sci U S A, 2005. 102(50): p. 18171-6. 
20. Ellenbroek, B. and J. Youn, Rodent models in neuroscience research: is it a rat race? 
Disease Models &amp;amp; Mechanisms, 2016. 9(10): p. 1079. 
21. Dawson, T.M., T.E. Golde, and C. Lagier-Tourenne, Animal models of 
neurodegenerative diseases. Nature Neuroscience, 2018. 21(10): p. 1370-1379. 
22. Kishimoto, N., K. Shimizu, and K. Sawamoto, Neuronal regeneration in a zebrafish 
model of adult brain injury. Disease Models &amp;amp; Mechanisms, 2012. 5(2): p. 
200. 
23. Kalueff, A.V., A.M. Stewart, and R. Gerlai, Zebrafish as an emerging model for 
studying complex brain disorders. Trends in pharmacological sciences, 2014. 35(2): 
p. 63-75. 
24. Howe, K., et al., The zebrafish reference genome sequence and its relationship to the 
human genome. Nature, 2013. 496: p. 498. 
25. Kimmel, C.B., et al., Stages of embryonic development of the zebrafish. Dev Dyn, 
1995. 203(3): p. 253-310. 
26. Sager, J.J., Q. Bai, and E.A. Burton, Transgenic zebrafish models of 
neurodegenerative diseases. Brain Structure and Function, 2010. 214(2): p. 285-302. 
 177 
 
 
27. Trede, N.S., et al., The Use of Zebrafish to Understand Immunity. Immunity, 2004. 
20(4): p. 367-379. 
28. Haque, E. and A.C. Ward, Zebrafish as a Model to Evaluate Nanoparticle Toxicity. 
Nanomaterials (Basel, Switzerland), 2018. 8(7): p. 561. 
29. Farokhzad, O.C. and R. Langer, Nanomedicine: Developing smarter therapeutic and 
diagnostic modalities. Advanced Drug Delivery Reviews, 2006. 58(14): p. 1456-
1459. 
30. Masserini, M., Nanoparticles for brain drug delivery. ISRN biochemistry, 2013. 
2013: p. 238428-238428. 
31. Saraiva, C., et al., Nanoparticle-mediated brain drug delivery: Overcoming blood–
brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 
2016. 235: p. 34-47. 
32. Truong, L., et al., Surface functionalities of gold nanoparticles impact embryonic 
gene expression responses. Nanotoxicology, 2013. 7(2): p. 192-201. 
33. Krishnaraj, C., S.L. Harper, and S.I. Yun, In Vivo toxicological assessment of 
biologically synthesized silver nanoparticles in adult Zebrafish (Danio rerio). J 
Hazard Mater, 2016. 301: p. 480-91. 
34. Griffitt, R.J., et al., Exposure to Copper Nanoparticles Causes Gill Injury and Acute 
Lethality in Zebrafish (Danio rerio). Environmental Science & Technology, 2007. 
41(23): p. 8178-8186. 
35. Hsieh, F.-Y., H.-H. Lin, and S.-h. Hsu, 3D bioprinting of neural stem cell-laden 
thermoresponsive biodegradable polyurethane hydrogel and potential in central 
nervous system repair. Biomaterials, 2015. 71: p. 48-57. 
36. Witherel, C.E., et al., Host–Biomaterial Interactions in Zebrafish. ACS Biomaterials 
Science & Engineering, 2018. 4(4): p. 1233-1240. 
37. Sharifi, F., D. Kurteshi, and N. Hashemi, Designing highly structured 
polycaprolactone fibers using microfluidics. J Mech Behav Biomed Mater, 2016. 61: 
p. 530-540. 
 178 
 
 
38. Moers-Carpi, M.M. and S. Sherwood, Polycaprolactone for the correction of 
nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. 
Dermatologic surgery : official publication for American Society for Dermatologic 
Surgery [et al.], 2013. 39(3 Pt 1): p. 457-463. 
39. Woodruff, M.A. and D.W. Hutmacher, The return of a forgotten polymer - 
Polycaprolactone in the 21st century. Progress in Polymer Science (Oxford), 2010. 
35(10): p. 1217-1256. 
40. Pitt, C.G., et al., Aliphatic polyesters. I. The degradation of poly(ϵ-caprolactone) in 
vivo. Journal of Applied Polymer Science, 1981. 26(11): p. 3779-3787. 
41. Saad, B. and U.W. Suter, Biodegradable Polymeric Materials, in Encyclopedia of 
Materials: Science and Technology, K.H.J. Buschow, et al., Editors. 2001, Elsevier: 
Oxford. p. 551-555. 
42. Sharifi, F., et al., Polycaprolactone Microfibrous Scaffolds to Navigate Neural Stem 
Cells. Biomacromolecules, 2016. 17(10): p. 3287-3297. 
43. Echave, M.C., et al., Gelatin as Biomaterial for Tissue Engineering. Curr Pharm Des, 
2017. 23(24): p. 3567-3584. 
44. Uz, M., et al., Gelatin-based 3D conduits for transdifferentiation of mesenchymal 
stem cells into Schwann cell-like phenotypes. Acta Biomaterialia, 2017. 53: p. 293-
306. 
45. Sakaguchi, D.S. and E. Henderson, Isolation and Characterization of Glial Cell Lines 
from Xenopus Neuroepithelium and Retinal Pigment Epithelium. Neuroprotocols, 
1993. 3(3): p. 249-259. 
46. Karlsson, J., J. von Hofsten, and P.E. Olsson, Generating transparent zebrafish: a 
refined method to improve detection of gene expression during embryonic 
development. Mar Biotechnol (NY), 2001. 3(6): p. 522-7. 
47. Becker, C.G. and T. Becker, Adult zebrafish as a model for successful central nervous 
system regeneration. Restor Neurol Neurosci, 2008. 26(2-3): p. 71-80. 
48. Bernardos, R.L. and P.A. Raymond, GFAP transgenic zebrafish. Gene Expr Patterns, 
2006. 6(8): p. 1007-13. 
 179 
 
 
49. Uz, M., et al., Gelatin-based 3D conduits for transdifferentiation of mesenchymal 
stem cells into Schwann cell-like phenotypes. Acta Biomater, 2017. 53: p. 293-306. 
50. Baumgart, E.V., et al., Stab wound injury of the zebrafish telencephalon: A model for 
comparative analysis of reactive gliosis. Glia, 2012. 60(3): p. 343-357. 
51. Chimenti, I., et al., Human cardiosphere-seeded gelatin and collagen scaffolds as 
cardiogenic engineered bioconstructs. Biomaterials, 2011. 32(35): p. 9271-9281. 
52. Choi, M.-Y., et al., Engineered extracellular microenvironment with a tunable 
mechanical property for controlling cell behavior and cardiomyogenic fate of cardiac 
stem cells. Acta Biomaterialia, 2017. 50: p. 234-248. 
53. Ponticiello, M.S., et al., Gelatin-based resorbable sponge as a carrier matrix for 
human mesenchymal stem cells in cartilage regeneration therapy. Journal of 
Biomedical Materials Research, 2000. 52(2): p. 246-255. 
54. Ghaderi Gandomani, M., et al., The enhancement of differentiating adipose derived 
mesenchymal stem cells toward hepatocyte like cells using gelatin cryogel scaffold. 
Biochem Biophys Res Commun, 2017. 491(4): p. 1000-1006. 
55. Cepeda, I.L., et al., Characterization and Survival of Long-Term Implants of Human 
Retinal Pigment Epithelial Cells Attached to Gelatin Microcarriers in a Model of 
Parkinson Disease. Journal of Neuropathology & Experimental Neurology, 2007. 
66(7): p. 585-596. 
56. Faghihi, F., et al., Differentiation Potential of Human Bone Marrow Mesenchymal 
Stem Cells into Motorneuron-like Cells on Electrospun Gelatin Membrane. Journal of 
Molecular Neuroscience, 2015. 55(4): p. 845-853. 
57. Koshy, S.T., et al., Injectable, porous, and cell-responsive gelatin cryogels. 
Biomaterials, 2014. 35(8): p. 2477-2487. 
58. Ekmark-Lewen, S., et al., Vimentin and GFAP responses in astrocytes after contusion 
trauma to the murine brain. Restor Neurol Neurosci, 2010. 28(3): p. 311-21. 
59. Du, B.L., et al., Graft of the gelatin sponge scaffold containing genetically-modified 
neural stem cells promotes cell differentiation, axon regeneration, and functional 
 180 
 
 
recovery in rat with spinal cord transection. J Biomed Mater Res A, 2015. 103(4): p. 
1533-45. 
60. Xu, X., J. Hu, and H. Lu, Histological observation of a gelatin sponge transplant 
loaded with bone marrow-derived mesenchymal stem cells combined with platelet-
rich plasma in repairing an annulus defect. PLOS ONE, 2017. 12(2): p. e0171500. 
 
 181 
 
 
Figures and figure legends 
 
Figure 1: Cryosectioned Tg(gfap:GFP)mi2001 zebrafish brain sections. Row A depicts a control 
zebrafish without an implant, while Row B contains images of a fish with a PCL implant in its 
brain. PCL implant is located in the ventricle of zebrafish. Row C and D are higher 
magnifications of control and implanted zebrafish, respectively. (A1-D1): Acetylated Tubulin 
labeling (red) of neurons in the zebrafish brain. (A2-D2): Tg(gfap:GFP)mi2001 fluorescence 
(green) of the endogenous zebrafish glial cells. (A3-D4): DIC image of zebrafish showing PCL 
implants. (A4-D4): Acetylated Tubulin labeling, Tg(gfap:GFP)mi2001 fluorescence merged with 
DAPI (blue) staining of cell nuclei and DIC. Scale bar = 50 μm. 
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Figure 2: Retinotectal labeling with DiI of zebrafish with biomaterial implant (arrow) in optic 
tectum of the brain implanted at 4 dpf and fixed at 7 dpf. (A) DiI tract tracer dye (red) labeling 
axonal projections of retinal ganglion cells into optic tectum. (B) DIC light image of zebrafish 
head. (C) Merged DiI and DIC image. Scale bar = 100 µm. (D, dorsal; V, ventral; A, anterior; 
P, posterior). 
 
 
 
 
 
Figure 3: Gelatin scaffold with CM-DiI labeled Xenopus neuroepithelial cells. (A1, B1): CM-
DiI (red) staining of XR1 cells. (A2, B2): DAPI (blue) staining of the cell nucleus within gelatin 
scaffold. (A3, B3): Merged image showing both DiI and DAPI staining. (A4, B4):Merged image 
showing DiI and DAPI staining along with DIC. Top row was imaged using a 20x objective 
and bottom row imaged using 40x objective. Scale bars = 50 μm.  
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Figure 4: Four Tg(gfap:GFP)mi2001 zebrafish with one gelatin scaffold implant in the posterior 
region of the brain. (A1 – D1): DIC image of zebrafish. (A2 – D2): Tg(gfap:GFP)mi2001 
fluorescence (green) of the zebrafish. (A3 – D3): DIC image of the zebrafish merged with 
Tg(gfap:GFP)mi2001 fluorescence (green). Rows A, B, C and D show four different fish with 
gelatin implants (white box) in the posterior regions of the brain 1 day post implantation (dpi). 
Scale bar = 100 μm.  
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Figure 5: Cryosectioned Tg(gfap:GFP)mi2001 zebrafish posterior brain sections, showing 
posterior diencephalic region. Row A depicts a control zebrafish without an implant, while 
Row B contains images of a fish with a gelatin implant in its brain, however no visual scaffold. 
(A1, B1): Acetylated Tubulin labeling (red) of neurons in the zebrafish brain. (A2, B2): 
Tg(gfap:GFP)mi2001 fluorescence (green) of the zebrafish glial cells. (A3, B3): DIC image of 
sectioned tissue. (A4, B4): Acetylated Tubulin labeling, Tg(gfap:GFP)mi2001 fluorescence, and 
DAPI (blue) staining of cell nuclei merged with DIC. Clear disorganization and 
Tg(gfap:GFP)mi2001 fluorescence between control and implanted zebrafish. Scale bar = 50 μm. 
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Figure 6: Live Tg(gfap:GFP)mi2001 zebrafish from 1 day post implant through 5 days post 
implant with cell-seeded gelatin scaffold in the diencephalon/mesencephalon of the brain. (A1-
E1): DiI staining (red) of XR1 cells within the gelatin implant. (A2-E2): Merged image of the 
DiI staining (red) of XR1 cells within the gelatin implant and the Tg(gfap:GFP)mi2001 
fluorescence (green) of the zebrafish. (A3-E3): Merged image of the DiI staining (red) of XR1 
cells within the gelatin implant, the Tg(gfap:GFP)mi2001 fluorescence (green) of the zebrafish, 
and the DIC image of the zebrafish. Rows A through E show the location of DiI-labeled cells 
within the gelatin implant from 1 through 5 days post-implantation, respectively. Scale bar = 
100 μm.  
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Figure 7: A single transgenic Tg(gfap:GFP)mi2001 zebrafish with a gelatin scaffold implanted 
in the metencephalon (composed of the cerebellum and pons) and the hindbrain. Top row of 
images are coronal sections from a zebrafish with a gelatin scaffold implant, as shown on the 
far top right. Bottom row of images are parallel coronal sections of a control zebrafish, one 
that did not receive any implant. There is clear disorganization and asymmetry of the 
architecture of the implanted brain as well as greater GFAP expression compared to control 
zebrafish. Middle zebrafish illustration adopted from [1] 
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CHAPTER 7.    GENERAL CONCLUSIONS 
 
Summary 
The studies conducted in this dissertation demonstrate the use of three-dimensional 
(3D) scaffolds as a means to direct stem cell differentiation in vitro. This work is relevant in 
the field of regenerative medicine as it provides insight into developing novel methods for cell 
transplantation therapies for central nervous system (CNS) rescue and repair. Conventional 
strategies for delivering cells have proven effective to varying degrees, however the use of 
biomaterial-based scaffolds may increase the efficacy of such therapies, thus promoting 
functional repair. Additionally, we provide insight into how zebrafish may be used as a model 
system to study biomaterial-based cell delivery strategies. 
In chapter 2, we investigated the influence of poly (ε-caprolactone) microfibrous three-
dimensional (3D) scaffolds on adult hippocampal progenitor cell (AHPC) differentiation in 
vitro. Fibrous scaffolds can mimic the natural extracellular matrix (ECM), which includes 
three-dimensional macromolecules including fibronectin and collagen [2]. Therefore, we 
hypothesized that the 3D environment from the scaffold would influence AHPC proliferation 
and differentiation in vitro. To our knowledge, this was the first study demonstrating and 
characterizing AHPC survival, proliferation and differentiation on PCL microfibrous scaffolds 
of various diameters and topographies. Our goal was to use a microfluidic technique in which 
micron-range fibers can be fabricated in which cells are seeded on in vitro. Our results show 
that PCL microfibers selectively guide AHPC differentiation into glial cells, particularly 
astrocytes, therefore demonstrating the use of 3D scaffolds as a novel platform to guide cell 
behavior. Transplantation of AHPCs within a scaffolding construct may provide cues to 
enhance cell proliferation and differentiation in vivo.  
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In chapter 3, we further studied the influence a 3D scaffold by encapsulating AHPCs 
within an alginate hydrogel using a microfluidic technique. A conventional two-dimensional 
(2D) culture system does not accurately mimic the environment cells are in in vivo, thus making 
hydrogels an attractive platform to better mimic the microenvironment [3]. Various methods 
can be used to fabricate fibers, including microfluidics, electrospinnng, wet spinning, and melt-
drawing [4, 5], however in order to encapsulate cells within a hydrogel the technique must be 
biocompatible. The microfluidic spinning technique does not produce toxic gas during the 
fabrication process and the solvent used is water opposed to volatile solvents used in 
electrospinning [4]. Therefore, we proposed to use the microfluidic technique to encapsulate 
AHPCs within an alginate hydrogel to study the influence a 3D environment may have on stem 
cell differentiation. Once cells were encapsulated, we successfully recovered and cultured them 
in vitro for an additional 24 or 72 hours to assess changes in proliferation and differentiation. 
Our results demonstrated that the number of cells immunolabeled for proliferation and 
neuronal markers (Ki-67 and TuJ1, a class III β-tubulin marker) were higher at 24 hours 
compared to 72 hours, demonstrating that the 3D environment created by the hydrogel 
provided unique cues that facilitated proliferation and differentiation. This work provided 
further evidence that 3D scaffolds influence cell fate in vitro and may be useful for directing 
cell differentiation in vivo.  
From chapter 2, we sought to better understand if PCL microfibers could serve as 
potential cell delivery vehicles in an animal model. As our model, we chose zebrafish mainly 
due to its transparency at early stages, allowing for observation of the microfiber in the living 
animal [6]. However, AHPCs are mammalian cells cultured at 37°C whereas zebrafish are 
grown at 28.5°C [1]. This temperature difference is not optimal for AHPCs to survive and 
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therefore we sought an alternative cell type. Zebrafish cells would be an optimal cell source in 
this study because it would be an autologous cell transplant in conjunction with biomaterials. 
In chapter 3, we described a new method for dissociating neural tissue from embryonic 
zebrafish brains. Compared to previous methods [7-9], our group characterized dissociated 
cells in culture and found a majority of cells expressing neuronal markers Elavl-Acetylated 
Tubulin. Cells were cultured for up to 9 days in vitro (div) and cell death assays were conducted 
at 3,6 and 9 div. At 3 div, cells were immunolabeled using mature neuronal markers, anti-Elavl 
and Acetylated Tubulin, and we found that 48% of the cells were positive for Elavl indicating 
our method was sufficient in dissociating and culturing neurons from larval zebrafish brains. 
Further, we studied the migration of neurons and glial cells derived from the larval zebrafish 
brain using time-lapse microscopy, a system that could potentially be used to further 
investigate mechanisms in which zebrafish regenerate, unlike mammalians.  
Finally, as proof-of-concept experiments described in chapter 5, we proposed to study 
PCL microfibers along with a different type of scaffold made of gelatin in vivo. 
Tg(gfap:GFP)mi2001 zebrafish express green-fluorescent protein within glial cells and were 
selected for this study to understand what effect biomaterials may have on the zebrafish CNS. 
For these studies, Tg(gfap:GFP)mi2001 were implanted with PCL microfibers or cell-seeded 
gelatin scaffolds to better understand the practicality of using zebrafish as model system to 
study biomaterials as a means for cell delivery. Preliminary results indicate the zebrafish could 
potentially be a great model to study such novel therapies, as the animal can be tracked for 
multiple days and no sacrifice is required. However more studies are needed to quantify our 
results and further our understanding of the endogenous glial response of the fish over time 
with a biomaterial within its CNS.  
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Conclusions 
Collectively, the research chapters presented in this dissertation describe the usefulness 
of 3D scaffolds as a platform to study stem cell differentiation in vitro as well as implementing 
them as a cell delivery vehicle to a zebrafish nervous system. The use of biomaterials offers an 
exciting avenue in multiple fields of regenerative medicine, not just for neural regeneration. 
Stem cells offers possibilities beyond the scope of brain rescue and repair, and there is a 
tremendous amount of work to be done in the field. Our work has direct impact on the field of 
tissue engineering and regenerative medicine to not only guide cell differentiation but promote 
the survival and proliferation of transplanted cells in vivo.   
In the future, we hope to further studies using biomaterials in conjunction with cells to 
better understand novel ways to direct stem cell differentiation. Understanding if cells undergo 
reorganization of actin structures would lead to better understanding of gene expression 
changes as well as stem cell differentiation. Using techniques like reverse transcription 
polymerase chain reaction (RT-PCR) and proteomics would allow us to verify our results and 
better understand cell behavior on scaffolds.  
Additionally, it is our hope that we can optimize the use of zebrafish as a high-
throughput model to screen biomaterial-based therapeutic strategies. Combined with the 
hundreds of polymers available along with the cost of conducting rodent studies, the financial 
burden on researchers is high. Therefore, we proposed using zebrafish as a model to pre-screen 
biomaterials in order to better predict outcomes in a rodent model. Our proof-of-concept study 
can be used as a platform to further investigate biomaterials using zebrafish. Currently, 
zebrafish serve as a great model for toxicity studies, however few have utilized them as models 
to study cell-delivery methods. In order to achieve quantifiable data that can be used as pre-
screening information prior to rodent models, implantation methods have to be optimized. 
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Next, using a high-content screening system (HCS), the goal is to devise a method in which a 
single embryo can be seeded into a 96 well plate in the correct and proper orientation for 
imaging. This would allow for rapid screening of larval zebrafish health and survival, as well 
as transplanted cells, after implantation of cell-seeded scaffolds.  
 
Future outlook 
We have shown that we can direct stem cell differentiation using mechanical cues 
provided by biomaterials without the use of chemicals. Our work can be translated to studying 
biomaterial-based cell therapies in larger animal models. However, the ultimate goal for animal 
studies is to translate to human clinical trials. Experimental work, as conducted in this 
dissertation, regarding biomaterial-based cell transplantation therapies encourages a path 
towards developing clinically efficacious therapies. Repairing the damaged CNS is a daunting 
task, however the diversity of biomaterials available provide hope and promise that these 
experimental concepts could be translated to clinical use in the near future. Factors for deciding 
what biomaterial to use include if it is biomimetic capable of supporting cell survival, no 
significant immune response would be further exaggerated due to the biomaterial, the polymer 
is biodegradable and biocompatible.  
Parkinson’s disease is caused by the selective loss of dopaminergic neurons in which 
several investigators have transplanted dopamine-neuron rich fetal ventral mesencephalon 
grafts into the human brain and have demonstrated improved motor function [10-12]. 
However, a 2001 clinical trial conducted by Freed and colleagues resulted in graft-induced 
dyskinesias in several patients as a result of poor tissue dissection from donors [13]. Olanow 
and colleagues had similar results in patients receiving transplants in which significant motor 
improvements were seen at first, however within a year several patients experienced graft-
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induced dyskinesias [14]. Studies have also shown grafted dopamine neurons improve motor 
impairments, however display Lewy body pathology, demonstrating that disease progression 
continued [15-18]. Results of such clinical trials raises concerns on the use of fetal tissue, 
especially considering the poor survival and engraftment of dopaminergic neurons in the brain. 
Reports show less than 20% of cells surviving, thus requiring more fetal donors for 
transplantation therapies to be advantageous, increasing the ethical and moral concerns 
associated with the use of fetal tissue for therapies [19-21]. Further, it has been demonstrated 
that cell apoptosis in rodent models is triggered by a variety of factors including growth factor 
deprivation in the host [22], shearing of cells during delivery [23], and neuroimmune cell 
recruitment to the graft [24]. Each of these factors provides points at which graft survival could 
be improved, thus opening avenues for biomaterials to emerge as potential scaffolds to improve 
the adhesion, survival and growth of cells during and post-transplantation. 
Injectable hydrogel scaffolds can provide a 3D matrix in which cells can experience 
normal cell-matrix interactions [3, 25, 26]; studies have shown that the use of biomaterials in 
conjunction with cell therapies in rodent models of Parkinson’s disease improve survival and 
reinnervation once transplanted into the brain [27-31]. Hydrogels are not only used as cell 
delivery vehicles, but also as materials to help rebuild damaged tissue by filling in cavities [32, 
33] and may be used to modulate the glial cell response. Unlike the peripheral nervous system 
(PNS), when the CNS becomes damaged astrocytes undergo reactive gliosis and form a glial 
scar, inhibiting axonal regrowth [34]. Thus, hydrogels can be used as a way to decrease 
astrocyte expression and support regeneration. To develop such a hydrogel, it would be 
important to assess cytokines associated with reactive astrocytes and assess the inflammatory 
response further. Inflammation occurs in the brain to minimize tissue damage, which leads to 
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scar formation. However, biomaterials can be manipulated to release growth factors, biological 
cues, and provide physical support for endogenous cells, all which provide instructive cues to 
the host tissue for it to repair itself. Therefore, in vitro experiments are crucial in manipulating 
biomaterial parameters to better understand what type of hydrogel would favor regeneration. 
In doing so, hydrogels may be used to change the endogenous injury response to one that 
supports regeneration, rather than inhibit it. Further, by injecting a hydrogel within a cavity, it 
is replacing the inhibitory environment with a more permissive one that can be manipulated to 
attract endogenous cells, release neurotrophic factor and/or provide signaling cues to promote 
axonal regrowth. In this way, alginate is an optimal choice for hydrogels as it is naturally 
reoccurring and biocompatible, but also has shown to increase axonal regrowth [35, 36]. In 
this dissertation, we provide further evidence into how alginate hydrogels may direct AHPCs 
to differentiate into neurons, thus making them an option for treating neurodegenerative 
diseases. Hydrogels may modulate cellular behavior, thus making them an ideal candidate to 
investigate in larger animal models as a means for future human clinical trials.  
Ciliary neurotrophic factor (CNTF), a neurotrophic factor shown to reduce 
photoreceptor cell death [37], has commonly been used to treat retinal degeneration in 
experimental models [38-40]. Neurotech Pharmaceuticals is a clinical-stage company focused 
on developing therapies for chronic eye diseases. Recently, it was granted Fast Track 
designation for Renexusâ, a device with human-derived cells encapsulated within a semi-
permeable fiber membrane engineered to release CNTF. Intravitreal delivery of this device to 
human patients has slowed progression of retinal degeneration compared to patients receiving 
a sham procedure [41, 42]. Genetically engineered fibroblasts releasing CNTF have also been 
administered to patients with amyotrophic lateral sclerosis (ALS) [43, 44] and Huntington’s 
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disease [45], showing no toxicity and a sustained release of the neurotrophic factor. Although 
there is not a plethora of trials utilizing biomaterials, pioneering studies have encouraged 
investigators to continue to research such combinatorial approaches.  
Great progress has been made in tissue engineering, stem cells, biomaterial sciences 
and the development of a multifaceted approach. Although numerous challenges still exist, the 
promise of such therapies exists. Currently, there is a noteworthy trend of 3D scaffolds for 
neural tissue engineering, however the use of such materials is limited in clinical trials. In cases 
of spinal cord injuries and traumatic brain injuries, the severity and complexity of damage 
varies patient to patient. Before such biomaterials can be considered for use in the human brain, 
they must go through rigorous testing to understand cytotoxic effects. Also, the ability to create 
reproducible biomaterials, with exact chemistry, must be achieved to ensure large-scale 
production. Although such factors should be considered before the conducting clinical trials, 
it is important to continue and progress research in stem cells, biomaterials and fabrication 
technologies. The impact of biomaterials is well understood in experimental models and can 
change the field of regenerative medicine in the future. The combinatorial approach of stem 
cells with biomaterials for CNS rescue and repair shows extraordinary potential and promise 
to advance experimental applications to the clinic in order to impact human medicine.  
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